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Abstract 
Managers and care providers in the health sector are expected to deliver safe, efficient 
and effective services within a resource constrained, complex system.  Services are provided 
through execution of multiple processes.  Healthcare organizations tend to be structured in 
functional based silos with process improvement efforts often focused on individual 
processes within the discrete silos.  This silo based improvement approach fails to take into 
account upstream and downstream processes executed and managed in other silos.  A 
patient’s journey will typically include processes from multiple silos and therefore, 
improvement efforts need to focus on end-to-end processes if the goal is to deliver a positive 
patient experience.  In order to optimize processes in a complex adaptive system like 
healthcare and to effect meaningful change a combination of management disciplines is 
required.  This research explored the use of Business Process Management (BPM), Business 
Architecture (BA) and Business Process Management Ontology (BPMO) as a 
comprehensive, integrated approach to design, redesign, evaluate, improve and monitor the 
safety, efficiency and effectiveness of medication management processes in a multi-site 
healthcare organization. 
The contribution of the research was threefold.  First, identified benefits of applying 
BPM, BPMO and BA to increase organization capacity and improve the end-to-end process 
of medication management; second, demonstrated the application of an ontology and the 
business layer of enterprise architecture used in other sectors could be successfully utilized in 
the healthcare sector; and third, developed a process reference model for medication 
management processes in acute care and long term care facilities.  
 Keywords:  Business Process Management, Business Architecture, Business 
Ontology, Medication Management, Quality Improvement  
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1 Introduction 
1.1 Background 
Healthcare organizations face challenges delivering services which are safe, effective, 
efficient, reliable and compliant with legislation, regulations and standards.  Healthcare 
providers are expected to provide high quality, patient centered care while meeting growing 
demands, changing technologies and constrained resources.  A specific area of concern is the 
incidence of adverse drug events (ADEs) that are the result of medication errors in 
prescribing, dispensing, administering, documenting or inpatient monitoring.  The medication 
process spans multiple functional units and involves a number of different clinicians and 
allied healthcare workers.  The functional units include acute care inpatient wards (surgery, 
paediatrics, maternity, etc.), emergency rooms, ambulatory care units, operating rooms, long 
term care facilities, harm reduction units, and community services.  People involved in the 
process include prescribers (usually a physician), clinical pharmacists, dispensary 
pharmacists, pharmacy technicians, supply chain staff, and point of care staff including 
Registered Nurses, Licensed Practical Nurses and specially trained Care Aides.  Healthcare 
services and prescription medications are highly regulated and clinicians themselves are 
responsible for adhering to the regulations and standards set out by their licensing bodies.  
The number of people involved, the need to comply with relevant regulation, legislation, and 
standards, combined with the high degree of potential harm to patients and competing 
demands being placed on clinicians contribute to the complexity of the medication 
management processes.  In addition to patient safety, there is also a need to consider worker 
safety and the increasing costs of pharmaceuticals when designing processes.  The problems 
with medication management have been well documented (Baker, et al., 2004 & Keers, 
Williams, Cooke, Walsh & Ashcroft, 2014); however, no single standardized way of 
   
2 
 
addressing the problem has been identified. This research is an attempt to identify a 
systematic approach to deal with patient safety and quality issues within medication 
management that could be used in other healthcare service areas. 
Business Process Management (BPM) has been described as a key enabler for the 
analysis and improvement of health care processes (Antonacci, et al., 2016); however, it has 
not yet been widely adopted within healthcare organizations (Mertens, Gailly, & Poels, 
2015).  This research explored the use of BPM and the introduction of a Business Process 
Management Ontology (BPMO) and Business Architecture (BA) as a comprehensive 
management approach to improve the quality of medication management processes within a 
healthcare organization.  In this research it is proposed that high quality medication 
management processes would need to meet the following five objectives:  1) Safe (eliminate 
or at least reduce medication errors & adverse drug events), 2) Effective (produce desired 
results), 3) Efficient (minimum resources and time), 4) Compliant (meet standards, 
guidelines and legislation), and 5) Reliable (minimal variation in outcomes).  These five 
objectives were derived through discussion with working group members and review of host 
organization quality improvement efforts specific to pharmacy and medication management 
prior to this research. In addition to improving the quality of medication management 
processes within the organization, the perceived challenges and benefits of this management 
approach were also explored from the perspective of those involved in the improvement 
efforts and the organization’s leaders. 
1.2 Thesis Outline 
There are five chapters included in this thesis: 1) Introduction, 2) Literature Review, 3) 
Methodology, 4) Results and 5) Discussion and Conclusion.   
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Chapter 1, the current chapter, establishes and sets the foundation for this research.  This 
chapter includes background of the problem being studied, the research objectives and 
rationale for the research.  This chapter includes terminology and definitions used in the 
thesis along with the approach that was used in the research.  It also provides the context of 
the host organization and concludes with the contributions made to the body of knowledge on 
Adverse Drug Events and the use of BPM, BPMO and BA in the healthcare sector.   
Chapter 2 provides a Literature Review which covers six topic areas. These topics 
and the identified relationships represent all the components that formed the basis of the 
thesis.  Figure 1 provides a visual representation of these topics and their relationships.  The 
relationships shown within the figure were derived by looking at the overarching goal of high 
quality medication management and then determining how each of the research topics 
contributed directly or indirectly to achieving that goal.    
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Figure 1. Literature Review Topics & Relationships 
Chapter 3 describes the research methodology (mixed methodology) which included both 
quantitative and qualitative methods.  This chapter also describes the procedures and tools used 
in this research. 
Chapter 4 describes the results of the research.  A total of 7 business artefacts were 
developed during the research.  These are: 1) strategy map, 2) strategy canvas, 3) business 
competency model, 4) value chain, 5) strategic action plan, 6) prioritized list of improvement 
initiatives and 7) performance monitoring plan.  Semi-structured interviews with workshop 
participants and organizational leaders were recorded, transcribed and analyzed.  Analytical 
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Hierarchy Process (AHP) was used to prioritize the list of improvement initiatives.  A 
proposed process reference model for medication management was developed including 
processes categorized as core (main), support and management processes in acute care and 
long term care facilities. 
Finally, chapter 5 summarizes contribution and limitations of the research, in addition to 
potential future research topics arising from this work. 
1.3 Research Objectives 
There were three objectives of this research.  The first objective was to determine the 
impact of introducing BPM, BPMO and BA to improve medication management quality in a 
publicly-funded health care organization.  The second objective was to explore the perceived 
challenges and benefits of using BPM, BPMO, and BA in a healthcare organization.  The 
third and most enduring objective was to create a process reference model for medication 
management which could potentially be adopted by other healthcare organizations interested 
in applying BPM to improve medication management processes within their organization.   
The information required to meet the first objective included domain information 
specific to medication management service such as current ‘as is’ process and proposed 
improved or ’to be’ process along with how the quality of the service would be measured.  
The information required to meet the second objective included qualitative information from 
the process participants to determine what they perceived were the impact, if any, of using 
the comprehensive management approach.  This information was gathered from the 
workshop participants and organizational leaders through semi structured interview 
questions.  The information required to meet the third objective required the development of 
appropriate business artefacts that provided specific information and definition of business 
objects.  Examples of business artefacts were strategy map, strategy canvas, process models, 
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and business competency models.  Examples of the business objects were: business 
competencies, organizational areas and the process groups for medication management 
service within the host organization.  Business artefacts include business objects and these 
were used in this research to develop consensus and increase participants’ understanding of 
medication management end-to-end processes within the context of the host organization. 
The three objectives were explored from the perspective of the following five research 
questions. 
1) How can a Business Process Management Ontology used in other industries be 
effectively applied to healthcare services?  
2) What processes should be included in a process reference model for Medication 
Management applicable to hospitals and long term care facilities? 
3) What performance measurements in addition to medication errors are appropriate for 
monitoring and controlling Medication Management? 
4) How can BPM be effectively applied to a situation that involves multiple sites and 
multiple business units responsible for Medication Management functions? 
5) What are the benefits and challenges of using BPM, BA and BPMO to improve 
Medication Management? 
The relationship between the three research objectives and the five research questions is 
provided in Table 1. 
Table 1 Research Objectives & Questions 
Objective Research questions 
Objective 1 - determine the impact of introducing BPM, 
BPMO and BA to improve the quality of medication 
management in a publicly-funded health care organization. 
 Question 3 
 Question 4 
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Objective 2 - explore the perceived challenges and benefits 
of using BPM, BPMO, and BA in a healthcare organization 
 Question 1 
 Question 5 
Objective 3 - create a process reference model for 
medication management  Question 2 
 
The relationship between research objectives, research questions and data collected is provided in 
Table 2. 
 
 
Table 2 Relationship between Objectives and Data Collection 
Objective Data Collected and Analyzed to Answer Related Research Questions 
Objective 1  
 Question 3 Performance measures 
 Question 4 Business Artefacts based on systems approach and 
utilization of Business Architecture principles also example provided 
of how BPM was applied to a single business process within 
medication management. 
Objective 2  
 Question 1  As demonstrated by using a comprehensive approach that 
included the business ontology along with BPM and BA 
 Question 5 Thematic and summative content analysis of participant 
and leaders interviews 
Objective 3   Question 2  Processes included in Process Reference Model  
developed based on business artefacts 
 
1.4 Rationale for Research 
The need to improve delivery of health care services has been well documented in 
literature and often discussed in the public forum.  There is a belief that quality and patient 
safety within current services could be improved and costs could be contained (Canadian 
Foundation for Healthcare Improvement, 2011).   
Patient safety and specifically adverse events related to medication errors continue to 
be a major concern in the health care sector.  Medication errors are one of the most common 
reported adverse events, it has been estimated that 7.5% of patients admitted to Canadian 
hospitals in 2000 experienced an adverse event (Baker, et al., 2004).  A subsequent study of a 
single hospital in Ontario in 2003 detected 4.4 adverse drug events per 100 patient days 
(Forester, Halil, & Tierney, 2004).  A systematic review of adverse drug events among adult 
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inpatients showed a range of 3.6% to 60.7% reported in 28 published articles between 
January 2000 and June 2013 (Martins, Giordani, & Rozenfeld , 2014).  Adverse events cause 
harm to patients and tragically in some instances lead to permanent injury or death.  There is 
also additional cost to the healthcare system as adverse events result in extended length of 
stay or readmission to acute care facilities.  The medication management process involves 
many people including patients, nurses, physicians, pharmacists, pharmacy technicians, and 
pharmaceutical companies.  The quality of the information used in the medication 
management process and the effectiveness of the translation of this information are key to 
reducing adverse events. 
It has been demonstrated that several healthcare organizations have successfully 
transformed their organizations by focusing on quality improvement resulting in better 
service at lower cost (Canadian Foundation for Healthcare Improvement, 2011).  These 
organizations operated from a systems perspective, remained committed to quality 
improvement and used information as a critical platform for guiding improvement, 
measuring results and monitoring performance.  This study reported on outcomes but did not 
provide any specifics as to the management approach taken, nor the methods for identifying 
and prioritizing process improvement initiatives.  Taking a systems view of the organization 
requires an understanding of the end-to-end processes that deliver the value in the system.  
BPM focuses on end-to-end processes.  It is a management discipline that integrates the 
quality improvement principles of Deming and Shewart with the business process 
reengineering approach promoted by Hammer and Champy (Hammer, 2010). 
This research explored the impact of using BPM to develop a process model for 
medication management within a regional health authority serving a geographically dispersed 
population.  BPM has been described as including: management of business processes, 
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measurement of business processes and modeling of business processes (Bandara, Chand, 
Chircu, Hintringer, & Karagiannis, 2010).  This research included all three elements and 
resulted in identification of appropriate measures, a comprehensive process model and 
recommendations on management of the processes.   
It is important to understand why medication errors occur and how they can be 
avoided or detected before any harm is caused.  High quality medication management 
processes would be safe, effective, efficient, compliant and reliable.  Zero medication errors 
may not be a realistic expectation due to the complexity of healthcare; however, it is feasible 
to mitigate the likelihood or severity of medication errors.  Contributing to the complexity of 
the medication management processes are the numerous clinicians and technicians involved 
in the process and the multitude of standards, guidelines and legislative requirements 
applicable to prescription medications.  As described in Section 2.1 adverse drug events most 
often occur in the Prescribing step or the Medication Administration step in the end-to-end 
medication process.  The causes of these errors can be categorized as people issues (lapse of 
attention or negligence on the part of an individual) or system issues (systemic issues such as 
unnecessary complexity in process, poor communication and inadequate information 
systems).  
BPM has evolved from the three process traditions of 1) management tradition, 2) 
quality control tradition and 3) information technology tradition (Harmon, 2014).  BPM 
requires the process for medication management be explored within the context of the system 
it is operating in.  This requires an understanding and comprehension of ’systems thinking’ as 
it relates to an organization.   
The BPM lifecycle consists of six phases: 1) process identification, 2) process 
discovery, 3) process analysis, 4) process redesign, 5) process implementation and 6) process 
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monitoring and controlling (Dumas, La Rosa, Mendling, & Reijers, 2013).   The process 
identification and process discovery phases when combined with a clear understanding of the 
system will provide the necessary information to develop a process architecture (Dumas et 
al., 2013)   
There are a number of domains involved in the medication management process 
including the medical domain, information technology domain, information management 
domain and the business domain.  Each domain has its own unique vocabulary and indeed 
the clinicians and professionals within each of the domains often do not share the same 
language which can be problematic to successful execution of the process.  A shared 
vocabulary or common language would increase understanding and decrease confusion when 
documenting processes and objects within the medication management process.  The 
introduction and use of a BPMO would provide a common language and the means for 
illustrating the relationship between objects within the processes themselves or between other 
objects within the organization.  Enterprise Architecture (EA) provides a structure for the 
objects within the organization.  Examples of objects in a complete EA include: software 
application, network server, business area, process owner, strategic business objective, and 
critical success factor.  The objects included in this research can be found in the business 
layer of the Enterprise Architecture and therefore are referred to as Business Architecture 
(BA) throughout this dissertation.   
Healthcare and healthcare organizations are complex and disciplines such as BPM, 
BPMO and BA have the potential to reduce the level of complexity and create a shared 
understanding of medication management safety across the organization.   
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1.5 Terminology and Definitions 
This section includes definitions and terminology used throughout this document and 
is intended to provide clarification on how terms were applied in this specific research. 
Medication errors have been defined by the National Coordinating Council for 
Medication Error Reporting and Prevention (NCCMERP) as: 
“A medication error is any preventable event that may cause or lead to 
inappropriate medication use or patient harm while the medication is in the 
control of the health care professional, patient, or consumer.  Such events may 
be related to professional practice, health care products, procedure, and 
systems, including prescribing, order, communication, product labeling, 
packaging, and nomenclature, compounding, dispensing, distribution, 
administration, education, monitoring and use.” (National Coordinating 
Council for Medication Error Reporting and Prevention, 2017).  
Adverse events have been defined as “adverse events are unintended injuries or 
complications resulting in death, disability or prolonged hospital stay that arise from health 
care management” (Baker, et al., 2004, p. 1678).  Medication errors that lead to an adverse 
event are referred to as Adverse Drug Events (ADEs). 
Process has been defined as “a collection of interrelated tasks and activities that are 
initiated in response to an event which aims to achieve a specific result for the consumer of 
the process” (von Rosing, Scheer, & von Scheel, 2014, p. 1).  Customers can be external or 
internal to the organization and from the perspective of publicly funded health services 
external customers are synonymous with clients, patients & consumers.   
Over the last ten years the definition of BPM has evolved from being narrowly 
defined at the individual business process level to being defined as spanning organizational 
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and system boundaries.  The focus of most definitions of BPM, however, is on process 
improvement of end-to-end core business processes.  It has been defined narrowly by Khan 
as “BPM is a methodology for modeling, automating, managing and optimizing a business 
process through its lifecycle to increase profitability” (Khan, 2004).  The BPM Institute 
defines BPM as  “the definition, improvement and management of a firm’s end-to-end 
enterprise business processes in order to achieve three outcomes crucial to a performance-
based, customer –driven firm: 1) clarity on strategic direction, 2) alignment of the firm’s 
resources and 3) increased discipline in daily operations” (Business Process Management 
Institute, 2016).   
Swenson and von Rosing (2015) undertook a review of over 100 articles that included 
definitions of BPM.  They have proposed the following definition that suggests BPM is to 
take a ‘systems thinking approach’ to process management.  
“Business process management (BPM) is a discipline involving any 
combination of modeling, automation, execution, control, measurement, and 
optimization of business activity flows in applicable combination to support 
enterprise goals, spanning organizational and system boundaries, and 
involving employees, customers, and partners within and beyond the 
enterprise boundaries” (Swenson & von Rosing, 2015, p. 87). 
It would appear then that BPM could be used to improve a single end-to-end process 
or used at a system level to transform and improve an entire organization.  This would be 
determined by which of the myriad of BPM definitions that a practitioner subscribes to.  For 
the purposes of this research, the definition offered by Swenson and von Rosing above will 
be applied.  The medication management process includes many actors and influencers, some 
within the organization but many external to the organization including pharmaceutical 
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suppliers, professional standard setting organizations and legislative bodies.  The need to 
view the end-to-end process including drivers and influencers beyond the enterprise 
boundaries is also consistent with the more comprehensive definition of BPM. 
BA is defined as “A blueprint of the enterprise that provides a common 
understanding of the organization and is used to align strategic objectives and tactical 
demands.” (Business Architecture Guild, 2017, p. 1).  BA and BPM are two separate but 
closely related disciplines.  BA is a component of EA.  EA has been defined as “a set of 
concepts and practices based on holistic systems thinking, principles of shared language, and 
the long-standing disciplines of engineering and architecture” (Kappelman & Zachman, 
2013, p. 87). 
Ontology has been defined as a “formal, explicit, specification of a shared 
conceptualization” (Gruber, 1993, p. 199).  It has also been defined generally as “a 
representation of the entities in reality and the relations between those entities (Blobel, 
Goossen, & Brochhausen, 2014, p. 58).  A more comprehensive definition is “An ontology is 
an artefact, more precisely an intentional semantic structure that encodes the set of objects 
and terms that are presumed to exist in some area of interest (i.e. the universe of discourse or 
semantic domain), the relationships that hold among them and the implicit rules constraining 
the structure of this (piece of) reality” (Giaretta & Guarino, 1995, p. 314).   
1.6 Approach 
This research employed a mixed methods approach incorporating both quantitative 
design and qualitative design.  Quantitative design consisted of the use of Analytical 
Hierarchy Process (AHP) to rank improvement opportunities while performance data was 
collected based on a repeated measures design and analyzed using statistical process control 
charts.  Qualitative design included workshops and semi-structured interviews.   
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The scheduling of workshops and working group meetings was highly dependent on 
availability of participants.  Three half day workshops were held over an eight week period. 
The invitation to attend was sent to twenty- six individuals recommended by the Chair of NH 
Medication Management Safety and Quality Committee.  This group included representatives 
from management staff of all areas included in the end to end process for medication 
management in the organization. The first workshop was attended by twenty-two of the 
twenty-six individuals who had been invited.  The second workshop included fourteen of the 
original twenty-two attendees and the third workshop included thirteen of the original 
twenty-two attendees.  The workshops consisted of an introduction to BPM, strategy maps, 
business competency models and value chains along with discussion and consensus on what 
should be included on the medication management business artefacts.  At the conclusion of 
the workshops two smaller working groups were formed to work on the prioritization of 
improvement opportunities and the development of a performance measurement plan for 
medication management in the host organization.  These working groups met monthly for 
five months which was followed by another meeting to finalize the work.  The duration of 
each meeting was from one to three hours for a total of twelve hours for the prioritization 
working group and eleven hours for the measurement working group.  The final results from 
these working groups were then provided to workshop participants  
Two separate sets of semi-structured interviews were also conducted.  The first set of 
interviews was with individuals who had participated in the medication management 
workshops and working groups.  These individuals were selected by the Medication Safety & 
Quality Committee of the host organization based on their role within medication 
management processes.  Those identified provided a reasonable representation of the various 
clinicians and support staff knowledgeable in medication management issues.  It was 
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determined that they constituted a reasonable sample of individuals with responsibility for 
medication management. The criteria for inclusion was that individuals had to have 
participated in at least one of the workshops.  Exclusion criteria was any individual who had 
participated in the workshop that had a reporting relationship with the researcher in her 
supervisory role within the host organization. In total, twenty individuals were invited to 
participate in these interviews and eleven (55%) individuals were interviewed.  This group 
had a view on the entire process of development of business artefacts, identification of 
performance measures, identification of improvement initiatives and prioritization of those 
initiatives using AHP.  This put them in a unique position to comment on the benefits and 
challenges of the comprehensive management approach. 
The second set of interviews was with individuals in senior leadership roles within the 
host organization.  A senior leadership role was defined as a member of the Executive Team 
or a staff member reporting directly to a member of the Executive Team.  This group 
encompassed strategic management roles across all business areas and geographic locations 
of the host organization. The only direct report staff who were excluded were individuals in 
administrative assistant roles.  In total, seventy-three individuals were invited to participate 
and twenty-one (29%) agreed to be interviewed. This group had exposure to the business 
artefacts across all portfolios and represented those responsible for strategic planning across 
the organization. Thus, they provided a valuable perspective on the challenges and benefits 
from an organization wide perspective.  
The transcribed interviews were analyzed using thematic and summative content 
analysis.  The following six themes were identified: Capacity Building, Communication, 
Collaboration, Competing Priorities, Culture and Connection to Strategy.  The summative 
content analysis of the transcribed interviews was completed to shed light on differences and 
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similarities in language used by respondents as they described the benefits and challenges of 
using BPM, BPMO and BA related to medication management. 
1.7 Context of Host Organization 
In the province of British Columbia, Canada there are two population based health 
authorities and five geographic health authorities.  The Provincial Health Services Authority 
(PHSA) provides tertiary services province wide including cancer care, renal services, 
ambulance services, transplant services, pediatrics, and high risk pregnancy services among 
others.  The First Nations Health Authority (FNHA) has a mandate to support the health and 
wellness of First Nations people in BC.  Northern Health (NH) is one of the five geographic 
health authorities responsible for providing the full spectrum of publicly funded health care 
services from health promotion and protection through to acute care and end of life care.   
NH provides health services to a population of approximately three hundred thousand 
people spread across six hundred thousand square kilometers in northern British Columbia, 
Canada with service provided in mainly rural and remote communities.  Acute care and 
diagnostic services are provided in eighteen hospitals and nine diagnostic and treatment 
centres.  Long term complex care residential services are provided in thirteen standalone 
facilities and ten of the eighteen hospitals have beds allocated to long term complex care. 
Medication management processes in acute and complex care facilities are of concern 
to the organization as evidenced in internal documentation that includes medication 
management as one of its eight strategic action plans in its 2016/17 to 2018/19 Operational 
Plan.  Medication error events were the second highest reported event in the Patient Safety 
Learning System (PSLS) of the host organization in the fiscal year ended March 31, 2017.  
This was second only to reported safety events related to in-facility falls.  The PSLS is a 
voluntary reporting system where clinicians and health workers can report events related to 
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patient safety.  Between April 1, 2016 and March 31, 2017 there were a total of twelve 
thousand, three hundred and sixty five safety events reported and three thousand, two 
hundred and fifty (26.28%) of these were medication safety events.  The events reported 
included situations where no harm came to the patient, and the more serious events where 
there was harm to a patient.  Since this is a voluntary reporting system it is reasonable to 
conclude that not all reports of medication errors are being reported. 
Publicly funded Canadian healthcare organizations, including Northern Health, report 
financial cost based on a standard Management Information System (MIS).  The Canadian 
Institute for Health Information (CIHI) maintains the standards for the general ledger chart of 
accounts which is the basis of the financial and statistical general ledgers used in publicly 
funded Canadian healthcare organizations. 
Priority setting and resource allocation within NH is a challenge with requests for 
resources, both financial and human, exceeding the resources available (Urquhart, Mitton, & 
Peacock, 2008).  Medication management processes and drug costs are a material portion of 
the annual operating expenses.  Unfortunately, physician and nursing costs specific to 
medication management processes are not available due to the lack of an activity based 
costing system or workload measurement system within NH.  Pharmacy and drug costs are 
available and the annual cost in 2016/2017 was in excess of eighteen million dollars.  In 
addition to the financial costs, recruitment and retention of clinicians, particularly 
pharmacists to a rural setting is an ongoing challenge for NH.  
The organization was in the early stages of introducing BPM and BA when the 
research commenced with the medication management initiative being the first to officially 
adopt this management approach.  During the research period an additional organizational 
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BPM initiative was undertaken to address concerns in home based services related to aging 
of the population and growing demand for home based services. 
1.8 Contribution  
Healthcare has been slow to fully adopt BPM despite the success demonstrated in other 
sectors.  This has been largely attributed to the dynamic, flexible, knowledge intensive 
processes within healthcare (Mertens et al., 2015).  This research combines BPMO and BA 
with BPM to demonstrate a holistic and comprehensive management approach to improve 
medication safety and quality within acute care and long term care facilities.  Although this 
research does not solve all the problems related to complexity of the healthcare system, it 
provides a repeatable approach to demystifying the connection between strategies aimed at 
patient safety and the underlying processes in need of redesign.  Further, this research 
included a thematic analysis of healthcare leader’s perceived benefits and challenges of using 
BPM, BPMO and BA, as well as, development of a process reference model for medication 
management.  The reference model could be used by other healthcare organizations 
interested in introducing BPM to improve quality of medication management services within 
their organization.   
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2 Literature Review 
The medication management process spans organizational boundaries, involves 
numerous healthcare professionals, results in high costs, and is governed by a multitude of 
standards, guidelines and legislative requirements.  Achieving sustainable improvements in 
such a complex process requires an understanding of the process itself and the context in 
which the process is executed.  The literature review explored what is currently known about 
medication errors and how management disciplines such as BPM, BPMO and BA could be 
employed to create a high quality medication management process.  The literature review 
includes six areas: 1) medication errors and adverse drug events, 2) standards, guidelines and 
legislative requirements, 3) BPM, 4) viewing the healthcare organization as a system, 5) 
BPMO, and 6) reference models.   
2.1 Medication Errors and Adverse Drug Events 
Quality concerns related to medication errors and adverse events occurring in 
hospitals and long term care facilities continue to be a subject of interest.  Medication errors 
can happen anywhere in the medication management process and as a result of rigorous 
checks and balances these errors are often caught before they impact the patient.  Adverse 
drug events occur when the administration of medication results in an unexpected or 
unwanted reaction in a patient.  An adverse drug event could be the result of an undetected 
medication error or a drug reaction that could not have been known in advance (such as an 
allergy not known to the patient or an unusual side effect of a medication). 
Reported statistics from a United States study showed 39% of medication errors were 
the result of inaccurate ordering by physicians, and almost half of those errors were 
intercepted by nurses or pharmacists before the medication was administered to the patient.  
Meanwhile 38% of errors occurred during medication administration, generally by nurses, 
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and only 2% of those were intercepted (Leape, et al., 1995).  It is important to understand 
where in the process errors occur and also the possible root causes of the errors.  This 
knowledge is essential in order to select appropriate and sustainable improvement efforts that 
will have positive impact on lowering the number of adverse drug events as well as 
mitigating the degree of harm to the patient. The remaining 23% of medication errors 
occurred in one of the following steps in the medication management process:  dispensing, 
documenting or monitoring.  It was also reported that nurses intercepted 86% of medication 
errors and pharmacists intercepted 12% (Leape, et al., 1995). 
A Canadian study of adverse events showed that, in the fiscal year 2000, for every 
100 patients admitted to an acute care hospital, 7.5 patients experienced at least one adverse 
event.  Drug or fluid-related services accounted for the second highest incidence of adverse 
events at 23.61% just below surgical service at 34% (Baker, et al., 2004).  The 7.5% of 
patients who experience one or more adverse events reported in this study are similar to a UK 
study (Vincent, Neale, & Woloshynowych, 2001), lower than studies in New Zealand 12.9% 
and Australia 16.6% (Wilson, et al., 1995) and higher than two large US studies 3.7% 
(Brennan, et al., 1991) and 2.9% (Thomas, et al., 2000).  These studies did not all use the 
same selection criteria and the US study had focused on finding negligence while the other 
studies focused on quality improvement and preventability of adverse events.  The authors of 
the Canadian study concluded that 58% of all adverse events found were attributed to either 
medication safety or surgical services; therefore, efforts to improve these two services would 
have considerable positive impact on reducing adverse events in Canadian hospitals (Baker, 
et al., 2004).  
There are numerous articles that report on the causes of medication errors in acute 
and long term care facilities with a focus on the medication administration step in the process  
   
21 
 
(Chircu et al., 2013; Elliott & Liu, 2010; Keers et al. 2014; Poon, et al., 2010; Keers et al. 
2013).   A systematic review of fifty-four articles relating to causes of medication 
administration errors in hospitals was conducted and the authors categorized the causes into 
the following three levels based on Reason’s model of accident causation:  1) High Level 
Strategy, 2) Error/Violation Provoking Conditions and 3) Unsafe Acts and Omissions (Keers, 
et al., 2014; Reason, 2000).  Included in the High Level Strategy category were management 
decisions, organization policies, economic & regulatory context, safety agenda, and clinical 
negligence schemes.  The Error/Violation Provoking Conditions category included:  training 
and experience, patient factors, errors in medicines supply, physical/mental health, 
inadequate procedures, poor communication, poor supervision, heavy workload, staffing/skill 
mix, unsuitable environment, and local working culture.  The Unsafe Acts and Omissions 
category included:  memory lapses, action slips/failures, knowledge and rule based mistakes 
and violations (Keers et al., 2014).   
There were several themes that arose in the review of the literature related to 
medication errors, and adverse drug events.  These themes are also evident in the information 
provided by the various accrediting bodies and organizations focused on patient safety and 
quality of healthcare.  The collection of “best possible medication history” and the 
importance of medication reconciliation upon admission and at time of transfer or discharge 
is a repeating theme.  The “five rights” of medication administration is taught to all nursing 
students and is expected to be a standard of practice (Right patient, Right drug, Right time, 
Right dose and Right route).  Over time the traditional five rights of medication 
administration have been expanded to nine rights including Right documentation, Right 
action, Right form and Right response (Elliott & Liu, 2010).  Northern Health’s internal 
policy document on Medication Administration includes a tenth right which is the Right of 
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the client to refuse medication when deemed capable to do so.  An interesting point is the 
CRNBC practice standard on medication administration includes seven rights.  It does not 
refer to Right action, Right form or Right of client to refuse medication (College of 
Registered Nurses of British Columbia, 2016).  Most often the nurse is the last line of 
defence in preventing medication errors and it therefore stands to reason that supporting 
nurses by providing appropriate information and adequate time to execute evidence informed 
processes in medication administration could reduce medication errors (Chircu et al., 2013).  
Communication of information among healthcare providers and between patients and 
healthcare providers has also been identified in the literature as an area that requires further 
study.  Liu, Manias & Gerdtz (2011) explored and contrasted six conceptual models to 
determine how to improve medication safety practices.  The six models include two causal 
models and four exploratory models.  The two causal models are Human Error Model and 
System Analysis Model.  The four exploratory models are Shared Decision-Making Model, 
Medication Decision-Making and Management Model, Partnership Model and Medication 
Communication Model.  They concluded that the Medication Communication Model was the 
most insightful (Liu, Manias, & Gerdtz, 2011).  The model identified antecedents and defined 
attributes of actual communication encounters and consequences when tested in an 
Australian hospital (Manias, 2010).  The application of standard procedures and conceptual 
models in healthcare settings are challenging due to diversity of the setting and various 
players within the setting (Liu, Manias, & Gerdtz, 2011).   
The Human Error Model was used in a systematic review of medication 
administration errors to categorize the causes of errors.  The authors concluded that 
interventions to reduce medication errors should focus on system factors versus person 
factors (Almaney, 1974; Keers, Williams, Cooke, & Ashcroft, 2013) .  A medication 
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communication framework was developed using the Circle of Care Modeling approach.  This 
work led the authors to identify that there is a Coordinating step in addition to the other five 
steps of Determine Need, Prescribe, Dispense, Administer and Monitor that they had initially 
anticipated (Kitson, Price, Lau, & Showler, 2013)  
Addressing medication errors could be approached from either a person or a systems 
perspective.  The Person Approach to addressing medication errors would focus on the 
person identified as responsible for creating the error such as the physician, pharmacist, nurse 
or technician.  This traditional approach assumes there was some lapse of attention or 
negligence on the part of an individual resulting in the occurrence of the error.  The 
underlying assumption in this model is that the ‘safe’ process was not followed.  Conversely, 
the System Approach to medication errors assumes there are systemic factors which cause 
errors and the focus of addressing errors should not be directed at individuals but at the 
system in which individuals work (Reason, 2000).  The National Coordinating Council for 
Medication Error Reporting and Prevention balances both these perspectives in its 
publication ‘Reducing Medication Errors Associated with At-risk Behaviours by Healthcare 
Professionals’.  This document suggests that healthcare providers are willing to take risks 
which could result in patient harm because the risk to the patient seems remote and the at-risk 
behaviour may save time or be more convenient for the provider.  They attribute the at-risk 
behaviours to unnecessary complexity in processes and an organizational culture which 
tolerates and often rewards at-risk behaviours (National Coordinating Council for Medication 
Error Reporting and Prevention, 2017). 
A soft systems approach would appear appropriate in addressing a process such as 
medication management where there is a high reliance on individual clinicians following a 
dynamic process that spans organizational functional boundaries.  Siriam (2012) proposes 
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BPM which combines soft systems methodology (qualitative) with hard systems 
methodology (quantitative).  The author suggests that involving people early in the process 
will lead to a higher level of success and demonstrates how to engage people through a case 
study of an information technology service, using a combination of developing “rich 
pictures” and using Analytical Hierarchy Process (AHP) to identify the most critical 
processes for improvement efforts.  The rich pictures were developed during workshops with 
extensive consultation with individuals involved in the service area which was followed by 
applying a hard systems approach of using the AHP methodology to numerically quantify 
and rank the options (Siriam, 2012).  
A conceptual process map for the medication management process of a hospital 
inpatient stay or long term care resident stay may include the following steps:  1) 
Registration, 2) Patient Assessment 3) Prescribing including Medication Ordering, 4) 
Dispensing, 5) Administering including Documenting, 6) Monitoring and 7) Discharge.  This 
process reflects the steps as linear when in reality there could be many iterations within the 
process as medications are changed or orders are clarified.  These steps do not include the 
supporting processes or management processes such as inventory management, quality 
assurance, drug formulary management or the multitude of other activities that support a high 
quality medication management process.  A review of eight articles that have incorporated 
information related to a conceptual process map for medication management show a range 
with a minimum of five steps to a maximum of sixteen steps (Bell, Cretin, Marken, & 
Landman, 2004; Bell, et al., 2007; Bepko, Moore, & Coleman, 2009; Chircu, Gogan, Boss, & 
Baxter, 2013; Classen & Metzger, 2003; Uberoi & Sibal, 2008; Qian & Yu, 2013; Redley & 
Botti, 2013; Uberoi & Sibal, 2008; Verrue, et al., 2011).  The article documenting the sixteen 
steps was a case study focused on the information quality which would explain the 
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granularity and why the number of steps were higher than the other articles reviewed (Chircu  
et al., 2013).  The remaining articles contained either five, six or seven steps and 
interestingly, registration was not a step in any of the articles.  This is a crucial step in the 
process as all subsequent steps rely on the accuracy of the registration information, 
particularly the information related to any “known” allergies.  The four steps included in all 
eight of the examples were prescribe, order (transmit), dispense and administer.  Not all 
processes reviewed included a monitoring step or a documentation step however, both 
monitoring and documentation are assumed to be included as part of the Administer step.  
Documentation occurs immediately following the administration of medication and 
monitoring is an ongoing activity of nursing care.  
Information technology is purported to be one of the solutions to address medication 
safety issues (Bell et al., 2004; Bepko et al. 2009; Beuscart-Zephir et al., 2010; Chen & Tsai, 
2014; Classen & Metzger, 2003; Keers et al., 2014; Keohane, et al., 2008; Pham, et al., 2012; 
Poon, et al., 2010).  Electronic medication management systems, closed-loop bar coding for 
medication administration, automated medication dispensing cabinets, computerized 
practitioner order entry, as well as data collection and reporting systems that can provide real 
time information to support clinicians in decision making have been shown to reduce 
medication errors (Bepko et al., 2009; Keers et al., 2014). 
 Measurement of medication safety in real time is a key to reducing medication errors 
and “surveillance” is the appropriate term to use when considering the reasons for the 
measurement.  Physicians and pharmacist could benefit by having easy and timely access to 
clinical information, such as most recent lab results, when prescribing or reviewing 
medication therapy.  Real time clinical data could assist the physician in prescribing the most 
appropriate medication or dosage level.  Likewise, it could assist the pharmacist as they 
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double check appropriateness of the prescription (Classen & Metzger, 2003).   Automated 
medication dispensing cabinets and closed loop bar coding systems provide clinicians with 
valuable information and a secondary check at time of medication administration (Pham, et 
al., 2012; Poon, et al., 2010).  Automatic alerts can be programmed into medication infusion 
pumps which alert a nurse when the dosage being administered is outside normal range and 
this would trigger a second check by the nurse before the medication is administered to the 
patient.   
The prescribing phase of the medication management process has been identified as 
one of the more error prone phases.  Electronic prescribing shows great promise in reducing 
the errors at this phase of the process (Bell et al., 2004).  Legibility is an issue with manual 
prescribing as are transcribing errors and completeness of information.  Electronic 
prescribing eliminates the legibility issue as all prescriptions would be entered into the 
computer system by the prescriber.  Transcription errors could be reduced by the electronic 
transfer of data.  Electronic prescribing also provides clinicians with drug information, 
patient history, drug formulary information and medical records at time of prescribing.  
The implementation of information technology within healthcare can be extremely 
challenging and a Human Factors Engineering approach is recommended.  This approach is 
similar to BPM in that one of the first steps is to analyze the work system.  The authors found 
very few standardized processes in healthcare which made it difficult to introduce the 
technology in a way that lead to efficient and effective workflows (Beuscart-Zephir et al., 
2010).  A study in Ireland looked at a failed attempt to implement a human resources and 
payroll software application for nation-wide healthcare services.  The failure was attributed 
to the difficulty in implementing a single system in a non-standardized environment (Helfert, 
2009). 
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The introduction of technology may reduce certain types of errors but complexity of 
the software applications and end-user knowledge could result in the introduction of new 
types of errors in the process (Redley & Botti, 2013).  This does not mean that new 
technology should not be introduced but that it is necessary to fully understand the processes 
and relationships so users of the software applications are capable and prepared to use the 
new technology effectively.  BPM’s focus on the processes within an organization reveals 
opportunities to use information technology to automate steps within the process.  This 
allows clinicians to have access to real time information for clinical decision making thereby 
increasing the opportunity for the correct decision to be made and avoid errors.  BA provides 
the context in which the processes are being executed thereby increasing the understanding of 
processes included in specific business areas. It also identifies information systems, data 
stores and infrastructure which  supports the processes. 
Identifying and quantifying medical errors and adverse drug events has relied on 
voluntary reporting by clinicians, or on the use of chart reviews or ‘triggers’ for non-
voluntary reporting (Classen & Metzger, 2003).  In addition to these two methods six other 
approaches were identified in the literature.  These include: 1) review of claims data, 2) 
patient monitoring, 3) administrative data examination, 4) direct care observation, 5) 
computer monitoring and 6) incident reporting of sentinel events (Montesi & Lechi, 2009).   
Quality improvement efforts by National Health Services (NHS) in the United 
Kingdom (UK) have led to the design, development and implementation of a ‘Medication 
Safety Thermometer’ (Rostami, et al., 2017).  This approach to improve safety requires data 
on harm and potential harm related to medication be collected one day per month and the 
data is then used to inform and monitor efforts to improve medication safety.  This approach 
combines direct care observation, patient monitoring and chart review.  Claims data focuses 
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on review of litigation information and incident reporting sentinel events only addresses the 
most serious errors where obvious harm has occurred to the patient.  The examination of 
administrative data is limited due to its retroactive perspective and the absence of clinical 
data. 
Computer monitoring refers to the use of clinical information systems to harvest 
electronic data relevant to medication errors and adverse drug events which has the potential 
to provide real time data that could prevent medication errors.  Major limitations of computer 
monitoring are inserted errors, poor software, poor triggers and undetermined future risks 
(Montesi & Lechi, 2009).  In addition, there are very high costs to purchase, implement and 
maintain clinical information systems.   
The Patient Safety Learning System (PSLS) is a software program used in all British 
Columbia health authorities.  Care providers are expected to voluntarily report all adverse 
events or “near misses” within that software application.  Reported incidents are then 
followed up by management to determine the remedial action required to prevent these or 
similar incidents from happening again in the future.  Data from the PSLS is analysed by risk 
managers to determine where specific organizational improvement efforts are required to 
improve overall patient safety.  The expectation is for all events to be recorded; however, 
there has been some resistance by healthcare providers to report incidents in fear of blame or 
repercussions.  It is suspected within the host organization that the information recorded and 
available for “no harm” incidents is underreported.  There is slightly more confidence in the 
information reporting of incidents causing moderate to significant harm as these incidents 
typically require some escalated medical response as well as discussions with another 
clinician or supervisor.  A study found several issues with the underreporting of adverse drug 
events when voluntary reporting was used.  The results revealed only three incident reports 
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had been filed in the same period that case finding showed fifty-four adverse drug events had 
occurred (Cullen, et al., 1995).  A systematic review of literature related to the causes for 
underreporting of adverse drug events by health professionals indicated similar results.  The 
review included twenty-nine articles from seventeen different countries published between 
1992 and 2012.  Causes of underreporting were categorized in seven attitudes:  1) 
complacency, 2) fear of litigation, 3) guilt, 4) ambition or financial benefit, 5) ignorance on 
when or how to report, 6) insecurity and 7) indifference.  These have been labelled as the 
seven deadly sins of adverse drug events underreporting (Inman, 1976).  The authors of the 
article concluded there should be an eighth deadly sin added, the lack of training in 
pharmacovigilance for health professionals (Varallo, Guimaraes, Abjaude, & Mastroianni, 
2014).   
2.2 Standards, Guidelines and Legislative Requirements 
There are numerous standards, guidelines, industry practices and legislative 
requirements that need to be considered in the development of an end-to-end process map for 
medication management.  Healthcare professionals are registered with their respective 
colleges and are expected to meet the standards and ethical conduct set out by their governing 
bodies.  Physicians, pharmacists and nurses all require a licence to practice their profession; 
for example, Nurse Practitioners and Registered Nurses practicing in British Columbia are 
required to be members of the College of Registered Nurses of British Columbia (CRNBC) 
and both have Professional Standards and Practice Standards they must adhere to.  There are 
four Professional Standards and seventeen Practice Standards documented on the CRNBC 
website.  Three of the seventeen Practice Standards are specifically related to the medication 
management process.  These Practice Standards are Dispensing Medication, Medication 
Administration and Medication Inventory Management (College of Registered Nurses of 
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British Columbia, 2015).  The CRNBC website also references sixty-seven separate pieces of 
legislation including provincial and federal legislation that are relevant to Nurses’ practice 
(College of Registered Nurses of British Columbia, 2014).  The four specific pieces of 
legislation related to medication management are:  Controlled Drugs and Substances Act 
(Federal), Hospital Act, Pharmaceutical Services Act and Pharmacy Operations and Drug 
Scheduling Act.  Physicians, Pharmacist, Licenced Practical Nurses and Certified Pharmacy 
Technicians also have standards and legislation guiding their work and influencing how they 
must perform their duties.  These standards and legislative requirements need to be 
considered in development of a comprehensive process model for medication management.  
In addition to the individual professional responsibilities to meet standards and legislation, 
the health care organization is also subject to legislation and standards.  The organization 
must also operate within the confines of the government mandated practices.  Most health 
care organizations in Canada also voluntarily participate in Accreditation Programs, the 
conditions of which must also be considered when developing a comprehensive process 
model for medication management. 
Accreditation Canada classifies required organization practices (ROPs) in six major 
categories:  Safety Culture, Communication, Medication Use, Work life /Workforce, 
Infection Control, and Risk Assessment.  The purpose of the required organizational 
practices is to help guide the provision of safe, high quality health care (Accreditation 
Canada, 2015).  NH is accredited and is committed to meeting these ROPs.  The activities 
within the comprehensive medication management process model will need to comply with 
the ROPs.  An example of one of the ROPs in Medication Use category is the requirement to 
obtain a best possible medication history (BPMH) and complete a medication reconciliation 
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upon admission to hospital or long term care facility, and before and after transfers between 
and within facilities. 
Compliance with standards, guidelines and legislative requirements must be built into 
the medication management processes.  This can be a challenging task as there is often 
conflicting goals between business and control objectives (Sadiq, Governatori, & Naimiri, 
2007).  The comprehensive management approach of using BPM, BPMO and BA in the 
process modeling and process improvement could help facilitate the development of process 
models that incorporate business rules and business objects related to compliance. 
2.3 Business Process Management 
Academics and practitioners have both contributed to the literature on BPM.  
Practitioners have contributed a multitude of articles and books providing case studies, 
frameworks and “how to” guides of BPM.  There has been far less publications in academic 
journals on the “why” of BPM (Smart, Maddern, & Maull, 2009; Trkman, 2010).  The result 
has been that most articles have been atheoretical (Melao & Pidd, 2000).  Despite the 
imbalance there has been progress in addressing the need to identify the theories 
underpinning BPM (Biazzo, 2002; Lacerda, Cassel, & Rodrigues, 2010; Niehaves, 
Poeppelbuss, Plattfaut, & Becker, 2014; Trkman, 2010; Trkman, 2013). The five theories 
proposed as relevant to BPM are socio-technical theory, theory of constraints, dynamic 
capability theory, contingency theory, and task-technology fit theory.  Socio-technical theory, 
theory of constraints, and dynamic capabilities theory are proposed as being able to 
singularly explain the ‘why’ of BPM.  Alternatively, a combination of contingency theory, 
dynamic capability theory and task-technology fit theory are used to explain the why of 
BPM. 
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1. The socio-technical theory referenced by (Biazzo, 2002) and (Xiang, Archer, & 
Detlor, 2014) highlighted that for BPM to be successful both technical aspects 
(the techniques, tools and methods used) and the socio aspects (attitudes and 
beliefs of people) need to be considered in implementation of a design or redesign 
process. 
2. The limitations of the performance of an organizational system were explored 
through the use of the thinking process which is derived from the theory of 
constraints and attempts to determine ‘why’ things happen versus ‘how’ they 
happen (Lacerda et al., 2010).  
3. The dynamic capabilities theory refers to an organization’s ability to change 
rapidly in response to changes in the external or internal environment.  This is 
crucial for an organization that wants to maintain a competitive advantage.  If 
implemented appropriately, BPM could be considered as a dynamic capability 
(Niehaves, Plattfaut, & Becker, 2010; Niehaveset al., 2014).   
4. Contingency theory, dynamic capability theory and task-technology fit theory 
when taken together provide a theoretical base for BPM (Trkman, 2010).  Trkman 
was able to draw logical and substantiated alignment between the critical success 
factors of BPM and each of the theories.  The author further explored this 
alignment in 2013 when looking at critical processes that must be in place within 
a BPM focused organization (Trkman, 2013).  
There is a lack of an agreed upon theoretical base for BPM.  Practitioners have taken 
the lead in publishing which has resulted in a proliferation of articles espousing best practice.  
There is an assumption that these best practices are transferrable.  This is not necessarily true 
because the design of the service process is driven by contextual factors (Ponsignon, Smart, 
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& Maull, 2012).  The existing literature is consistent in understanding of the evolution of 
BPM and referencing business re-engineering and workflow management approaches.  It has 
been expressed that BPM might be considered as simply the repackaging of old ideas that 
enabled consultants and management gurus to promote their approaches as novel (Trkman, 
2013).  
BPM has evolved from three business process traditions (Harmon, 2014).  These are:   
1) management tradition, 2) the quality control tradition, and 3) the information technology 
tradition as shown in Figure 2. 
Figure 2. Evolution of BPM 
The management tradition focuses on overall performance of an organization and 
examples of contributions to BPM include the findings of Porter’s Value Chain, Kaplan & 
Norton’s Balanced Scorecard, Process Frameworks, Business Process Engineering and 
Business Process Reengineering.  (Harmon, 2014; Margherita, 2014; von Rosing et al., 
2014). 
 
Business management/process redesign 
Quality control, Six Sigma, lean  
Information technology BPMS 
Work simplification/industrial engineering 
Business 
Process 
Management 
Focus:  Improvement of organizational performance 
through aligning or changing major business processes 
Adapted from:  Harmon, P. (2014) Business Process Change, Morgan Kaufman, Massachusetts Figure 1.5 pg 15 
Focus: Improvement of 
operational processes 
Focus: Process Automation 
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The quality control tradition has focused on the quality and production including 
contributions such as, Total Quality Management, Six Sigma, Lean, Lean Six Sigma and 
Capability Maturity Models.  Notable contributors in this field include Shewart, Deming, 
Juran, Ohno and Womack (Harmon, 2014; Margherita, 2014; von Rosing et al., 2014). 
The information technology tradition has enabled the automation of work processes 
and examples of contributions from this tradition include IT Architectures, Structured 
Software Methodologies, CASE tools, Business Process Modeling Tools, Expert Systems, 
and Business Process Management Notation (BPMN).  Notable names in this tradition 
comprise of Martin, Davenport, Hammer, Champy, Gartner, and Object Management Group 
(Harmon, 2014). 
Business Process Engineering (BPE) and Business Process Reengineering (BPR) are 
both business management strategies that focus on the design or redesign of processes for the 
purpose of creating maximum value for an organization.  This approach to process 
improvement has been attributed to Hammer and Champy (Harmon, 2014).  The quality 
improvement approach proposed and popularized by Shewhart and Deming focused on using 
statistical process control to reduce variation in individual processes and supported 
continuous quality improvement through monitoring of processes via ongoing measurement 
(Hammer, 2010).  The process engineering and reengineering approach focuses on end-to-
end processes which is an improvement over the approach to quality process improvement 
proposed by Shewhart and Deming.  The primary criticism of the Shewhart and Deming 
approach was that it defined process very narrowly as any activity which included an input, 
activity steps and an output.  The result of this general definition is that an organization could 
have thousands of processes.  Quality improvement activities that look at individual 
processes outside the context of the end-to-end process could yield improvements in one 
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process but create inefficiency in either upstream or downstream processes.  BPE and BPR 
were an improvement to these approaches as they examined the entire process from the 
perspective of producing value for the customer.  However, BPE and BPR are perceived as 
episodic or radical approaches with a less disciplined approach to performance measurement 
and continuous process improvement (Hammer, 2010; Niehaves et al., 2010; Looy, Backer, 
& Poels, 2014).  BPM combines the strengths of both approaches to quality improvement and 
also incorporates the use of information technology.  BPM is more consistent with a systems 
perspective because it takes into account the interrelationships between the processes being 
designed or redesigned and other processes, rules and requirements within the system.  The 
business process management software applications (BPMS) available in the market have led 
to confusion in the interpretation of what BPM actually is.  It is not a software program but 
rather a management discipline that can be facilitated through the use of technology and 
software applications (Palmer, et al., 2014). 
Standardization of processes and process automation are a desired outcome of most 
BPM projects (Harmon, 2014).  Standardization and automation of processes can result in 
technical efficiency and has shown to have a positive impact on process time, cost and 
quality (Munstermann, Eckhardt, & Weitzel, 2010).  Lack of standardization and manual 
processes tend to be more expensive and result in unintended variances in both cost and 
quality of services (Langley, et al., 2009).  Process automation using technology is a common 
means of creating an efficient and effective process.  It has been shown that hospitals with a 
high degree of process orientation are more efficient than the ones without such process 
orientation (Vera & Kuntz, 2007).   
Measuring quality improvement requires measures be collected on the performance or 
output of the service as well as measures such as time and cost (Davenport & Beers, 1995).  
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These measures of both output and process enables an organization to overcome the over 
reliance on financial measures only to measure their performance.  The development of 
process based management information and the ability to incorporate this with financial 
management information increases management knowledge of the functioning of the entire 
organization and assists in the identification of opportunities for improvement.  It also 
facilitates an organization to develop a balanced scorecard.   
The balanced scorecard approach to performance management requires performance 
measures be balanced among four perspectives:  1) financial, 2) customer/market, 3) process 
capability, and 4) learning/growth (Kaplan & Norton, 1992).  The performance measures of 
the medication management process should include measures from all four of these 
perspectives.  Financial measures report on the financial results and include such 
performance measures as return on investment or operating margin.  Customer/market 
measures include market share and customer satisfaction.  Process capability measures 
include cost, time to market and quality.  Learning/growth measures include employee 
engagement and availability of systems ( (Kaplan & Norton, 1992).  These four perspectives 
or quadrants developed for business use can be appropriately adapted to a publicly funded 
health care organization.  The financial quadrant focuses on the stewardship of public 
funding with the measures being expense variance to budget and annual capital cost 
allowance of equipment compared to annual investment in new equipment.  Customer/market 
measures can be adapted to represent Service Excellence measured by patient and family 
satisfaction with services and compliance with legislation or government mandates.  Process 
capability refers to internal processes and appropriate healthcare system measures can 
include clinical outcomes such as hospital readmission rates and hospital mortality rates.  
Learning and growth is the perspective on staff and physicians’ ability to maintain 
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professional learning and appropriate measures can include employee engagement and access 
to training and education. 
Development of safety indicators for medication use was undertaken by a group of 
twenty national experts in Canada (Nigam, et al., 2008).   Table 3 shows a listing of these 
indicators.  The indicators all relate to error rate except 16, 17 and 18 which refer to cycle 
time or wait time.  
Table 3. Safety Indicators for Medication Use 
1. Frequency of potentially dangerous medication abbreviations 
2. Frequency of potentially dangerous dose abbreviations 
3. Frequency of ambiguous prescription dosing instructions 
4. Frequency of incorrect prescription dose designations 
5. Dosing for pediatric medications that have a narrow therapeutic index 
6. Documentation of allergy status 
7. Administering protocols for high-alert prescription medications 
8. Verification of high-alert prescriptions 
9. Machine-readable coding systems for administration 
10. Rate of Adverse drug event (ADE)- related hospitalizations 
11. Rate of ADE-related ER visits 
12. Monitoring and reducing ADEs by assigning pharmacists on rounds 
13. Differentiation of high-alert prescription medications 
14. Medication histories for inpatients with complex high-risk regimens 
15. Medication reconciliation rate 
16. Medication reconciliation rate upon admission 
17. Medication reconciliation rate prior to discharge 
18. Timeliness of discharge medication summary sent to community physicians 
19. Discharge medication summaries sent to community physicians (rate)* 
20. Safety of compounding sterile medications 
*Note item 19 is an interpretation for the safety indicator as the published article showed the same description 
for both 18 and 19 (Source Nigam et al., 2008) 
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In addition to the safety indicators noted in Table 3, eight clinical pharmacy key 
performance indicators (cpKPIs) have been reported in the literature (Fernandes, et al., 
2015).  Using a modified Delphi approach with a group of clinical pharmacists across Canada 
they reached consensus on eight cpKPIs Table 4.    These cpKPIs are specific to clinical 
pharmacists working within the hospital setting and have overlap with the Safety indicators 
for Medication Use noted in Table 3.  The processes associated with these cpKPIs reflect 
how the work of clinical pharmacists contributes to the reduction of medication errors and 
adverse drug events.  
Table 4. Clinical Pharmacist Key Performance Indicators 
1. Proportion of patients who receive formal documented discharge medication 
reconciliation and resolution of identified discrepancies by a pharmacist 
2. Number (or proportion of patients who receive formal documented admission 
medication reconciliation by a pharmacist (includes a pharmacist best-possible 
medication history or pharmacist best-possible medication history review as part of 
the medication reconciliation process as well as resolution of identified 
discrepancies) 
3. Number (or proportion) of pharmacists who actively participate in interprofessional 
patient care rounds to improve medication management 
4. Number (proportion) of patients for whom clinical pharmacists have completed 
(executed/implemented) a pharmaceutical care plan 
5. Number of total drug therapy problems resolved by pharmacists 
6. Number (or proportion) of patients receiving proactive comprehensive direct 
patient care by a pharmacist in collaboration with the health care team 
7. Number (or proportion) of hospital patients who receive medication counseling by 
a pharmacist at discharge 
8. Number (or proportion) of Patients who have received in-person education from a 
pharmacist about their disease(s) and medication(s) during their hospital stay 
Adapted from (Fernandes et al., 2015) 
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The quality of medication management processes can be measured by the number and 
frequency of medication errors.  There are numerous participants in medication management 
processes who transfer information between each other either verbally, electronically or on 
paper.  The transfer of patients and related information between clinicians or functional 
(business) units is referred to as “handoffs”.  These handoffs can result in errors and 
unnecessary duplication of effort due to incomplete or inaccurate information flows between 
the siloed business units (Gemmel, Vamdaele, & Tambeur, 2008).  It has been found that the 
information quality during handoffs can and often does lead to medication errors.  Using 
BPM combined with accounting control theory these researchers determined how 
information quality impacts medication administration and contributes to medication errors.  
The researchers evaluated the information quality in the categories of validity, accuracy, 
completeness and timeliness.  An interesting finding from the study was that often the 
handoffs resulted in errors detected earlier in the process thereby serving as a separate check 
by individuals executing the subsequent step in the process.  The parameters in the study 
were focused on the quality of the information and also identified controls in the process that 
acted as preventative, detective or corrective activities (Chircu et al., 2013). 
  Business orientation is the way an organization looks at itself.  If an organization 
sees itself as a collection of services it would be classified as having a “service orientation”,  
if it saw itself as project based it would have a “project orientation”, likewise, if it saw itself 
as a collection of business processes it would have a “business process orientation” (BPO).  
An organization can be viewed from an organizational chart perspective based on functional 
units and hierarchical reporting relationships or from the business processes being performed 
with the latter reflecting a BPO.  The traditional business orientation has been described as 
having vertical functional units where people providing specialized services are grouped in 
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departments and business units with management roles in each of the departments and 
business units (Maddern, Smart, Maull, & Childe, 2014).  This approach can result in 
suboptimal service for a customer (patient) since they would need to deal with several 
functional areas and information does not always flow efficiently between functional areas.  
The result is the patient may have to tell their story numerous times or key information is not 
transferred accurately or in a timely manner which could lead to serious errors.  The 
transition of information and decisions between the silos adds waiting time or results in 
rework related to incomplete or inaccurate information flow.  An alternate orientation has 
been described as a “horizontal” view in which the organization is process centric and views 
itself based on end-to-end processes that deliver value to their external and internal customers 
(Maddern et al., 2014).  This business orientation is aligned with BPM because the main 
premise of both is that value creation and competitive advantage can be gained through 
focusing on business processes.  In its purest form, a business process oriented organization 
would have an organizational chart that aligns with its business processes rather than the 
traditional organization structure based on functional units.  In reality many organizations 
choose to maintain the traditional structure but incorporate a matrix management whereby 
process owners are identified for the core processes (Armistead & Machin, 1997).   
Enterprise Architecture (EA) has been defined as “a set of concepts and practices 
based on holistic systems thinking, principles of shared language, and the long-standing 
disciplines of engineering and architecture” (Kappelman & Zachman, 2013, p. 87).  EA 
originated when IT experts began developing models demonstrating how all the enterprise 
software applications were connected (Harmon, 2014).  The discipline has evolved to now 
include not just the modeling of software applications but also the technology (hardware) 
aspects and the business processes using the applications and technology.  EA is a 
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comprehensive description of key enterprise elements and the relationships between those 
elements (Kang, Lee, Choi, & Kim, 2010).  There are numerous EA frameworks including: 
Zachman Framework for Enterprise Architecture, The Open Groups Architecture Framework 
(TOGAF), US Federal Enterprise Architecture Framework (FEAF), Business Architecture 
Guild of the Objects Management Group (BIZBOK), and Layered Enterprise Architecture 
Design (LEAD) to name a few (Harmon, 2014; von Rosing et al., 2014).  The literature 
references a multitude of “architectures” or layers within the EA frameworks that when 
combined would represent a holistic EA.  The FEAF framework includes four distinct 
architectures: Technology Architecture, Applications Architecture, Data Architecture and 
Business Architecture.  The TOGAF framework includes three architectures: Technology 
Architecture, Information Systems Architecture, and Business Architecture.  It has also been 
proposed that most frameworks include five layers: Business Architecture, Process 
Architecture, Integration Architecture, Software Architecture and Technology (or 
Infrastructure) Architecture (Winter & Fischer, 2006).   
Layered Enterprise Architecture Design (LEAD) describes three layers of 
architecture.  Layer 1 is the Business Layer which includes four sub layers: Purpose & Goal, 
Competency, Service and Process.  Layer 2 is the Application Layer and it includes two sub 
layers: Application and Data.  Layer 3 is the Technology Layer and it includes two sub 
layers:  Platform and Infrastructure (Figure 3).  This layered approach to enterprise 
architecture design enables development of models and meta-models which show the 
relationships between objects and meta-objects from one layer to objects and meta-objects 
within the same layer and also within the other layers. 
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Figure 3 Layered Enterprise Architecture Design 
 
The LEAD standards provide a comprehensive enterprise architecture and related 
business ontology that enables the reuse of business objects across multiple layers of the 
architecture.  The host organization had used LEAD’s business layer as the principle 
enterprise architecture tool prior to commencement of this research.   A formal analysis and 
comparison of the various enterprise architectures was not undertaken as selection of the 
‘best’ enterprise architecture was not the focus of this research.  Instead, the focus was the 
study of potential benefits and challenges of combining BPM, an ontology and the business 
layer of an enterprise architecture as a management approach to quality improvement within 
a healthcare organization. 
The need to identify a suitable enterprise architecture for a hospital was the subject of 
an extensive study in which 17 different enterprise architecture frameworks were reviewed 
and 5 were shortlisted for evaluation. (Haghighathoseini, Bobarshad, Saghafi, Rezaei, & 
Bagherzadeh, 2018).  .  LEAD was not included in the list of frameworks reviewed.  The 
Open Group Architecture Framework (TOGAF) was found to be the best suited to be used in 
hospitals. LEAD includes all the architectural elements within TOGAF with the added layer 
of Purpose and Goal in the business layer.  This along with the convenience of being able to 
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reuse the business artefacts already created within the host organization using LEAD 
standards supported its selection for this research. 
The BA layer of EA is the most relevant to the current research.  BA and BPM are 
two different management disciplines which are closely related.  However, reconciliation of 
the two disciplines is required to ensure the appropriate artefacts and their use is well 
understood (Dugan, 2014). 
There are six advantages/common values associated with implementing an EA:  1) 
Readily available documentation of the enterprise, 2) Ability to unify and integrate the 
business processes across the enterprise, 3) Ability to unify and integrate data across the 
entries and to link with external partners, 4) Increased agility by lowering the complexity 
barrier, 5) Reduced solution delivery time and development costs by maximizing reuse of 
enterprise model and 6) Ability to create and maintain a common vision of the future shared 
by both the business and IT communities, driving continuous business/IT alignment (Brown, 
2004).   
Business artefacts such as strategy and business models can be very useful tools in 
developing understanding of an organization.  The traditional organization chart does not 
provide a systems view of the organization.  BPM requires that the principal focus of 
understanding the organization is through the perspective of its processes.  It is important to 
understand both the processes and the context in which the processes are being executed 
(Harmon, 2014; Margherita, 2014). 
BPM is used to better understand end-to-end processes and the relationships of the 
process steps to the other processes and objects within a system.  Examples of objects would 
be location, roles, business rules, controls, cost, etc.  This knowledge in turn can be used to 
improve processes.  Cycle time, wait time, transport time, process cycle efficiency, error rate, 
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throughput and cost have been identified as seven basic measures that should be considered 
when undertaking process improvement (Kowalski, 2014).  Errors in the medication 
management process occur both within the core processes and also within the management 
and supporting processes.  A comprehensive measurement plan needs to incorporate all 
measurement types, not just the error rates.  Also process improvement should be undertaken, 
not only in core processes, but also in support and management processes.  The traditional 
focus in BPM is on the core processes only which has been viewed as a shortfall (Van der 
Aalst, Hofstede, & Weske, 2003).  
There are four main criticisms of BPM identified in the literature.  The first is BPM is 
merely a repackaging of old ideas by consultants and business gurus who are using it to 
promote their own business or “how to” books (Trkman, 2013).  Second, there is an absence 
of a theoretical base in the literature (Melao & Pidd, 2000) which has since been addressed 
by several authors, although there does not appear to be consensus (Biazzo, 2002; Lacerda et 
al., 2010; Niehaves et al., 2014; Trkman, 2013).  Third, BPM projects can take considerable 
time to complete and realize results (Siriam, 2012).  Fourth, the majority of the articles are 
from practitioners reporting on successful case studies and very few articles reporting on 
failed BPM projects (Helfert, 2009).  
Several authors have established the connection between BPM and ‘systems thinking’ 
(Maddern et al., 2014; Margherita, 2014; Siriam, 2012; Smart et al., 2009).  Having a 
systems perspective requires us to not only measure and monitor the parts of the system but 
also requires that we measure the interactions and process between the various components 
of the system.  This is especially true in healthcare as it has been shown that the greatest risk 
to patient safety is in the transitions between the component parts of the system (Chircu et al., 
2013).   The reductionist approach to control and performance measurement focuses on the 
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component parts.  This approach has been critiqued and the author concludes that 
performance management must focus on the interactions between the components and not the 
components themselves (Gregory, 2007).  This article is very persuasive and fits extremely 
well with the ‘systems thinking’ approach to organizational understanding and management. 
2.4 Healthcare Organization as a System 
In quality improvement literature a system has been defined as “an interdependent 
group of items, people or processes with a common purpose” (Langley, et al., 2009, p. 37).  
An organization can be perceived as an ‘open system’ or a ‘closed system’ with the main 
difference being that in a closed system the organization does not interact with the external 
environment whereas in an open system the organization interacts with and is affected by 
external environment factors (Khorasai & Almasifard, 2017).  Important to note is an open 
system is more than a grouping of individual elements; it has an organization and wholeness.  
That is, it is more than the mere “sum of its parts”.  The concept of an “open system” is 
attributable to biologist, Ludwig von Bertalanffy (Peters, 2014).  Thinking of the 
organization as an open system and realizing that it is more than the sum of its parts is 
foundational to BPM and the need to understand the end-to-end processes and the 
relationships both within the process and the relationships with the environment in which the 
processes are being executed. 
A metaphor used to make the distinction between two types of systems underlying 
organizations is “Organizations as machines, organizations as conversations” (Suchman, 
2011)  Suchman claims that an organization can be viewed as a machine (dead - closed) 
system or as an adaptive (living - open) system and conversations are the basis for change in 
an adaptive system.  The expectation of control within a machine type system is realistic as a 
machine can be controlled; however, such is not the case in an organization involving people 
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as they are not so easily controlled.  Executing change in an adaptive (living) system requires 
focus on the human element to a much higher degree than in an organization characterized as 
a machine (Suchman, 2011). 
Healthcare organizations have been described as complex adaptive systems (Begun, 
Zimmerman, & Dooley, 2003).  The traditional view of a healthcare organization is the 
hierarchical organization chart, the simplicity of which belies the complexity of the nonlinear 
relationships and emergent nature of a complex adaptive system.  Individual agents acting in 
a healthcare organization most often act independently based on their personal knowledge 
and the environment they are working in.  Interconnectivity exists between the various 
functions or subsystems but these tend to be nonlinear and often small changes in one process 
or function can have major implications on other functions.  Therefore, it is important that a 
systems approach be taken when initiating change in a healthcare organization.   
W. E. Deming, an early pioneer of quality improvement, proposed that a system could 
be described as having three types of processes:  Drivers or Influencers, Mainstay Processes 
and Support Processes (Langley, et al., 2009).  This system of modeling has been used by the 
Jonkoping County Council to describe the health care system provided to the residents of 
Jonkoping County in Sweden.  This organization has been identified as a high performing 
healthcare system and renowned for its ability to provide high quality health services at low 
cost (Baker, et al., 2008).   
Seeing the whole system requires an understanding of structure, function and process 
and these must be understood at the same time (Gharajedaghi, 2011).  EA and modeling can 
be employed to provide such a view.  EA has often been viewed from an information 
technology perspective but this considers only one aspect of the system.  A more holistic 
view of EA would include the representation of all elements of the enterprise and the 
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relationships between them (Mykityshyn & Rouse, 2007).  Conceptual models provide a 
representation of an object or event and can be quite simple or very complex.  An example of 
a simple conceptual model is a process flowchart that provides the steps in a simple linear 
process.  An example of a complex conceptual model is a Business Process Model that 
depicts a process including the business process, the related information elements, software 
applications and technology used to support the business process.  EA and the use of BPM 
are consistent with system thinking and could provide the tools and methodology to address 
the quality and cost challenges inherent in a healthcare organization.   
2.5 Business Ontology 
An ontology provides a set of terms and describes the relationship between the terms 
(O'Leary, 2010).  Ontologies are the key building block of enterprise architecture which 
enables a holistic view of the enterprise where each functional area uses the same vocabulary 
to describe like objects (Kappelman & Zachman, 2013). 
Four kinds of ontology have been described based on the level of generality.  The 
four layers are top-level, domain, task and application (Guarino, 1998).  Top–level ontology 
describes concepts related to objects, events, actions etc. at a very high level and is not 
dependent on a specific domain or particular problem.  It is reasonable to assume a top-level 
ontology would be useful across a large user group since at the highest level of concepts 
everyone can agree on the meaning.  A top-level ontology can also be referred to as a 
foundational ontology and is needed in any field or domain (von Rosing & Laurier, 2015).  
Domain ontology describes concepts using the vocabulary of a generic domain while task 
ontology uses the vocabulary of a specific task.  Examples of concepts within a domain 
ontology are strategy, roles, cost, finance, or medicine.  Examples of concepts within task 
ontology are analysis, design, investing, diagnosing or selling.  Application ontology 
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describes concepts from both the domain and task ontologies and is a specialization of the 
ontology used from both (Guarino, 1998).  A concept from a domain is a business process 
within a specific company and a concept from a task is data analysis within a specific 
department.  
Business ontology has business as its area of discourse and it attempts to create a 
vocabulary that best represents relevant meaning that can then be shared through information 
exchange (Au-Yong-Oliveira & Ferreira, 2014).  The exchange of information can be human 
to human, human to machine or machine to machine.  Research in the area of business 
ontology has covered two different streams.  The first included developing methodologies 
that enable practitioners to develop their own unique ontology specific to their domain.  The 
second includes academic and standard setting bodies building of reference ontologies that 
could be tested and adopted by practitioners (von Rosing & Laurier, 2015).   
BPMO is a domain ontology built on the top of the business ontology which is a 
foundational ontology (von Rosing et al., 2014).  Both the business ontology and BPMO are 
generic ontologies applicable to various industries including healthcare.  von Rosing and 
Zachman (2017) argue that the foundational business ontology and with it the BPMO is 
applicable to any type of organization, independent of complexity or industry.  The business 
ontology can then be used as the basis for the development of integrated enterprise standards 
for any industry (von Rosing & von Scheel, 2016).  Therefore, applying the business 
ontology to specific healthcare industry practices (medication management) is a research, 
analysis and study into the applicability of the business ontology and concepts in a specific 
industry setting.  The current research required identifying the many different existing 
healthcare concepts from the value chain, the business model, the operating models, service 
and process model and applying them to the business ontology. 
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There are numerous ontologies described in the literature (Appendix 1).  Ontologies 
have been developed by academics, standard setting bodies, architects or practitioners and in 
some cases through extensive collaboration between academics, practitioners and standards 
setting bodies.  Ontologies evolve as they mature and more knowledge is gained due to 
expanded use or changes in business and technology.  Two of the listed ontologies Health 
Language 7 (Health Level Seven International, 2015) and Basic Formal Ontology (Blobel et 
al., 2014) have been used in healthcare.  The main use of both has been related to 
interoperability within and between clinical information systems with process automation as 
the goal.  HL7 RIM (Reference Information Model) has evolved and is now referred to as 
RIM v3.  “HL7 v3 has been heavily criticized by the industry for being internally 
inconsistent even in its own documentation, too complex and expensive to implement and has 
been accused of contributing towards many failed and stalled systems implementations” 
(Bender & Sartipi, 2013, p. 326).  BFO is a foundational or upper level ontology designed for 
use in bio-informatics to guide the development of domain ontologies.   
The business ontology and BPMO developed by Global University Alliance was 
selected for use in this research as it covers both the clinical and business aspects of 
medication management processes.  The ontology is designed in layers enabling the 
incremental adoption across the organization.  This ontology has been adopted by several 
software vendors including SAP (Rosenberg, Chase, Omar, Taylor, & von Rosing, 2011), 
iGrafx (iGrafx, 2013), and Objects Management Group (OMG) a well-known software 
standards organization (Object Management Group, 2014).  It has also been academically 
well described with published case studies demonstrating its utility (von Rosing & Laurier, 
2015; von Rosing & von Scheel, 2016; von Rosing, Urquhart, & Zachman, 2015).  A detailed 
description of the business ontology and BPMO is provided in Appendix 1. 
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2.6 Reference Models 
A reference model is either a narrative or visual conceptual representation of the 
recommended (best) practices of a specific domain.  In this research, the medication 
management process reference model is a narrative representation of the processes that 
should be included in a process architecture for medication management.  A business process 
reference model can be used to inform and guide the development of a business process 
where no such business model previously existed or it can be used to compare current 
business process to the generic reference model which has incorporated leading or best 
practices within the domain (Pajik, Indihar-Stemberger, & Kovacic, 2012).  Since developing 
business process models is time consuming and can be expensive, reference models can be 
used to shorten the time to design or standardize process models across an organization.  
 The challenge with producing generic business process models is they may be 
context specific; therefore, not necessarily transferrable to other organizations.  It is possible 
that best practice in one organizational or industry may not translate to best practice in 
another organization if there is a major difference in the strategy of the two organizations 
(Ponsignon et al., 2012).  Despite these concerns there are many examples of reference 
models for business process in use and referenced in the literature.  These include SCOR – 
Supply Chain Operations Reference Model, SAP R/3 reference model and the Process 
Classification Frameworks developed and published by the American Productivity and 
Quality Council (APQC) (Pajik et al., 2012; American Productivity and Quality Centre 
(APQC), 2014).   
There were two sources of information available for use in validating the business 
process reference model for medication management: the APQC Process Classification 
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Framework, and the Supply Chain Operations Reference (SCOR) (Supply Chain Council 
Inc., 2012).  Further information on how these were used is reported in Section 4.4. 
2.7 Literature Review Summary 
The occurrence of medication errors and the resulting adverse drug events are a 
problem in hospitals and long term care facilities.  The literature shows that the medication 
administration phase is one of the most error prone and that there is a low likelihood that 
these errors will be intercepted.  Technology has been proposed as a potential solution for 
reducing medication errors; however, simplification and standardization of processes is 
required in order for the technology to be effective in reducing medication errors.  Clinicians 
would need to accept the technology and associated changes to their workflow. 
The medication processes are subject to numerous standards, guidelines and 
legislative requirements that must be met within the processes.  While these controls are 
intended to provide for a high quality medication management process they also contribute to 
the complexity of the processes.  
Researchers and practitioners have contributed to the literature on BPM.  The 
definition of BPM ranges from very narrow to very comprehensive depending on whether 
one is looking at a single process or encompassing an entire organizational view including 
suppliers and customers.  There has been differing views on the theoretical basis of BPM.  
Several authors agree on the evolution of BPM and claim it is an improvement over the 
predecessor approaches because it incorporates the benefits of its predecessor traditions.  The 
applicability of BPM in a complex system such as healthcare has been questioned because of 
the high degree of the ‘human element’ that must be considered when designing processes 
where individuals may need (or choose) to deviate from ‘standard’ processes.  The three 
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elements of modeling, measurement and management of processes are foundational to BPM.  
BA provides the structure in which business processes can be explored.   
The need to look at processes from a systems perspective has been established as 
desirable if maximum value from the organization is to be realized.  This ‘systems thinking’ 
approach is especially important in organizations such as healthcare, which are traditionally 
hierarchical organizations that rely on individual clinical expertise to assess, diagnose, treat 
and monitor patients. 
Business ontology provides the ability to create a shared vocabulary across domains.  
This shared vocabulary will create a shared understanding that could contribute to reducing 
complexity which in turn would reduce errors related to communication challenges.  A 
shared understanding of the process and its underlying objects could facilitate process 
automation and reduction in variation in outcomes. 
Developing process models is a time consuming and costly activity which could be 
expedited by having access to a process reference model.  Process reference models have 
been developed in many business sectors but no process reference model specific to 
medication management in hospitals and long term care facilities was discovered in the 
literature review. 
The literature review provided examples of how BPM had been employed on specific 
healthcare processes but there were no articles found that showed the use of a combination of 
BPM, EA and business ontology.  In order to determine whether a research gap existed in 
this area, a comprehensive literature review was conducted using BPM, EA and ontology as 
the keywords.  Several premier databases were searched for recent peer reviewed articles.  It 
was observed that while extensive research has been done in the areas of BPM and EA, there 
has not been any effort towards using ontology to combine concepts from these two 
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disciplines.  Similarly, this concept of using ontology to integrate BPM and EA in the context 
of healthcare organizations was found to be non-existent.  One article reviewed, however, 
made the case for using EA and BPM to improve quality of health care services (Wouters, 
2015).  
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3 Methodology 
This chapter outlines the methodology and the research design used in the 
development of this dissertation.  There are three sections in this chapter.  The first section 
briefly presents the rationale for using the mixed methods research methodology to address 
the research questions.  The second section outlines the research design.  The third section 
provides detail on the reliability, validity, generalizability, and limitations of this research. 
3.1 Approach 
There are two approaches to research:  the deductive approach and the inductive 
approach.  The deductive approach begins with the researcher asserting a theory, he or she 
would then develop a hypothesis related to the theory, collect and analyze data to either 
confirm or reject the theory and then if appropriate propose a revised theory (Bryman, Bell, 
Mills, & Yue, 2011).  The inductive approach does not lead with a theory; rather, the 
researcher starts with a question(s), collects and interprets the data to develop concepts and 
theories based on the interpretation of the data and will often add more specificity to the 
research questions as he or she gains additional knowledge from the interpretation of the data 
(Bryman et al., 2011).  
This research had two purposes; firstly, to determine if an ontology used in other 
industries could be successfully applied to the healthcare industry and secondly, identify the 
benefits and challenges of introducing BPM, Business Ontology and BA as a comprehensive 
approach to address medication management safety and quality concerns within a multi-
facility healthcare organization.  The exploration of introducing the ontology could be 
considered to be deductive approach while the identification of benefits and challenges of 
introducing the combined approach to quality improvement could be considered to be 
inductive approach.  The development of the business artefacts and the use of those to 
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develop a generic reference model for medication management was a secondary focus that is 
more closely associated with design science.  The focus therefore, was theory testing in 
respect to introduction of the ontology and problem solving, design and theory generation in 
respect to identifying the benefits and challenges.   
The methodology selected was mixed methods as opposed to purely quantitative or 
purely qualitative methods.  The research design employed predominantly qualitative 
methods with embedded quantitative methods.  Mixed methods has been described as “the 
class of research where the researcher mixes or combines quantitative and qualitative 
research techniques, methods, approaches, concepts or language into a single study” 
(Johnson & Onwuegbuzie, 2004, p. 17).  Qualitative design in the form of researcher 
facilitated workshops was used to develop business artefacts, select performance measures, 
and identify improvement opportunities.  Semi-structured interviews were used to identify 
the challenges and benefits as perceived by the members of the medication management 
working group.  Also, leaders of the host organization were interviewed using a different set 
of questions to gather data on the benefits and challenges of using BPM, BPMO and BA 
from a leader’s perspective. Quantitative design was used to analyze the organizational 
performance measures and prioritize the improvement opportunities.  Figure 4 shows the 
methods used and their classification as either qualitative or quantitative.  Each of the 
methods is discussed further in the Strategy and Research Design section below. 
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Figure 4. Combining Qualitative and Quantitative Methods & Techniques 
3.2 Strategy & Research Design 
Mixed methods design is often used in health services research (O'Cathain, Murphy, 
& Nicholl, 2007).  There are six types of mixed method strategies and it is important to 
consider four aspects of the research before selecting which type of mixed method design to 
use (Creswell, 2014).  The six strategies are: sequential explanatory, sequential exploratory, 
sequential transformative, concurrent triangulation, concurrent embedded and concurrent 
transformative.  The first three sequential strategies are used when the research is conducted 
in phases with one of the designs (i.e. quantitative or qualitative) used in one phase followed 
by the alternate in subsequent phases.  The concurrent strategies are used when the data from 
both qualitative and quantitative approach is collected concurrently.  The four aspects are: 
timing, weighting, mixing and theorizing. In this research, the respective research methods 
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are used concurrently; while the qualitative method weighed more heavily, the quantitative 
method was embedded within the more dominant qualitative approach and the theorizing was 
implicit.  Qualitative methods have been described as suitable to be used when researchers 
want to ask more questions than can be answered by quantitative methods, particularly in 
complex environments (O'Cathain et al., 2007).  The prioritization of improvement initatives, 
and measurement and analysis of change were better suited to a quantitaive approach.  
Therefore, both approaches were needed which resulted in the selection of a mixed methods 
designbased on a concurrent embedded strategy.  
Figure 5 provides an overview of the ten step research design that was developed and 
used.  In addition to the numbered steps, the figure outlines the major tasks included in each 
step.  The lessons learned in following this design are summarized in Table 5.  
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Figure 5.  Research Design 
Identify Problem Develop Research Question
Identify Potential Solution Identify Research Approach
Review and Analyze Relevant Literature Revise Research Questions if Required
Data Type - Qualitative & Quantitative Primary Data - Semi-structured Interviews
Data Source - Primary & Secondary
Primary Data - Workshop Developed Business 
Artefacts
Participants - Multidisciplinary Working Group 
Identified by Medication Safety & Quality 
Committee within Host Organization
Secondary Data - Relevant Documentation of Host 
Organization 
Develop Workshop Schedule
Develop Workshop Materials
Select and book venue Arrange for audio and video conferencing
Invitations to participants Conduct Workshops
Obtain Informed Consent Facilitate Working Groups
Invite Participants Obtain Informed Consent
Schedule Interviews Conduct Interviews
Transcribe Recorded Interviews Review Secondary Data
Conduct Analysis of Transcribed Interviews
Refine Business Artefacts to meet Layered 
Enterprise Architecture Standards
Prepare Dissertation Defence of  Dissertation
Prepare Journal Articles 
Prepare and Deliver Executive Level Report on 
Findings to Host Organization
Submit for Review
Seek opportunities for public presentations of 
findings
10. Write Up & Present Findings
7. Report Preliminary Findings to Workshop Participants
1. Develop Research Idea
2. Conduct Literature Review
3. Determine Data Collection Strategy
4. Data Collection Planning
5. Obtain Ethics Approval
6. Deliver Workshops & Facilitate Working Groups
Develop Questions for Semi-Structured Interviews 
8. Collection of Interview Data
9. Analysis of Data 
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Table 5 Considerations for Replication of Study 
Stage Key Points Opportunities for Improvement and 
comments 
Develop 
Research Idea 
Medication Management was 
used an example of a quality 
improvement focus that might 
benefit from the use of the 
comprehensive management 
approach.  Other service areas 
could be considered 
 
 *Need to identify and confirm 
a host organization willing to 
engage in the research 
*Need to identify and engage 
a project sponsor within the 
host organization 
*Recommendation to find a host 
organization which the researcher has 
no immediate or recent employment 
relationship.  
*Executive support is critical as the 
approach requires participation from 
the host organization 
*An organization considered to be a 
“Learning organization” as in most 
cases the approach and some of the 
concepts will be new to the participants 
and leaders 
 
Conduct 
Literature 
Review 
Follow a formal literature 
review approach  
*Expand the literature to include 
relevant sources and white papers that 
specifically address the problem to 
understand what is currently being 
undertaken by practitioners that may 
not be included yet in academic 
publications. 
Determine Data 
Collection 
Strategy 
Work with Project Sponsor to 
identify workshop 
participants 
*Ensure the workshop participant group 
is representative of the end to end 
process being reviewed  
* Include both operational and 
management staff if possible. 
 Primary Data Collection for 
use in development of 
Business Artefacts 
*Engage a research assistant to attend 
workshops or arrange for audio 
recording and transcription to ensure 
complete capture of all ideas and 
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Stage Key Points Opportunities for Improvement and 
comments 
discussions related to the business 
objects to be included within the 
Business Artefacts.   
 Secondary Data – Relevant 
documentation of host 
organization 
Recommend review of all organization 
strategic level documents as well as any 
specific strategy and planning 
document in the focus area.   
Data Collection 
Planning 
Develop Workshop Schedule *The ½ day workshop seemed to work 
well so would recommend that 
approach but plan on 4 sessions rather 
than 3 sessions and have them spread 
out over a four week period so 
participants have time to review and 
reflect on the work but not so far apart 
that they lose momentum with the 
development of the business artefacts. 
*The translation of the ideas into the 
relevant business objects and 
documentation will take some time so 
be sure to leave time available for 
transcribing and editing between the 
research dates so that participants can 
have time to conduct preliminary 
review of the draft business artefacts 
prior to each work shop.  
 Develop Workshop Materials *The introduction to the research and 
the orientation to BPM, BA and the 
BPMO sets the foundation of the 
research and therefore should be 
developed such that it is understandable 
to those being exposed to it for the first 
time.  
* Wherever feasible, include examples 
relevant to the focus area and also if 
possible from review of secondary data 
of host organization where it exists. 
 Develop Questions for Semi-
Structured Interviews 
Validate the interview questions.   
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Stage Key Points Opportunities for Improvement and 
comments 
Obtain Ethics 
Approval 
Allow for time as this process 
can take time depending on 
review and approval 
processes within host 
organization. 
 
Deliver 
Workshops & 
Facilitate 
Working 
Groups 
Arrange for audio and video 
conferencing if participants 
are geographically dispersed 
Include audio recording since this will 
ensure completeness of data collection 
of business objects to be included in 
business artefacts.   
 Conduct workshops A formal consensus developing method 
such as modified Delphi approach 
could be added as this would strengthen 
the “consensus” that the resulting 
business objects included within the 
business artefacts are agreed to by all 
participants.  
 Facilitate working groups The working group schedule in the 
current study was less than ideal due to 
availability of participants.  This 
extended the duration of the research 
significantly.  It would be advisable to 
have weekly meetings of the working 
groups rather than monthly. 
Report 
Preliminary 
Findings to 
Workshop 
Participants 
The working groups were 
formed from a sub group of 
the Workshop Participants 
and it was important to share 
the results with the workshop 
participants so they had a full 
picture of the results 
including the prioritization 
and performance measures to 
be added to the business 
artefacts. 
 
Collection of 
Interview Data 
Voluntary participation was 
lower than expected despite 
several reminders after initial 
invitations were sent. 
Try additional recruitment strategies  
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Stage Key Points Opportunities for Improvement and 
comments 
Analysis of 
Data 
Analysis of interview data 
using thematic and content 
analysis 
Design of business artefacts 
based on LEAD standards  
 
Write Up & 
Present 
Findings 
Disseminate results to 
research community 
periodically to obtain 
feedback. 
 
 
3.2.1 Research idea – motivation. The research idea evolved from an interest in 
resource allocation, quality improvement, and strategy execution in healthcare.  The 
challenge of meeting healthcare demands within the resources available is an issue for both 
healthcare providers and healthcare administrators.  There is a constant need to realize as 
much benefit as possible from the resources available.  This is true from the perspective of 
provision of healthcare services and also from the perspective of how we employ resources 
engaged in improving the effectiveness and efficiency of healthcare services.  At the system 
or macro level, resource allocation decisions determine what services will be provided while 
at the micro level individual clinicians decide on a case by case basis how they will allocate 
their clinical time.  
There is little debate on the need for improvement in the quality of healthcare 
services.  An essential area of interest is medication management due to the frequency of 
medication use in the treatment of patients and the high risk posed from adverse medication 
events.  In addition to patient safety, the efficiency and effectiveness of medication 
management processes are extremely important.  These processes consume resources in the 
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form of human resources and in pharmaceutical supply costs.  Errors in medication 
management result in undesirable outcomes which range in significance from extreme such 
as the death of a patient due to an adverse medication error to less obvious issues such as 
overstocking inventory that results in a waste of money due to expired drugs.   
The literature reports on approaches to reduce medication management errors some of 
which are included in Chapter 2.  The host organization for this research had previously 
employed some of those approaches with limited success.  The use of more advanced 
technology supported solutions that enable automation of processes are extremely expensive.  
Although there is a growing movement within the host organization to proceed with that 
approach, it is recognized that processes should be improved and standardized in advance of 
introducing new technology. 
Healthcare organizations have been described as complex adaptive systems.  One of 
the key attributes of such a system is that a small change in one area can result in unexpected 
results in a different area within the system.  Therefore, it was critically important to gain a 
comprehensive understanding of the system in which medication management operates 
before attempting to introduce changes.  An additional point to consider was that healthcare 
providers have a high degree of autonomy in their work and therefore when changes were 
being contemplated it was important to engage individuals involved in the processes in 
redesign planning.  These two points weighed heavily in the identification of potential 
solutions and choice of the research approach.  Using workshops as a means of developing 
the business artefacts and identifying critical processes for improvement provided 
participants the opportunity to engage early in the solution identification.  Exposure to the 
organizational BA provided participants with the opportunity to increase their understanding 
of how medication management processes fit within the larger healthcare system. 
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3.2.2 Literature review. The literature review provided in Chapter 2 evolved from 
the initial research idea generation step through to the final step of writing up and presenting 
the findings.  The research step of conducting a literature review included searching, reading, 
and critically appraising the literature on the topic(s) of interest.  This process facilitated 
achievement of a greater understanding of both the problem and the potential solutions.  The 
literature review was also instrumental in shaping the research questions and developing the 
research design.   
3.2.3 Data collection strategy. The data collection strategy included identifying 
what type of data would be collected, whom the data would be collected from, and how the 
data would be collected.  The type of data included both qualitative and quantitative data.  
The source of primary data was the workshops and semi-structured interviews.  The source of 
secondary data was the host organization records and information management systems.  The 
host organization had established a Medication Safety & Quality Committee (MSQC) and in 
recognition of this research the researcher participated as a non-voting member of the group.  
Identification of the appropriate individuals to be included in the multi-disciplinary team was 
based on the recommendation of that committee.  Those individuals recommended included: 
Nurse Managers, Medication Safety Nurse, Pharmacists, Information Management Director, 
Chief Medication Information Officer, physicians and performance improvement 
practitioners, all of whom participated or had knowledge of some aspect of the medication 
management processes.  Agendas and minutes of the MSQC meetings were reviewed to 
identify any additional initiatives or interventions undertaken in medication management 
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during the research period.  The results of that review are included in the Chapter 4 and 
further discussed in Chapter 5. 
3.2.4 Plan for primary data collection.  The collection plan for the primary data 
included two components.  The first was the information and business artefacts derived from 
the workshops and working groups’ activities.  The second was the data collected through 
semi-structured interviews with workshop participants and host organization’s leaders. 
Planning for the workshops required preparation of material for presentation to the 
group, both on the research project itself, as well as educational material on BPM, BPMO, 
and BA.  There were initially two full day workshops planned however, due to scheduling 
challenges with operational responsibilities of the participants the plan was changed to two 
half day workshops to be held one week apart.  The scheduling included capacity for video 
and audio conferencing to accommodate participation from outside the local area.  The host 
organization provides services across a large geographic area and it is common practice for 
staff of the organization to participate in organization wide activities using these types of 
communication technology.   
Prior to the formal research, the organization had undertaken to develop strategy 
maps and business models both at the organization level and at the organizational area level.  
The draft business model and a draft strategy map for the organization area of Pharmacy 
served as the starting point for the development of the Medication Management business 
model and strategy map presented in Chapter 4. The plan was to have these two documents 
reviewed, expanded upon as appropriate and validated by the workshop participants.  In 
addition to these two business artefacts, there were also numerous process models in a 
process repository relevant to this research.  Those business artefacts were foundational in 
the preparation of the initial workshop material.  The draft business model and strategy map 
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had been based on input from individuals in management positions within pharmacy services 
so those business artefacts needed to be expanded to include input from other business areas.  
There had been a limited number of participants involved in development of the initial draft 
of the business model and strategy map.  In an effort to promote buy-in and be sure the 
artefacts were complete and appropriately represented the service area additional consultation 
was required.  During the planning for the initial workshop, a draft value chain for 
medication management was developed based on the review of the business artefacts noted 
above and discussions with the Regional Director of Pharmacy.  
The agenda for the first workshop included four items:   
1) Introduction to the research  
2) Introduction to BPM, BPMO and BA,  
3) Review of draft strategy map and business model  
4) Discussion on development of an end-to-end process model of medication 
management.   
Chapter 4 provides further detail on the addition of a third half day workshop and also 
the formation of two working groups one focused on measurement and the other focused on 
prioritization activities.  This level of effort had not been anticipated during the planning of 
the research; however, there was a higher level of engagement and discussion during the 
workshops than had been planned for initially. 
The plan included two separate groups to be invited to participate in semi-structured 
interviews.  The first group included all participants from the workshops except two 
individuals who were support staff within the BPM business unit.  Twenty workshop 
participants were invited and eleven agreed to be interviewed for a response rate of 55%.  
The second group invited to participate in an interview were the senior leaders within the 
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host organization.  The senior leaders were identified by reviewing the organizational chart 
and invitations were delivered to all members of the Executive Team as well as all leaders 
who directly reported to an Executive Team member.  Seventy leaders were invited and 23 
agreed to be interviewed for a response rate of 33%.  Two separate interview instruments 
were developed, one for the workshop participants and the other for the leaders.  Copies of 
both interview instruments are included in the Appendices as Appendix 2 and Appendix 3.  
There were two individuals who fit both criteria for inclusion and these two were interviewed 
twice using the different interview instruments.  
3.2.5 Ethics approval. This research included human subjects and as such ethics 
approval for the research was required.  Northern Health signed on as a partner in this 
research and joint ethics approval was granted by UNBC Research Ethics Board and the NH 
Research Ethics Board.  Members of the Multi-disciplinary Working Group (MDWG) were 
informed of the research.  Informed consent was obtained from each member of the MDWG 
who participated in the workshops.  A copy of the information letter and consent form is 
provided as Appendix 4. Informed consent was also received from individuals who agreed to 
participate in the semi-structured interviews.  Appendix 5 is a copy of the amended 
information letter and consent form for the interviews.  The initial ethics approval stated that 
the researcher would complete all the transcription of the recorded interviews.  This decision 
was revisited and an amendment of the ethics application was filed and approved.  The 
transcription of the recorded interviews was achieved by a combination of a hired 
transcriptionist and the researcher. 
3.2.6 Delivery of workshops and facilitation of working groups. Three half day, 
researcher-led, workshops were delivered and these were followed up with monthly working 
group meetings.  The workshops were held between December 2016 and January 24, 2017 
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and the two working groups met monthly between February and September 2017.  Each of 
the two working groups focused on finalizing the work that had been initiated in the 
workshops.  The Measurement Working Group (MWG) focused on the performance 
management plan and the Prioritization Working Group (PWG) focused on reviewing the 
identified process improvement opportunities and finalizing the prioritization.  The PWG 
completed the prioritization exercise and all proposed improvement initiatives suitable for 
ranking were prioritized.  Those initiatives not prioritized had either been completed 
previously or were mandatory initiatives.  The MWG developed a listing of performance 
measures for inclusion in a scorecard for medication management safety and quality but were 
challenged to deliver a final complete product because some of the measures were not yet 
available  
Workshop meeting materials were circulated in advance and both the workshops and 
the working group activities were facilitator led.  Participants were invited to ask questions or 
request clarification on the documents prior to or during the workshops and working group 
meetings.  The first two workshops were held in December 2016 and the third was held in 
January 2017.  The attendance varied from a high of twenty-two in the first workshop to a 
low of thirteen in the third workshop.  Appendix 6 provides a log of the workshop attendees 
including position title and professional background.  Members of the two working groups 
were volunteers from the workshop participants with the exception of a financial business 
analyst who had not participated in the workshops but did participate in the measurement 
working group.  All workshop participants were invited to participate on the working groups 
if they were available and interested.  The attendance at working group meetings ran between 
five and seven individuals with a small group that formed the core of both groups.  This core 
group included: the Regional Director of Pharmacy, the Antimicrobial Stewardship 
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Pharmacist and the Lead, Regional Quality Processes who consistently participated in both 
working groups.  Participants were encouraged to challenge both their own assumptions and 
ideas as well as those of others.  Efforts were made to create an atmosphere of trust and 
mutual cooperation during the workshops and working group activities.  
The workshop participants finalized the development of the business artefacts that 
met the LEADing practice BPMO standards by the end of the second workshop.  The 
artefacts included the relevant business competency model, organization strategy map, value 
chain and some but not all of the process models related to medication management safety 
and quality.  In addition to the business artefacts listed above, two additional deliverables 
were achieved through the working groups.  These included the draft performance 
management plan and a prioritized list of process improvement opportunities.  
A repeated measures design to collect the performance measures was planned.  This 
included both key process indicators and key performance indicators.  The list of selected 
performance measures is provided as Appendix 7.  
Analytical Hierarchy Process (AHP) is a methodology intended to compare and 
contrast alternative options in order to rank the relative contribution each could make towards 
achievement of an overall goal (Saaty T. L., 1980).  The AHP scoring tool enables the 
conversion of a pairwise comparison of decision criteria from a verbal scale to a numerical 
value which can then be used to establish a weighting for each criteria being compared 
(Table 8).  The alternative options can then be rated against the weighted criteria and ranked 
based on their relative value.   
There are three steps in the AHP.  The first step is to identify the numerical weighting 
of the decision criteria using a pairwise comparison matrix (Table 9).  The second step is to 
calculate the relative score of each option (Appendix 15).  The third step is to rank the 
   
70 
 
options based on numeric score from highest to lowest (Appendix 16).  Further discussion of 
how the methodology was used and results of the analysis are provided in Chapters 4 and 5. 
AHP is based on four axioms: 1) comparability, 2) hierarchy, 3) homogeneity and 4) 
completeness.  Comparability refers to the need to measure relative value of two alternatives 
when making a pairwise comparison.  Hierarchy refers to the need to arrange options in 
declining order to support decision making. Homogeneity refers to the need to compare 
things of a similar nature. Completeness refers to the expectation that the ranked list includes 
all relevant options under consideration (Saaty & Kulakowski, 2016).   
3.2.6.1 Procedures and tools. Prior to this research in the host organization, 
development of draft organizational business artefacts had been achieved through 
consultation with business area subject matter experts in the respective business areas within 
the health authority.  There were twenty-three organizational areas identified and each area 
had a draft business competency model and a draft strategy map.  Modeling standards and 
objects included in the business artefacts and process models were based on the standards of 
LEADing Practice which had been researched and developed by members of the Global 
University Alliance and LEADing Practice certified practitioners.  
BPM methodology was used in the development of the end-to-end medication 
management process model, process measures and outcome measures.  Analysis of the 
process facilitated the identification of improvement opportunities.  It is acknowledged that 
the improvement opportunities identified exceeded the available resources; therefore, as 
suggested by (Siriam, 2012), AHP was used to identify those that were likely to have the 
most benefit to the overall process.  The process models were developed using Business 
Process Management Notation (BPMN) as the modeling language.  Business artefacts 
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including all process models were documented using iGRAFX software system and/or 
Microsoft Excel.   
Layered Enterprise Architecture Design (LEAD) includes three layers of architecture 
as described in section 2.3.  Figure 3 shows the three layers and 8 sub layers of LEAD.  This 
layered approach to enterprise architecture design enables development of models and meta-
models illustrating the relationships between objects and meta-objects within, and across 
other layers.  The ability to identify and model the relationships requires a common 
vocabulary be used throughout the layers and sub layers.  Researchers associated with the 
Global University Alliance and practitioners engaged with LEADing Practice have 
developed a Business Ontology that covers all aspects of business including the three layers 
as defined in the LEAD (von Rosing & Laurier, 2015).  The development of business 
artefacts for medication management applied the BPMO to the objects within the business 
layer only.  The objects within the application and technology layer were considered to be 
out of scope and therefore not included in this research.   
3.2.7 Interim reporting. Progress reports were provided to the MSQC to keep 
them apprised of the progress on development of business artefacts and identification of 
improvement initiatives.  The MSQC members were provided revised copies of the business 
artefacts as they were developed and verbal updates were provided on the activities 
undertaken by participants in the workshops and working groups. Workshop participants 
were invited to a wrap up meeting in October 2017.  This provided an opportunity for 
workshop participants who had not participated in the smaller working groups to review and 
comment on the final performance measurement plan and the ranked list of improvement 
initiatives.  The finalized business artefacts including process maturity evaluation results, 
prioritized listing of the planned improvements and listing of the performance measures were 
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provided in advance of the meeting.  There was a considerable level of discussion on the 
prioritized improvement initiative list which will be discussed further in Chapters 4 and 5. 
3.2.8 Collection of data. Data collection included both primary data and secondary 
data.  The primary data included recorded interviews with host organization staff in October 
and November 2017.  The recorded interviews were subsequently transcribed and analyzed 
using a thematic content analysis approach.  The workshops and working group provided 
primary data consisting of medication management business artefacts, listing of performance 
measures and ranked list of process improvement initiatives.  
Secondary data consisted of host organization business artefacts, performance 
measure values, MSQC meeting minutes, and operational planning documents.  This 
secondary data and its impact on the results will be discussed further in Chapters 4 and 5.  
3.2.9 Analysis of data. In addition to the AHP, two other analytic activities were 
undertaken.  These included analysis of: 1) the performance measures selected for inclusion 
in the performance management plan and 2) the transcriptions of the two sets of recorded 
interviews.  
The performance measurement data was analyzed using statistical process control 
charts or Shewart charts developed in Microsoft Excel.  This approach is well suited to 
determine whether a change in a process has resulted in an improvement (Benneyan, Lloyd, 
& Plesk, 2003).  Process control charts were used to analyze the performance measures to 
determine if there was a statistical change in the performance measures subsequent to the 
implemented process improvements identified during the research.  A statistical process 
control chart enables determination of the type of cause resulting from the change in the 
value of a measurement.  The cause is categorized as either due to common cause (random) 
variation or special cause variation.  It can also be used to determine whether there is a 
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“trend” in the data.  The repeated measures are plotted on a run chart and the upper and lower 
control limits are calculated based on the standard deviation from the mean.  Three deviations 
above the mean is used to show the upper control limit and three standard deviations below 
the mean is used to show the lower limit.  If the lower limit calculation results in a negative 
number then zero is used as the lower limit.  Two examples of an indication of a “special 
cause” would be a single point outside the control limits or a succession of eight data points 
in a row either all above or all below the average.  Figure 6 provides an example of a process 
control chart showing the use of the master drug library (MDL) for medication infusions on 
one inpatient ward where a quality improvement initiative had been implemented.  The detail 
related to that initiative is provided in section 4.2.1.  The performance measurement plan 
includes those measures reported to senior executive on a fiscal period basis.  No measures 
other than the one shown in Figure 6 have been reported in this document since the quality 
improvement initiatives had not been completed during the research period and many of the 
measures were not yet available.  The administrative burden of collecting the measures needs 
to be addressed and the intent is to develop appropriate software solutions to automate the 
process as much as possible. 
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Figure 6 Statistical Control Chant showing Percentage of Infusions Using MDL Prepared using Minitab 18 
Statistical Software (2018) 
 The interview data was analyzed using NVIVO software.  The analysis was 
undertaken as three separate activities.  The first analysis included only the transcripts of the 
interviews with the workshop participants.  The second analysis included only the transcripts 
of the interviews with the leaders.  The third analysis used a summative approach to content 
analysis which examined and compared the use of language by interview respondents.  There 
were two comparisons made; the first was the language used between clinical leaders and 
non-clinical leaders, and the second was between responses from workshop participants and 
those of the leaders. 
Thematic content analysis is, “a useful approach for answering questions about the 
salient issues for particular groups of respondents or identifying typical responses” (Green & 
Thorgood, 2004, p. 177) .  Thematic content analysis was employed to analyze the transcripts 
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from both sets of interviews.  The coding was undertaken by one coder and the analysis 
followed a cyclical process where each transcript was read individually to understand the 
text, it was re-read to identify preliminary themes which were coded in NVIVO, the 
preliminary themes were grouped into clusters and themes were tabulated in a summary 
table, thereby going from specifics to generalizations.  
Summative content analysis was used to examine the language used.  The preliminary 
identification was achieved through the automatic queries available in NVIVO software.  The 
results of the automatic queries were analyzed using Microsoft Excel.  
Other qualitative data analysis approaches considered were Interpretative 
Phenomenological Analysis (IPA) and grounded theory.  It was decided to use the content 
analysis approach (both thematic content analysis and summative content analysis) as it was 
more suited to the questions.  IPA is more suited when you want to analyze in depth 
responses at an individual level and is most often used in psychology studies.  Grounded 
theory was also a viable methodology; however, this approach requires selection of the 
approach at the outset of the research.  This methodology had not been selected at the outset; 
therefore, the content analysis was a more appropriate choice. 
3.3 Reliability, Validity, Generalizability and Limitations 
Reliability, validity and generalizability as it refers to quantitative research can be 
challenging to achieve in qualitative research.  It has been proposed that the definitions 
assigned to these terms in the context of quantitative research should be adjusted for 
qualitative research (Bryman et al., 2011).  It has also been proposed that the two primary 
criteria for assessing the quality of a qualitative study should be trustworthiness and 
authenticity (Guba, 1985).   
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3.4 Trustworthiness 
Trustworthiness addresses four criteria that parallel the quantitative research criteria 
of internal validity, external validity, reliability and objectivity.  The four criteria are 
credibility, transferability, dependability and confirmability respectively.  
Credibility (or internal validity) can be inferred with respect to the business artefacts 
since the researcher worked with a group of clinicians engaged in Medication Management to 
develop and validate the artefacts.  The credibility of the results of the analysis of the 
interview transcripts is less straight forward since there is always a risk the beliefs of the 
researcher influenced the results of the analysis despite best efforts to be objective in the 
interpretation.   
Transferability (or external validity) of the findings to another healthcare organization 
or indeed to another organization is questionable since the culture of the organization along 
with the experiences, views and beliefs of the participants played a major role in the 
outcome.  That being said, the medication management process itself is highly regulated so it 
is reasonable to believe the process models and business artefacts could be transferable, at 
least in part, to other healthcare organizations which are subject to similar regulations and 
legislation.  The process of engaging the participants, conducting the workshops, developing 
the business artefacts and using AHP to rank the improvement initiatives is transferable 
although the results would be different based on the social context of the host organization. 
Dependability (or reliability) could be shown through an audit of the research 
documents, interview recordings and secondary data of the host organization.  The research 
was overseen by the PhD Supervisory Committee which contributed to the dependability of 
the research.  An audit is neither reasonable nor feasible and reliance of the dependability of 
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the research is attributed to the researcher and the academics who supported it.  Ethics review 
of the research plan also contributed to the dependability of the research. 
 Confirmability (or objectivity) with respect to the degree the researcher was 
objective throughout the research is, like dependability, difficult to ascertain.  The researcher, 
was also an employee within the host organization and this in and of itself could be viewed as 
compromising objectivity.  Steps were taken to mitigate any situations where a participant 
may have felt that this dual role influenced them or their contributions.  The interviews were 
restricted to peer level or senior leaders within the organization.  The area of research 
’medication management’ is in a different portfolio within the organization then the portfolio 
the researcher worked in.  The Regional Director of Pharmacy played a meaningful role in all 
discussions and review of the final results which would strengthen the objectivity.  No 
interviews were conducted with members of the researcher’s portfolio so as not to create an 
undue influence.  The researcher, as an employee of the organization, did enjoy a level of 
accessibility to the host organization records and staff which is often not available to external 
researchers. 
3.5 Authenticity 
Authenticity in qualitative research has not been as influential as the trustworthiness 
criteria; however, it has been seen to be relevant to action research where practical outcomes 
are sought (Bryman et al., 2011).  The criteria included in authenticity includes:  fairness, 
ontological authenticity, educative authenticity, catalytic authenticity and tactical 
authenticity.   
Fairness requires all levels of organization be involved and in this research there were 
participants from senior and middle management levels within the organization.  Front line 
care providers were not included in the workshops nor were they interviewed.  There was not 
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a conscious decision to exclude front line practitioners but rather it was a consequence of 
operational constraints and the fact participants joined the research on a voluntary basis.  It 
could be assumed that this lack of front line participation limits the fairness of the process 
due to the absence of the opinions and beliefs of this level within the organization.  This 
would in turn be partially offset since the front line managers themselves were mainly 
clinicians some with very recent front line experience. 
The analysis of the process from end-to-end brought insight into the social context in 
which staff worked and how their actions might affect others participating in the process 
either upstream or downstream.  This exploration across organizational boundaries 
contributed to the ontological authenticity which requires that the research helps people 
engaged in the medication management process gain a better understanding of how they fit 
into the social context of their environment.   
The development of the business artefacts and selection of improvement efforts 
generated discussion and varying perspectives were heard by the participants some of which 
were not known by all workshop participants prior to this research.  This contributed to 
educative authenticity which requires the research provide participants with an opportunity to 
gain insight into perspectives of other members within the social setting.   
This research provided an opportunity for individuals to explore the value being 
delivered through medication management and also how that value might be increased 
through improvements in the processes.  Follow up research would show whether or not 
individuals took action subsequent to the research being completed but based on comments 
made during the interviews the participants indicate that they have already begun to 
implement improvements or were planning to do so.  This contributed to catalytic 
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authenticity which requires that individuals change their approach or engage in some sort of 
action to change their circumstances.   
The development of the business artefacts and the increased understanding of the 
entire end-to-end medication management process that each of the participants gained could 
definitely increase their ability to engage in informed discussion on where changes could or 
should be undertaken to increase safety and quality of medication management processes.  
Identification  and review of the Strategic Business Objectives and the Critical Success 
Factors provided clarity and a shared understanding on what was intended to be achieved and 
why.  This contributed to tactical authenticity that refers to whether participant’s level of 
empowerment to take action had increased as a result of the research.   
3.6 Limitations 
This research has the limitations associated with action research some of which are 
referred to in section 3.3.2.  The limitations can be categorized into three themes: 1) timing, 
2) objectivity and 3) transferability.   
There were two issues related to timing.  The research was conducted over an eleven 
month period which means there were changes happening within the organization during the 
time of the research which may or may not have affected the outcomes.  The time frame of 
the research was not of a duration to fully realize the implementation of the improvement 
initiatives and therefore the performance data does not demonstrate the full impact of the 
anticipated changes in process outcomes.   
Objectivity of the researcher could be a limitation due to the fact that a dual role was 
held, both as researcher and employee of the host organization.  This situation is referred to 
in the literature as an ‘insider researcher’ whose role is explored under  three major research 
paradigms of positivism, hermeneutics and action research (Brannick & Coglan, 2007).  Four 
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areas of concern that might be faced by an insider researcher - access, preunderstanding, role 
duality and organizational politics – were explored.  It was concluded that insider research is 
valuable despite the traditional thinking that the researcher should be external so as to avoid 
bias and the risk to objectivity in analysis of the data gathered during the research.  
Furthermore, they assert that with appropriate reflexivity, “insider research is not 
problematic in itself and is respectable research in whatever paradigm it is undertaken” 
(Brannick & Coglan, 2007, p. 72).  The disadvantage and potential bias of the researcher 
being an insider was in part balanced against the high degree of accessibility the researcher 
had to the employees and documentation of the host organization.  This level of access is 
rarely available to external researchers; not necessarily because the organization is 
withholding information, but rather the researcher does not know the information exists and 
therefore does not request it.  Organizational politics did not factor into the research as an 
issue because the organization had officially supported the research and the Regional 
Director of Pharmacy, as the organizational sponsor of the research, was very supportive of 
the work.   
The transferability of the findings to other organizations is of concern particularly 
when the strategy of the host organization may be different than that of other organizations.  
As noted above, medication management is highly regulated so processes are developed to 
ensure compliance with regulations or evidence based practices increase the transferability of 
the findings.  The transferability of the methodology and the tools used could be applied in 
other organizations or in other business areas within the host organization.   
3.7 Summary 
The methodology used in this research was based on a combination of deductive and 
inductive approaches.  A selection of methods and techniques found in both qualitative and 
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quantitative methodologies were used.  The research design was a ten step process that was 
undertaken in an organization that provides healthcare services in acute care hospitals, long 
term care facilities and community programs.  The research included interviews of workshop 
participants and organizational leaders; therefore, ethics approval was required and included 
in the design. Data collection included both primary data and secondary data.  Reliability, 
validity and generalizability of the results were considered in the context of trustworthiness 
and authenticity.  The limitations of the research were also considered particularly from the 
aspect of the researcher being employed by the host organization during the research period.  
The 8-step process followed in this research is summarized in Table 6. 
 
Table 6 Simplified Outline of Process 
Activity  Business Artefact  BPM Lifecycle 
Phase or BA 
Activity 
Identify Strategic Business Objectives, Critical Success 
Factors, Key Performance/Process Indicators 
Strategy Ma(Figure 2) 
Strategy Canvas and 
Performance Measures 
(Appendix 1) 
BA Activity 
Develop End‐to‐End process including core processes, 
management processes and support processes along 
with the Drivers/Influencers of the process 
Value Chain (Figure 4)  Process Discovery 
Identify Business Areas throughout the Organization 
that are involved in the End‐to‐End Process  
  BA Activity 
Identify Business Competency Groups and Business 
Competencies related to the End‐to‐End Process 
Business Competency 
Model (Figure 3) 
BA Activity 
Develop Listing of Processes based on Value Chain and 
Business Competency Model 
Process Reference 
Model 
BPM Activity 
Identify Pain Points and potential improvement 
initiatives and develop future state End‐to‐End 
process if different than current As‐Is process 
represented in Value  
  BPM  Process 
Analysis 
Rank Improvement Initiatives based on AHP approach  Ranked Improvement 
Initiatives (Table 5) 
Process Analysis 
Develop Improvement Plan based on Ranked 
Improvement Initiatives  
  Process Redesign 
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4 Results 
The results of this research are presented in four sections followed by a summary.  
The first section provides the results of the development of the medication management 
business artefacts and the relationships between them using the BPMO.  The second section 
provides an example of a process improvement project undertaken during the research period 
that utilized all phases of the BPM lifecycle.  The third section provides the result of the 
thematic content analysis and summative content analysis of both sets of interviews.  These 
results are presented based on the workshop participant interviews, organization leader 
interviews and analysis of language used in the responses from both sets of interviews.  The 
fourth section is the proposed process reference model for medication management.  
4.1 Business Artefacts 
Although relationships are mainly defined at the level of meta-objects (e.g., in 
enterprise ontologies), the BPMO contains a set of archetypal relationships that have been 
observed to apply to almost any process related object and artefact.  These relationships have 
been defined at the level of meta-object groups, which means that they apply to object groups 
in corporate ontologies, elicited using these meta-objects.  The BPMO identifies sixteen 
meta-object groups.  Although these groups contain meta-objects, they are not meta-objects.  
Their relationships with the process meta-object groups are summarized in Figure 7 which is 
an overview of these sixteen groups and how they relate to the process objects.  These sixteen 
groups assemble composition meta-objects, which can be observed in several areas of 
business other than processes.  Consequently, this template can be reused to represent the 
relations between these sixteen groups and other aspects of business (von Rosing et al., 
2014).   
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Figure 7 The 16 basic BPM Ontology process classes and groups where the examples applied are marked red 
(Source von Rosing, Scheer and von Scheel, 2015 page 107. Reproduced with permission.) 
As illustrated in Figure 7, the process meta-objects do not only have relationships to 
the central concept of a Business Process, but also with multiple other groups.  The 
specification of the various BPMO groups and artefact/template relationships provide an 
important tool to assess the details of the relationship between multiple concepts, as each 
object that belongs to one of these sixteen meta-object groups is expected to be related to any 
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business process object in order to obtain a complete business process specification (von 
Rosing et al., 2014).  This approach is expected to provide a powerful tool to assist in the 
identification and capture of all relevant process aspects, providing an overview of how 
various concepts and artefacts relate to BPM.  The following seven artefacts were key 
deliverables from the workshop and will be discussed further:  
1. Strategy map 
2. Strategy canvas 
3. Business competency model 
4. Value chain 
5. Strategic action plan 
6. Prioritized list of improvement initiatives 
7. Performance monitoring plan.   
The business artefacts were created based on LEADing Practice standards which have 
also been created based on the business ontology.  The content was developed through 
consensus of the workshop participants.  These business artefacts are specific to medication 
management and are aligned with the overall organization’s BA based on the objects 
included in the BPMO.  All business artefacts presented in this research were reviewed and 
accepted by the working group members as representative of medication management within 
the host organization.    
There are several business artefacts that could have also been developed including:  a 
Revenue Model, Cost Model, Process Governance Model, and Process Operating Model.  
The limited availability of workshop participants’ time necessitated the selection of business 
artefacts for development that were critical to identifying quality improvement opportunities.  
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The seven business artefacts chosen were deemed most appropriate.  The other relevant 
business artefacts that were developed but not presented in the results are the numerous 
medication management process models that are included in the process repository of the 
host organization.  The results do include an example of one such model which is presented 
in section 4.1. 
The business artefacts included cover the four sub-layers of the business layer of the 
layered enterprise architecture.  In addition, the business artefacts for the strategic action plan 
and prioritization documents show how the objects within the business artefacts were used in 
the planning and scheduling of process improvements.  Appendix 8 provides a visual 
representation of the business objects and how these objects are related to each other. 
4.1.1 Strategy map and strategy canvas. The purpose of developing a strategy 
map for medication management was to identify the purpose and value of this service.  It 
enabled alignment of objectives for medication management with the organization level 
objectives.  The development of the strategy map also enabled consensus building on the 
strategic business objectives (SBOs), critical success factors (CSFs) and key performance 
indicators (KPIs) which are the objects included in the strategy map.  
LEADing Practice describes SBOs, CSFs and KPIs in a Meta Object Taxonomy 
which they provide to certified practitioners. Unfortunately this document is not publicly 
available.  SBOs are used to describe the strategy which is defined as “The direction and 
ends which the enterprise seeks, as well as the means and methods by which these ends will 
be attained”.  CSFs are described as “Time bounded milestones to measure and gauge the 
progress towards a strategy or goal”.  KPIs are described as “Any of a series of metrics used 
by an enterprise to indicate its overall ability to achieve its mission”.  Table 7 is an excerpt of 
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Appendix 9 Strategy Map objects where the full listing of SBOs, CSFs and KPIs are shown.  
The strategy map shows the organization level SBO, the related medication management 
SBO, the CSFs associated with each SBO and the KPI(s) associated with each CSF.  CSFs 
2.1 and 2.2 do not have a KPI identified for them.  The group acknowledged these are 
important objectives but remained uncertain on how they could be measured.  
Table 7. Medication Management Strategy Map Excerpt 
Organization SBO   Medication Management SBO(s)    Medication Management CSF(s)     Medication Management KPI(S) 
Improve Clinical Outcomes   1.0 Improve Clinical Outcomes    1.1 Ensure medication reconciliation at all transitions in care 
    % of discrepancies (requiring intervention) found after/during 
medication reconciliation 
    % of patient with Medication Reconciliation completed within 24 
hours of admission 
    % of Patients with Medication Reconciliation Completed at 
Discharge 
 
  
Information from organizational level business artefacts was combined with medication 
management specific documents to develop a strategy canvas showing the relationships 
between the CSFs on the medication management strategy map and objects from the 
organizational level artefacts.  This model shows the relationship between CSF and the 
following business objects: 
 Organizational Business Area 
 Medication Safety Working Groups 
 2016-2021 NH Strategic Plan Priorities 
 NH Strategic Business Objectives 
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 Medication Management 3 year Strategic Action Plan Initiatives 
 KPIs 
Figure 8 is an excerpt of Appendix 10 Strategy Canvas for Medication Management 
 
Figure 8. Excerpt from Medication Management Strategy Canvas 
 
4.1.2 Business competency model. The purpose of developing the business 
competency model was to identify and document the business competencies (functions) 
required to deliver the value identified in the strategy map.  The business competency model 
identified the business areas, the business competency groups within the business areas and 
the business functions required to provide medication management services.  The business 
competency groups are shown in three accountability tiers: strategic, tactical and operational.  
The strategic tier includes functions related to governance and long term planning.  The 
tactical tier includes functions associated with monitoring and controlling.  The operational 
tier includes functions related to delivery of the service.  A business competency model can 
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be developed for the entire organization, a single business area or a business service.  The 
business competency model described below is specific to medication management services 
within the host organization. A business competency is defined as “a firm’s ability or 
capacity to turn its resources into customer value and profits” (Rosenberg et al., 2011, p. 45).  
The term competency created some confusion among workshop participants as they struggled 
with delineating the ‘business’ competency from ‘personal or clinical’ competency.  The 
term function was easier for the group to use so in this document the term ‘competency’ is 
interchangeable with the term ‘function’.  Similarly, the clinicians struggled with reference to 
‘business area’ and preferred to use the term ‘organizational area’. 
The medication management business competency model represents a service that has 
processes executed in eight organizational areas.  These include Pharmacy, Acute Care, Long 
Term Care, Home Support, Primary Care, Community Specialized Services, Public Health 
and Records Management.  Appendix 11 shows the business competency ‘map’ which is a 
listing of the competency groups and functions.  The map includes all functions within 
Pharmacy in addition to medication management functions in other organizational areas.  
Appendix 12 is the business competency model which uses the business competency map as 
the starting point. 
In addition to distinguishing the competencies based on organizational area, the 
business competency model also includes rating of the maturity level of the underlying 
processes on the operational tier competencies and several of the tactical tier competencies.  
Due to time constraints not all competencies were assigned a maturity rating by the workshop 
participants.  The maturity level was assigned based on a 1 to 5 ranking (von Rosing et al., 
2014, pp. 408-420).  The result was that most functions were assigned a very low maturity 
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level either 1 or 2 due to the variability in the processes underlying functions across sites.  
The maturity levels are described as: 
 Level 1 - Typically process & procedures of a function are undocumented and in a 
state of dynamic change.  Tends to be siloed, ad hoc, uncontrolled and chaotic 
 Level 2 - Processes & procedures are repeatable, possibly with consistent results, 
discipline is unlikely to be rigorous. 
 Level 3 - Defined and documented process & procedures for function are 
established and subject to some degree of improvement over time.  Standards are 
in place and used to establish consistency of performance. 
 Level 4 - Performance is measured and function can be effectively managed & 
controlled.  Management can identify ways to adjust and adapt the function to 
meet requirements. 
 Level 5 - Focus is on continuous improvement of performance, effectiveness & 
efficiency through both incremental and innovative changes with feedback & 
collaboration. 
4.1.3 Value chain.   A value chain provides a high level view of the functions and 
underlying processes that create value for the customer.  The Medication Management 
Services value chain developed by the workshop participants includes four groupings of 
functions: the core functions are categorized as 1) Manage Medication at Point of Care, 2) 
Provide Clinical Training & Professional Development, 3) Manage Medication Supply Chain 
and 4) Manage & Administrate.   
The medication management core functions include the seven steps showing the end-
to-end process for a patient receiving medication therapy.  These seven steps are:  Patient 
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Registration, Patient Assessment, Prescribing, Point of Care Dispensing, Medication 
Administration, Patient Monitoring and Patient Discharge.  The value chain is shown as 
linear, however, the process is iterative between Patient Assessment and Patient Monitoring 
based on patient response to medication therapy.  
The three groups categorized as either support or management functions include: 1) 
medication supply chain functions, 2) provide clinical training & professional development, 
and 3) manage & administrate.  Medication supply chain functions include: medication 
sourcing, inventory management, medication packaging/repackaging, medication distribution 
and medication returns.  Provide clinical training & professional development functions 
include:  provide pharmacy staff training, provide clinical pharmacy competency 
development, provide clinical education and manage clinical student placement.  Manage and 
administrate functions include:  planning, risk management, compliance management, 
contract management, human resource management, financial management, information 
management, procure and maintain equipment & facilities, and provide operational oversight. 
 The value chain also shows fifteen external influencers or drivers which are known 
to have an impact on how medication management services are organized, delivered and 
governed.  Examples of influencers and drivers include;  Community Partners, Labour 
Unions, Ministry of Health, Geography, Consumer Expectation, Legislation and Professional 
Regulatory Colleges.  The medication management value chain is included as Appendix 13. 
4.1.4 Strategic action plan.   The host organization developed an operational plan 
with eight operational priorities one of which was medication safety and quality (Northern 
Health, 2016).  The Regional Director of Pharmacy was identified as the process owner and 
responsible for the development of a three year strategic action plan to improve medication 
safety and quality throughout the organization.  The initiatives identified were based on 
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selected critical success factors (CSFs) from the medication management strategy map.  
There were a total of twenty-nine initiatives identified based on the review of the end-to-end 
medication management process and the maturity levels of the core, management and support 
processes.  
 The strategic action plan business artefact showed the relationship of each of the 
twenty-nine initiatives to the Medication Management CSFs, and SBOs as well as the 
organizational level SBOs and CSFs.  It also illustrated the alignment to one of the five 
Strategic Plan Priorities included in the 2016-2021 Strategic Plan.  The KPIs from the 
respective medication management CSFs were included in addition to some specific process 
performance indicators (PPIs) depending on the initiative.  The resource requirements to 
achieve the twenty-nine initiatives exceeded those available so there was a need to prioritize 
the initiatives.  This was achieved by the prioritization working group based on criteria 
established by the workshop participants.  The results of the analytical hierarchy process used 
to prioritize the initiatives are presented in the next section. 
4.1.5 Prioritized improvement initiatives.  The objective of the prioritization 
exercise was to develop a ranked listing of the improvement initiatives based on which 
initiatives would contribute the most benefit to medication management safety and quality.  
This was achieved as a three step process.  The first step was to identify and define the 
appropriate criteria for comparison.  The second step was to establish the weighting of the 
criteria.  The third step was to rate each initiative against the criteria.  The result was a ranked 
list of initiatives based on how well each initiative satisfied the criteria. 
The workshop participants identified seven criteria to evaluate each of the initiatives.  
The seven criteria were 1) Business Continuity, 2) Feasibility, 3) Patient Safety, 4) Worker 
Safety, 5) Process Maturity, 6) Strategic Alignment and 7) Financial Impact.  Criteria 
   
92 
 
questions and definitions were established to assist in creating a shared understanding of each 
of the criteria.  Each of the criteria was explored from the perspective of questions related to 
that criteria.  Appendix 14 provides a table showing the complete listing of the criteria, 
criteria questions and definition of each criteria.   
The weighting of the criteria was achieved through a pairwise comparison of the 
criteria based on an AHP scoring approach shown in Table 8.  This scoring approach and the 
excel template are based on an AHP example presented by Dr. Michael Cochrane from Value 
Function Analytics.1  The approach used a one to nine scoring scale (Saaty T. L., 1980).  
When the criteria being scored was higher in value than the criteria it was being compared to, 
a value between 1 and 9 was assigned.  When the criteria being compared was lower in value 
than the criteria it was being compared to, the reciprocal value was assigned.   
Table 8. AHP Scoring Approach  
 
Each of the criteria when compared to itself would have equal value and as a result 
was assigned a value of 1.  When business continuity was compared to feasibility, the 
prioritization working group decided business continuity had a slightly higher value than 
feasibility and assigned a score of 3.  When they compared business continuity to patient 
safety, they decided patient safety was of a higher value and assigned a score of 1/5 which 
                                                 
1 available at https://www.youtube.com/watch?v=zsld4TQacBU  
Intensity of Value
1
3
5
7
9
2,4,6,8
Reciprocals
Intermediate scales between two adjacent judgements
If the criteria being ranked has a lower value than the comparator criteria
Interpretation
Criteria being compared are of equal value
Criteria being ranked has a slightly higher value than the comparator criteria
Criteria being ranked has a strongly higher value than the comparator criteria
Criteria being ranked has a very strongly higher value than the comparator criteria
Criteria being ranked has an absolutely higher value than the comparator criteria
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was the same score assigned to worker safety.  When business continuity was compared with 
process maturity and strategic alignment, they assigned a score of 1/2 to each of those criteria 
as they determined business continuity was of a lower value.  They determined financial 
impact was equal in value to business continuity and assigned a score of 1.  This process was 
completed for each of the criteria.  Table 9 shows the results of the pairwise comparison of 
all seven criteria and the resulting criteria weighting based on the AHP approach.  Not 
surprising that the criteria of Patient Safety and Worker Safety were rated higher in value 
than the other five criteria at 29.5% and 28.9%, respectively. 
Table 9. Pairwise Comparison of Criteria 
Item 
Number Item Number 1 2 3 4 5 6 7 
  Item Description 
Business 
Continuity Feasibility 
Patient 
Safety 
Process 
Maturity 
Strategic 
Alignment 
Financial 
Impact 
Worker 
safety 
1 Business Continuity 1.00 3.00000 0.20000 0.50000 0.50000 1.00000 0.20000 
2 Feasibility 0.33 1.00 0.14286 3.00000 0.20000 3.00000 0.33333 
3 Patient Safety 5.00 7.00 1.00 5.00000 5.00000 5.00000 1.00000 
4 Process Maturity 2.00 0.33 0.20 1.00 0.14286 0.14286 0.14286 
5 Strategic Alignment 2.00 5.00 0.20 7.00 1.00 0.14286 0.14286 
6 Financial Impact 1.00 0.33 0.20 7.00 7.00 1.00 0.20000 
7 Worker safety 5.00 3.00 1.00 7.00 7.00 5.00 1.00 
  Sum 16.33 19.67 2.94 30.50 20.84 15.29 3.02 
                  
 STANDARDIZED MATRIX  
    
Business 
Continuity Feasibility 
Patient 
Safety 
Process 
Maturity 
Strategic 
Alignment 
Financial 
Impact 
Worker 
safety Weight 
1 Business Continuity 0.06 0.15 0.07 0.02 0.02 0.07 0.07 6.5% 
2 Feasibility 0.02 0.05 0.05 0.10 0.01 0.20 0.11 7.6% 
3 Patient Safety 0.31 0.36 0.34 0.16 0.24 0.33 0.33 29.5% 
4 Process Maturity 0.12 0.02 0.07 0.03 0.01 0.01 0.05 4.3% 
5 Strategic Alignment 0.12 0.25 0.07 0.23 0.05 0.01 0.05 11.1% 
6 Financial Impact 0.06 0.02 0.07 0.23 0.34 0.07 0.07 12.0% 
7 Worker safety 0.31 0.15 0.34 0.23 0.34 0.33 0.33 28.9% 
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This criteria weighting was included in the tool used to rank each of the improvement 
initiatives.  The tool was developed in Microsoft Excel.  The tool rated the initiative against 
each of the criteria on a 7 point scale of -3 to +3.  If there was a negative impact anticipated, 
the initiative was given a rating of -3 and the maximum optimistic positive impact was rated 
as +3.  If there was no or minimal impact based on the criteria, the initiative was rated as 0.  
Appendix 15 is a copy of the ranking tool used.  The 7 point scale was used because it 
provided sufficient opportunity for respondents to distinguish and rate the improvement 
opportunities.  A 5 point scale would have resulted in less variance in the rating between the 
initiatives.  A larger scale required respondents to answer with more precision and in some 
cases information was not available to be able to provide the level of precision that would be 
required to respond in a reliable and consistent manner in respect to all initiatives. Appendix 
16 provides the results of the ranking exercise.  Of the twenty-nine initiatives seventeen were 
included in the ranking activity.  The remaining twelve initiatives were not ranked because 
some had been completed, others were mandatory, and therefore excluded, and the remainder 
did not provide enough information to complete the exercise.  
The ranked list was presented to the workshop participants at the final meeting.  The 
participants thought the final list appeared reasonable with the exception of Medication 
Administration rating of 424.7 which ranked it 10th out of the seventeen initiatives.  The 
workshop participant who raised this as an issue had not participated in the prioritization 
working group so was not as familiar with the process and the criteria as those who had 
participated.  One of the participants addressed this concern by referring to the feasibility and 
financial impact criteria explaining that this initiative would require a financial cost and, in 
addition, it would necessitate a change in the practice of all front line nursing staff.  This 
issue was also raised during the interviews and is discussed further in Chapter 5.  
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4.1.6 Performance monitoring plan. The workshop participants and the 
measurement working group developed a list of ninety-one KPIs and PPIs.  The full list of 
measures is provided in Appendix 7.  The majority of these measures are tactical, meaning 
they are intended to be used to monitor or control medication management processes and 
practices.  Eighteen of the measures have been identified as appropriate for Executive level 
reporting.  These are shown in Table 10. 
Table 10. Medication Management Strategic Level Indicators 
 
The strategy map includes forty-eight of the ninety-one identified indicators and the 
strategic action plan includes sixty-one of the indicators.  There is an overlap of twenty-seven 
indicators that appear on both the strategy map and the strategic action plan.  
A review of availability of the indicators was undertaken and there are forty-three 
indicators currently available in electronic format with thirteen available from manual 
sources.  During the research period, an internally developed application to collect clinical 
pharmacy related indicators was being trialed at the host organization.  This application 
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provides values for an additional ten indicators on a fiscal period basis.  The performance 
reporting is expected to include the sixty-six available indicators.  The remaining twenty-five 
indicators will not be considered for reporting unless an efficient method can be developed to 
gather the information.  Appendix 17 provides the anticipated reporting frequency of the 
sixty-six available indicators. 
The performance monitoring report had not been developed but the future design will 
follow similar organizational reporting that provides indicators at the organizational level 
with the ability to drill down to specific facility indicators.  Visualization will include 
statistical process control charts for each of the indicators at the organization wide level and 
at the facility level.  
4.2 Example of Process Improvement Using BPM Lifecycle 
The BPM lifecycle consists of six phases:  1) Process Identification and Opportunity 
Assessment, 2) Process Discovery (AS IS or Current State Process Mapping), 3) Process 
Analysis, 4) Process Re-design 5) Process Implementation and 6) Process Monitoring and 
Controlling.  This research has covered phases one through three with limited activities in the 
remaining three phases.  The process re-design and the process implementation phases were 
not completed due to time constraints and although a performance monitoring plan was 
developed it was not fully implemented.  This work however did set the stage within the 
organization for others to explore opportunities at a detail level which employed BPM and 
demonstrated use of all six phases of the lifecycle.   
4.2.1 Example. An example of this is a process improvement project that improved 
safety of medication administration for those medications administered through an infusion 
pump.  A brief summary of that project is included to demonstrate the use of BPM and how 
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the selection of the initiative can be directly related back to the strategy map and business 
competency model presented above. 
Process Identification & Opportunity Assessment:  Process identification requires the 
systematic identification of processes in an organization.  This example was restricted to a 
function within the medication management processes specific to the use of infusion pumps.  
The processes identified were those specific to the use of infusion pumps.  Three processes 
were identified for opportunity assessment:  1) development of master drug library, 2) 
education of nurses on the use of the infusion pump and 3) administration of medication 
using an infusion pump.  The opportunity identified and addressed was the education of 
nurses on the use of infusion pumps.  The master drug library is intended to improve the 
safety of the administration of medications when using an infusion pump.  The appropriate 
dosage and duration of the medication to be infused is pre-set in the software application of 
the infusion pump.  The nurse is able to set the infusion pump based on pre-set dosage and 
duration or override it and manually program the infusion pump.  The improvement 
undertaken was to increase the use of the master drug library as this would eliminate any risk 
of medication error related to programming either wrong dose or wrong duration.  The initial 
project focused on one nursing unit that had an average of seven thousand seven hundred 
infusions per month with a compliance rate of 74%.  There would be times for it to be 
appropriate for a nurse to override the master drug library and a target of 90% compliance 
was established. 
Process Discovery:  Current state mapping was undertaken to gain a better 
understanding of the current process used by nurses to administer medication using the 
infusion pumps.  Current state mapping was also undertaken to explore the process used to 
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train nurses on the use of infusion pumps.  Figure 9 provides a current state map of the 
infusion pump process.  
 
Figure 9 Current State Map Infusion Pumps 
 
Process Analysis:  Several activities were undertaken in this phase including 
interviews with nursing staff on why they were not using the master drug library and 
exploration of data available for monitoring the use of the master drug library.  It was 
suggested that non-compliance may be associated with a specific set of medications but the 
data was not available to confirm or refute this theory.  This phase revealed the main 
contributor to the non-compliance related to lack of adequate training on the use of infusion 
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pumps.  There was a common practice among the nurses to select basic mode and bypass the 
use of medication drug library when IV fluid was to be used in delivery of the medication.  
Figure 9 shows where in the process this decision point occurred. 
Process Redesign:  The current process for training nurses on the infusion pump was 
revised and the future state process was developed.  The future state process required revision 
of training material and incorporated an annual retesting step to ensure nurses maintained 
their skill level in using the infusion pumps.  There was training provided and an immediate 
change was realized in practice related to IV Fluids and how to use the infusion pump.  The 
decision point was changed to “is this an emergency” if yes bypass of medication drug 
library was appropriate if no use medication drug library. 
Process Implementation:  The new process for training nurses on the use of infusion 
pumps was implemented in the single unit where the project had been undertaken.  Feedback 
from the nurses was used to revise and improve the training before it was implemented in 
other nursing units.  This process has since become standard training across the organization. 
Process Monitoring and Control:  There are two aspects relevant to the process 
monitoring and control phase in this project.  There is a report issued quarterly on the level of 
compliance with the use of the medication drug library during medication administration 
using the infusion pumps.  There is a requirement for retraining of nurses practicing in units 
with low compliance.  The results in the original nursing unit have shown an improvement in 
compliance from the initial 74.15% in January 2017 to 88.63% in December 2017.   Figure 6 
provides a process control chart that shows the monthly changes in this indicator. 
This BPM project can be directly related to SBO 1.0 (Improve Clinical Outcomes), 
CSF 1.5 (Ensure Medications are Accurately & Appropriately Administered) and the KPI 
1.5.2 (Percentage of IV medications infused through MDL (medication drug library)).  The 
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researcher was the Executive Sponsor of this project providing guidance and oversight to the 
project lead. 
4.3 Analysis of Interview Results 
Semi-structured interviews were conducted with eleven of the twenty workshop 
participants and twenty-one of the seventy-three organizational leaders.  The transcribed 
results were analyzed using NVIVO software and a content analysis approach (thematic and 
summative).  There were a total of six themes identified between the two sets of interviews.  
These themes were explored through the lens of whether the respondent was identifying a 
challenge or a benefit within each of the themes.  The six themes identified were Capacity 
Building, Communication, Collaboration, Competing Priorities, Connection to Strategy and 
Culture.  The results of the analysis are presented individually for each of the interview 
groups followed by an analysis of the language used by survey respondents. 
4.3.1 Workshop participant interviews. The workshop participants engaged in a 
process to develop business artefacts expected to assist in the identification and prioritization 
of initiatives that would support improving the safety and quality of medication management 
within the host organization.  There was a 55% response rate to the invitation to workshop 
participants with eleven of the twenty individuals invited agreeing to be interviewed.  
Participants included clinicians and non-clinicians engaged in either the management or 
support for front line staff responsible for the core processes and support processes associated 
with medication management in acute care and long term care facilities.  The eleven 
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respondents had all been involved in either the workshops only or on the two working groups 
derived from the workshop participants. 
4.3.1.1 Capacity building.   The United Nations (2018) defines capacity building as 
“the process of developing and strengthening the skills, instincts, processes and resources 
that organizations and communities need to survive, adapt and thrive in a fast-changing 
world.” Workshop participants expressed their perceptions of the benefits, potential benefits 
and challenges of implementing and using the three methodologies.  Their responses included 
the use of the methodologies as well as the business artefacts.  They also expressed interest in 
taking the work to the next phase of the BPM life cycle of process redesign and 
implementation. 
Using the business artefacts as resources for others outside the workshop participants 
was seen to be a definite benefit.  “I learned a lot, and I think people coming in and looking 
at this work will be able to take bits and pieces or the whole thing and take it back to their 
sites and start working with what we have identified.”  The documentation provided by the 
business artefacts was seen as contributing value both from facilitating improvement of the 
maturity levels of the processes and also from an organizational knowledge perspective.  “It 
(documented processes) would be a good review and a good teaching model to use with new 
staff.” “The BPM, to me, gives you that higher level view and that along with the Business 
Architecture actually gives you a much richer picture of what you are dealing with.”” You 
need to understand the inner workings of that process in order to apply a solution, because I 
know from my past experience that applying an IT solution to a process that you don’t know 
all of the details of, usually results in a more broken process.” 
It was perceived very important to standardize medication management processes that 
are evidence based.  The modeling of the “current as-is process” and of the “future state 
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process” is of benefit when establishing standardized processes.  The need for standardized 
processes was a definite recurring desire.  “It’s a pretty clear science.  Pharmacy and 
medication management.  It’s not gray.  I don’t see why we wouldn’t be standardized.  The 
least amount of variation (in process) is better for patient safety”.  “If we standardize a 
process through nine different sites.  Then one of the sites has an issue, we can highlight it 
and fix it for all the other sites.  Along with that it’s great for employees and staff that move 
from one site to another.” “If you do not have standardized processes you run the risk of 
providing less than optimal care and unbalanced care… If you have totally different 
standards and systems then you run the risk of increasing errors and having decreased 
patient outcomes.”” I believe medication management and the processes should be evidence 
based…and should reflect practices for all stakeholders that ensure the best outcomes for 
patients and are cost effective and to me standardization helps to fulfill that.”   It was 
acknowledged that establishing standardized processes alone would not be enough.  People 
would need to actually follow the established standard process and some suggestions were 
made on how this could be achieved.  “Having a documented process that people have to 
follow, if there’s an understanding underneath it of why you’re following that process, I think 
it makes things safer.”” That’s right it’s got to be safe, and it’s got to make sense, and it’s 
got to be easy for people to do the right thing, and want to do the right thing.  If it doesn’t 
make sense, they either won’t do it or they’ll push back.” “Yeah absolutely we need standard 
processes, and then within that, wherever it’s possible have flexibility.” 
Complexity and challenges with understanding the methodologies and the language 
was a theme expressed by workshop participants.  “I must admit, some of it I did feel like it 
was way over my head. I did try and read the documents ahead of time but I think you did a 
very good job of trying to lay it out for us and explain it for us.”  “So, one of the things I 
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think people feel when they’re first exposed to this is that they don’t understand it and they 
don’t understand it for a while.”” And to compound that, another layer that sits on top of 
that, I think, is that I’m learning new concepts and I’m learning new language at the same 
time so I’m not saying, That’s a dog.  How do you say that in Cantonese?” One participant 
described the methodology as a “bit of a brain teaser.”  The AHP process was a challenge 
for at least one of the participants.  “Don’t ever make me do that number thing again.”                         
4.3.1.2  Communication. Benefits of the documentation and business artefacts as a 
communication tool were frequently expressed.  “I think the documentation forms a review 
and that is the work you want to do and I think it helps with communicating out to staff 
clarifying roles and responsibilities and communicating what those are to staff.”  ”So I think 
that’s going to be the interesting part, is the translation from taking it from the mapping and 
all the work that we’ve done, how do we communicate that to the sites?  Make it usable.”  
”We have to document the process so that we can see where they’re doing things that may 
introduce risk.” 
4.3.1.3 Collaboration. The business artefacts support collaboration by identifying 
gaps which may not otherwise be visible within single silos.  “It’s easy to work in silos and 
not realize where the gaps are.” “Siloing between departments.  It’s a big one.  Making sure 
the right information gets to the right person at the right time without overloading people.” 
“The lack of understanding of why it’s so important in one department to do it this way and 
so to follow through so it is a seamless system.  That’s a very high importance because there 
again if you don’t have that seamless across the different continuums that’s where you have 
your gaps and that’s where you have your highest points of risk.”  
Challenges identified with gaining collaboration included differences in interest level 
and lack of willingness to participate.  “Well, one, is just getting input from all the people 
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that touch it, particularly when people don’t necessarily see the importance or have an 
interest in it.” ”So the complexity of the med system is one that makes it challenging 
particularly when dealing with a large number of stakeholders and sometimes one 
stakeholder may not be able to have their own or all their interests met by making changes in 
the system.” 
4.3.1.4 Competing priorities. A potential benefit was identified related to 
establishment of the performance measurement plan.  This provides information to support 
the selection and prioritization of improvement initiatives.  “As we continue to collect these 
metrics, we can try to figure out where we can get the most bang for our buck, like the best 
outcomes for the limited time and resources we have.”  
The participants expressed a challenge concerning the competing priorities in respect 
to being able to complete this initiative in a fulsome and timely way.  “I don’t feel like we 
have necessarily had the extra resources available to make it feasible.” “It’s very labor 
intensive and probably requires a lot of financial commitment in the organization to make 
significant change.  “If you don’t think these initiatives provide more value than the stuff 
you’re doing currently, you’re not going to spend time on them.” ”But maybe the fact that we 
did spread it out so having shorter sessions spread out was in respect to we all have other, 
we have main jobs to get back to, right, and if you dedicate a whole week to this you are not 
paying attention to your own job.” 
4.3.1.5 Connection to strategy. Participants expressed their understanding of how 
BPM and the business artefacts were beneficial in assisting them in connecting their 
processes to strategy of the organization.  “I am thinking when you first document a process 
you are probably reviewing that process to ensure that process steps that you want to 
participate in to achieve your goals.” ”I think now that we have the metrics lined up to the 
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actual strategic action plan, the strategy map, will help drive which ones we should be 
doing.” “Make sure that we’re meeting our goals, make sure we’re efficient and not wasting 
time on other things like busy work.”   
The respondents did not indicate any challenges regarding connection to strategy.  
This may be related to the lack of representation from front line service delivery clinicians.  
Workshop participants were mainly drawn from management positions with some having 
limited responsibility to provide front line service. 
4.3.1.6 Culture. The workshop participants who agreed to be interviewed made 
several comments that suggest the host organization could be described as a “learning 
organization” where people are willing to try new approaches to problem solving.  “I lacked 
the insight of what I didn’t know at the time and I trust that the work that you are doing, like 
right off the bat, I trust that it was going to help us and it was going to work, even when I 
didn’t quite understand it, because I respected you.”  “Hats off to you and your team for 
taking the complexity of it all and somehow, I call it your magic, being able to turn the 
concept into something practical and useful.”   
The participants identified aspects of the culture they felt were challenges to 
improving medication safety.  One of the most frequently mentioned aspects was 
accountability.  “Because when it’s everybody’s job, it’s no one’s responsibility.” ”I am not 
sure how good the follow up is and are they adhering to those standards.  That’s something 
we have to look at is really the accountability in the system.”  “ There still seems to be this 
sense that a report (referring to self-reporting of medication errors) is going to get someone 
in trouble and that is one of the things getting in the way of people reporting.” Another 
aspect expressed related to risk tolerance.  “The quality piece is not being recognized in what 
people are doing.  They are focusing on getting it done rather than doing it right.”  
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4.3.2 Organizational leader interviews. The organizational leaders have had 
varying degrees of exposure to BPM, BPMO and BA which was evident in the responses to 
the interview questions.  This may also have contributed to the low response rate at 29% of 
those invited to participate.  All those who were invited to participate had been involved in 
presentations of information based on the BA and BPMO; however, not all had been engaged 
or familiar with the BPM methodology.  To date the use of the methodology had been limited 
within the organization.  Despite the lack of familiarity, those who responded to the interview 
were able to recognize the challenges along with the benefits or potential benefits of using 
the methodologies within the organization.   
4.3.2.1 Capacity building. The major theme identified was in the area of capacity 
building.  Interviewees consistently referred to the value of the methodologies in increasing 
their understanding of their program area.  This increased understanding and the 
reusability/transferability of the business artefacts are a potential valuable resource to the 
organization.  
One of the most notable quotes that demonstrates this perspective was from a 
Program Director who had developed BA artefacts for his program areas and based his 
annual planning on the SBOs and CSFs “I always kind of thought I knew the program but 
when you actually have to peel back the layers of the onion, so to speak, you know, you get 
all the aroma, you get your eyes stung out a little bit and it’s the full feel, right.  Versus 
basically picking up an onion, which was where I was at, and saying this is an onion “.  
Likewise another leader who had used the approach to gain clarity on an initiative that was 
spread across several portfolios provided the following quote indicating the approach does 
increase organizational knowledge.  “So we were doing the work without knowing why we 
were doing the work and the process allowed us to identify why are we actually doing this 
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work which allowed us to figure out what the strategic objectives are and the KPI’s would be 
that made sense for that.  And we had been spinning, thinking we knew what we were doing 
without really knowing what we were trying to accomplish.”  A third perspective was 
provided by a leader who had the opportunity to review business artefacts for a program 
within her portfolio including an end-to-end process model, strategy map and business 
competency model.  “It’s that great visual to really identify where the barriers are, where 
the opportunities are and again to be able to go from high level down to the real micro level 
depending on the work that you’re doing”.  A fourth perspective addressed the potential 
benefits of the business artefacts.  “So I think once you get the basic documents, if you 
allowed yourself to continue to use them , you get incredible value looking then at certain 
aspects, like where are we mature, where are we not mature? Where are we spending money 
that we don’t get value from? Where are we under resourcing? Where should we innovate, 
where should we standardize? Like I think the potential and I’ve seen elements of all those 
kinds of discussions going forward.”   A leader provided the following succinct comment in 
reference to the value of the business artefacts.  “At their best they definitely help with 
planning and monitoring and evaluation and then can also inform the various clinical 
operational and organizational shifts that need to occur to carry out the process as it is 
mapped.  So I think that, at their best, they can kind of really help the whole planning, 
implementation, and evaluation component.” 
There were also challenges identified in the area of capacity building which included 
the complexity of such a comprehensive approach.  This concern was raised both by those 
who had invested time using the approach and those who had only been involved at the 
periphery of the initiatives that used the methodologies.  Examples of quotes that 
demonstrate the challenge related to complexity of the methodologies.  “I think it has to be 
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still more intuitive to the different levels.”  “Unless I see what it (strategy map) looks like, 
because these things just confuse me”.  “I don’t know if we’ve done a very good job of 
teaching people what it really means.” I’ll be frank with you, it makes me feel, not stupid, but 
it makes me feel challenged that I’m not able to understand.  And I mean I have a graduate 
degree.”  
 There were also suggestions on how the methodologies could be introduced so they 
were more understandable by the end user.  These included suggestions to ’Fisher Price It’ or 
‘Develop a BPM and BA 101’.  “I know that just in my former role how many times you guys 
came and in, it probably took second or third time of hearing it to really get it and so I don’t 
need to be the knowledge expert in it, but a 101 on how to tap into the knowledge expert who 
can help me.”   Several leaders also suggested it would be an improvement to separate the 
work from the methodology by using an information gathering approach without reference to 
the technical aspects of BPM, BPMO and BA.  Their idea suggested an approach to gather 
the necessary detail so the Business Architects and Process Architects could develop the 
underlying detail and then share the information with the user groups in a simplified way that 
most participants would easily grasp.  “Instead of having the people, the subject experts 
learning another subject matter they’re actually just able to spit out what they do and 
someone captures that because they understand the healthcare system and the business 
architecture.”  There certainly was not consensus on this aspect as other leaders suggested 
they would require an increased understanding of the methodology before they would 
support the implementation in the organization or their portfolio.   
4.3.2.2 Communication. The development of the business artefacts within the 
organization have been achieved by interviews and workshops with those directly involved in 
the business or service area the artefacts are intended to represent.  This approach has 
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provided an excellent opportunity for increasing the communication both within program 
areas and across program areas.   
Leaders interviewed commonly spoke of the value these interactions have had on the 
participants.  One leader who had participated in the process modeling of the information 
request and report development process spoke of her personal experience.  “But had we not 
gone through that process of having the conversations and depicting it visually in front of 
people and what that looks like day to day work effort.  We would not have gotten there just 
in conversation alone.  I think it provides evidence but also provides a starting point for a 
much deeper conversation”.  The business artefacts themselves have also been described as 
beneficial to enhancing communication.  “It was actually one day that in a Directors meeting 
with just coordinating it that we put up the business map (Business Competency Model) and 
we showed how many of us overlap and it definitely improved communication to know when 
to involve people in what.”  One leader who had her group work with a Process Architect to 
develop a complete end-to-end process and use the BPMO to expand the process model to 
include competencies and risks in the clinical process described her thoughts on the benefits 
of the approach.  “It includes layers of information in a clear way and for me to be able to 
get to that level of detail with the chemo nursing has been probably the only way in which 
we’ve actually been able to fully articulate not only the process that the nurses follow but 
what competencies are needed and what risks there are if those competencies aren’t there.  
So I think it’s a really key communication piece, but it keeps you honest and it keeps us 
objective.”  The same leader spoke to using the business artefact as a communication tool.  
“The primary value of it for me is that it’s my source of truth for communicating within my 
team as to how things work.” 
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The introduction of new terminology to the organization was a major challenge and a 
common theme in the leader responses.  One leader in particular challenged the need for the 
terminology.  “And so why we’re forcing terminology that people are clearly having trouble 
with is something we might need to clarify”.  Another suggested that “it needs to be thought 
through to not create a lot of unnecessary confusion.”  Another leader stated “I think one of 
the challenges is that if I take the overall end-to-end thing and I presented it to a Chief 
Operating Officer that is not going to work.”   
These challenges with the terminology were also offset by at least one leader who 
thought the standardization of terminology was a definite benefit.  “So I think it helps us to 
have a common language that we can communicate in, Kind of a visual, but a kind of uniform 
way that now people are getting used to the different streams and they’re using them to some 
degree.” 
4.3.2.3 Collaboration. Healthcare services tend to be siloed and collaboration 
between business units is vital to developing and delivering services that are safe and 
effective for patients.  Promoting collaboration requires the mutual engagement and 
understanding of the organization to recognize where duplications of effort and gaps in 
services exist for the patient.  BPM and BA are effective in supporting collaboration.   
Speaking specifically of the business competency models and the strategy maps at the 
program level, one leader expressed his thoughts on the benefit of the approach.  “The great 
thing too is if the program is one of those programs that touches upon or overlaps with say 
my department, then I can see where we can collaborate on, right.” When asked whether the 
methodologies helped identify improvement opportunities, a leader responded positively.  
“Where I could see improvements is if you are doing one bit of things here that’s assigned 
and there is another group doing similar things you can maybe say well let’s try and see how 
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we can consolidate the functions.” Speaking specifically about the challenges of the current 
siloed approach to healthcare and the potential of these methodologies to identify 
opportunities for improvement one respondent commented: “It takes resources, right and 
capacity to promote and align with other groups, because if we are just in our silos doing our 
own thing.  And just where are the opportunities?”  There were no challenges identified in 
respect to how the use of the methodologies might negatively impact collaboration; however, 
there were challenges identified related to how to address the issue of collaboration when the 
methodology reveals the goals of one business area are seemingly in conflict with those of 
another business area.   
4.3.2.4 Competing priorities. There are limited resources available and the time 
demands on human resources is a constant challenge.  The use of these methodologies can 
support the prioritization of initiatives by identifying which processes are contributing more 
value than others.  However, the development of the business artefacts does require focused 
time from operational leaders and clinicians.   
The benefit of strategy mapping and clearly articulating the Critical Success Factors 
can support prioritization.  A leader articulated this quite succinctly.  “So, it’s been a 
challenge to respond to demand and without going through the strategy mapping process, I 
wouldn’t be able to say no, I don’t have the resources to do that.  Maybe next year.”  Another 
benefit or potential benefit was expressed by a leader in respect to the knowledge gained 
from the identification of functions using the Business Competency Model.  “Because we 
have capacity issues everywhere and if we find that through this process we identify that our 
subject matter experts are spending 50% of their time on work that could be done by a 
centralized shop, whether it’s place at HR or Finance, those kind of things, just there might 
be some efficiencies there”. 
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One leader specifically spoke to the time it takes to understand the methodology.  “I 
feel that I need time to be able to absorb, digest and use this and that in and of itself can also 
be a barrier for frontline staff and physicians who have all kinds of demands on their time.”  
This was reiterated by another leader who had explained why the process modeling she had 
started was not completed.  “I think we’ve just got a little bit more work to do, that piece of 
work for me has stalled just a tiny bit, not because of the mapping piece, but just because we 
had just a whole bunch of other things come up.”  
4.3.2.5 Connection to strategy. One of the purported benefits of BA is that an 
organization can gain insight into the relationship between business objects.  Specifically by 
combining the BPMO Ontology with BPM it is possible to show the relationship between 
processes and organizational strategy.  Leaders who had been involved in the initiatives 
undertaken to date realized this as a benefit to the organization.  In the words of one leader: “ 
so that’s the really strong piece of the business architecture and that approach of looking at 
the process and saying which processes are actually delivering value to the organization”.  
In reference to the development of a strategy map at the portfolio level one leader made the 
following observation.  “We didn’t really know what our strategic business objective was.  
We kind of did, so by identifying all that, now I can take all that work and say oh yes we are 
actually moving the yardsticks towards that objective that we’re trying to achieve.  So it was 
helpful.” One leader spoke about how the artefacts could be used to show front line staff how 
their work plan connected to the organization’s five year Strategic Plan.  “The next steps 
would be once we have that work plan finally finalized, right and then we decide on what are 
the focus areas we’re going to take on, then it’s basic.  Presenting it to the staff, to the 
internal staff and showing them.  This is what has developed in terms of work plan this is how 
it all ties in and integrates with the Northern Health Strategic Plan.”  Leaders who had been 
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active participants in the development of business artefacts were more likely to be able to 
make the connection between the business artefacts and the strategy of the organization.  
4.3.2.6 Culture. The culture of an organization needs to be considered when 
implementing these methodologies.  The degree to which an organization is considered to be 
a “learning organization” and whether there is a culture of “systems thinking” and 
commitment to quality, all contribute to the success of these methodologies.  Leaders spoke 
to the organizational culture both from the perspective of the benefits of the current culture 
and also the challenges of implementing change. 
The “learning organization” concepts were evident based on responses from several 
leaders within the organization indicating they would share their learning from their 
participation in using the methodologies with other leaders within the organization.  “And 
now I’m going to tell another Executive Lead this is what we did, and they’ll be okay, they‘re 
going to start and so it’s that use of it and that peer approach, peer promotion“.  “Because I 
have been lucky enough to be involved in the methodology for a couple of years now, I can 
speak to a certain extent, the language.  And sometimes I think I can and should and do take 
the opportunity to try and explain it to my fellow clinicians in a way I think will make more 
sense to them.  I think the other contribution I make, as a leader, I really value the 
methodology so I try to be a very good ambassador.”  Willingness to accept the methodology 
has been mixed but for the most part those who have engaged expressed they did gain value 
from their participation as indicated in the previous sections.   
Readiness of the culture within the organization to accept the new methodologies was 
expressed by another leader.  He felt the recent introduction of Business Owner Working 
Groups charged with understanding the business functions and business requirements for 
technology solutions has set the organization on a good path to incorporate these 
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methodologies.  “Business Owner Working Groups, I think we need to be opportunistic 
because right now my read on the organization is that it is ready.  That is like they’ve all 
done good work, I saw it in a recent all-day conference a couple of days ago, it’s all right 
there, so it’s low hanging fruit now to pick, organize and move it forward.”  
There were also challenges to the introduction and acceptance of the methodologies 
with leaders citing cultural issues such as: a reactive approach vs a proactive approach, and 
ineffective planning processes.  “We’re not going to get the big changes in healthcare that 
we need if we just keep tweaking”.  “I’m finding it really slow to get uptake actually because 
I don’t know that we do much formal planning...We’re still very reactive.” 
4.3.3 Analysis of language used in survey responses. A word count query of the 
survey responses of leaders was compared to the survey responses of workshop participants.  
The top twenty words accounted for 22.57% of the words in leaders’ responses and 21.83% 
of the words in workshop participant responses.  Looking at the top twenty words in each 
query result showed that there were thirteen words or similar words on both sets of 
responses.  Looking at the top ten words in each query result showed six words or similar 
words on both sets of responses.  The top three words on responses from both sets of 
interviews were the same.  Think (think, thinks, thinking) was number one with a weighted 
average of 3.1% by workshop participants and 2.88% by leaders.  Process (process, 
processing, processed) was second on both sets of surveys with a weighted average of 2.02% 
by workshop participants and 1.42% by leaders.  The third most frequent word used on both 
was like (like, liked, likely, likes) with a weighted average of 1.37% by workshop 
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participants and 1.33% by leaders. Table 11 provides a comparison of top twenty words in 
leaders responses compared to workshop participant responses. 
Interestingly, the respondents’ use of the word “think” could be interpreted as a 
benefit or a challenge.  If respondents use the word “think” to indicate uncertainty then it 
could be perceived as a challenge since this usage indicated a lack of understanding of the 
concepts included in the management approaches introduced.  On the other hand if the 
respondents used the word “think” to indicate these concepts are resulting in them revisiting 
their assumptions about how services are being delivered this then would definitely be 
considered a benefit.  It is a benefit to any organization to have staff and managers think 
critically about the processes being followed unless the status quo is already producing 
excellent results and there is no change in the external environment.  This is not the case in 
any sector and particularly not true in healthcare.  There is room for improvement in the 
processes related to medication management as shown by the medication errors occurring 
and the cost of delivering the service.  
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Table 11. Word Count Comparison – Leaders and Workshop Participants 
 
There were twenty-three leaders interviewed, twelve had a clinical background and 
eleven had a business background.  The management approach introduced is based on a 
collection of management, technology and quality improvement traditions as shown in Figure 
2.  Leaders with a business background would most likely have had exposure in their 
Leaders
Workshop 
Participants
Word 
think (think, thinks, thinking) 2.88 3.1
process (process, processes, processing) 1.42 2.02
like (like, likes) 1.33 1.37
working (worked, work, works, working) 1.31 1.08
business 1.26
know (know, knows, knowing) 1.21 1.15
using (use, used, useful, using) 1.15
right 1.1 0.82
just 1.06 1.03
one (one, ones) 1.06 0.98
people 0.95 1.04
need (need, needs, needed) 0.91 1.09
things (thing, things) 0.84 1.31
get 0.84 1.01
map (map, maps, mapped, mapping) 0.79
really 0.79 0.68
model (model, models, modelled, modelling) 0.75
going 0.74
organization (organized, organizing, organize, 
organization)
0.73
end (end, ended, ends) 0.71
yeah 1.3
medications (medication, medications) 0.89
well 0.68
manager (manage, managed, management, manager, 
managers)
0.63
times (time, timely, timing, times) 0.86
efficient (efficient, efficiency, efficiencies) 0.69
make (make, makes, making) 0.84
Grand Total 21.83 22.57
Weighted Percentage
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education with components of all these traditions while clinical leaders would most likely 
have had minimal exposure to management and technology traditions in their clinical 
education.  Therefore, it was important to determine whether or not this difference in 
foundational education between the two sub-groups would lead to a difference in words used 
in responses to the interview questions.  An additional analysis was conducted to identify 
whether there was any evidence of a difference in responses based on foundational education 
of the respondents.  The result of the top twenty words in each category of leader showed that 
the same eighteen words were in the top twenty words in the responses by both groups.  This 
result does not provide any evidence that the difference existed.   Table 12 shows the results 
of the comparison of the weighted average of the top twenty words between clinical leaders 
and business leaders.   
   
118 
 
Table 12. Word Comparison - Clinical and Business Leaders 
 
4.4 Medication Management Process Reference Model 
To be useful, a process reference model for medication management should be 
generic enough for use as a starting point for the development of any health organization’s 
process architecture.  The proposed reference model for medication management resulting 
from this research used the process meta-objects of the BPMO described in section 3.2.6.1.  
The reference model created as part of this research includes one hundred and sixty-four 
individual processes categorized in four process areas and twenty-five process groups.  
Clinical 
Leaders
Business 
Leaders
Word 
think (think, thinks, thinking) 2.68 2.6
process (process, processes, processing) 1.57 1.4
like (like, likes) 1.43 1.26
business 1.36 1.69
right 1.25 1.26
using (use, used, useful, using) 1.17 1.21
one (one, ones) 1.17 0.89
know (know, knows, knowing) 1.1 1.15
just 1.01 1.07
working (worked, work, works, working) 0.99 1.37
people 0.88 0.84
end (end, ended, ends) 0.88 0.86
area (area, areas) 0.82
get (get, gets, getting) 0.82 0.85
need (need, needs, needed) 0.81 0.89
map (map, maps, mapped, mapping) 0.75 0.82
organization (organized, organizing, organize, 
organization)
0.74 1.03
things (thing, things) 0.72 0.78
model model, models, modelled, modelling) 0.69 1.09
understanding (understand, understanding) 0.67
artifacts (artifact, artifacts) 0.72
really 0.85
Grand Total 21.51 22.63
Weighted Percentage
   
119 
 
Process Area is defined as “the highest level of an abstract categorization of processes”.  
Process Group is defined as “a categorization and collection of processes into common 
groups”.  Process is defined as “a set of structured activities or tasks with logical behaviour 
that produce a specific service or product” (Rosing, Scheer, & Scheel 2015, p.102).  The 
process steps and process activities were not included in the process reference model as this 
level of detail is context specific at an organizational and/or department level and could be 
different for every organization. 
Table 13 provides a comparison of LEAD process levels to APQC and SCOR process 
levels. 
Table 13. Comparison of Different Views of Process Levels 
Levels 
APQC Process 
Classification Framework 
LEAD Process 
Levels 
SCOR (Supply Chain 
Operations Reference 
Model) 
1 Category Process Area  
2 Process Group Process Group Level 1 
3 Process Process Level 2 
4 Activity Process Step Level 3 
5  Process Activity Level 4 
Adapted from Table 1 page 133 The Complete Business Handbook (von Rosing, Scheer & von Scheel, 2015) 
A process can be categorized and tagged according to the role it fulfills within the 
organization.  There are three types of processes including: 1) core (or main) processes, 2) 
supporting processes and 3) management processes.  Process architectures including the 
process reference model are designed based on the process type.  
The core (or main processes) are defined as those processes that provide a service.  In 
the case of medication management this includes the processes provided at the point of care.  
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The individual roles involved in main processes are the clinicians and care providers that 
assess, diagnose, prescribe, dispense, administer, monitor and discharge patients.   
The supporting processes support the delivery of the main processes.  In the proposed 
reference model, the support processes are categorized into two areas depending on whether 
the processes were related to management of medication supply chain or provision of training 
and education.  The recipients of training and education include both staff and external 
students who are placed in the organization as part of their formal education.  A separate 
grouping of these processes was deemed appropriate since they could be considered to be 
either support or management processes depending on the recipient.  The individual roles 
involved in support processes are the pharmacy staff with respect to medication supply chain 
and clinical pharmacist in respect to clinical education. 
Management processes include administrative processes and the processes required to 
manage the core and support processes.  The process reference model for medication 
management further categorizes these into nine groups based on the business function.  The 
individual roles involved in management processes are the Regional Director, Pharmacy 
Managers, Anti-Microbial Stewardship Pharmacists, Drug Utilization Pharmacist and 
Administrative Assistants.  
The Process Areas and the Process Groups used in the reference model were derived 
from the Value Chain described in section 4.1.3 and presented as Appendix 13.  A total of 
four Process Areas were identified.  These are:  1) Manage Medication at Point of Care, 2) 
Provide Clinical Training & Professional Development, 3) Manage Medication Supply Chain 
and 4) Manage & Administrate.  In addition, a total of twenty-five Process Groups were 
identified Table 14. 
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Table 14 Process Areas & Process Groups 
 
Appendix 18 shows the Process Areas, Process Groups and the one hundred and 
sixty-four Processes included in the proposed process reference model.  Each of the 
processes are associated with at least one business function.  Appendix 19  provides a 
Areas Groups
1. Manage Medication at Point of Care
1.1 Register Patient
1.2 Assess Patient
1.3 Prescribe Medication
1.4 Dispense Medication at Point of Care
1.5 Administer Medication
1.6 Monitor Patient
1.7 Transfer or Discharge Patient
2. Provide Clinical Training & Professional Development
2.1 Provide Pharmacy Staff Training
2.2 Provide Clinical Pharmacy Competency Development
2.3 Provide Clinical Education(External to Pharmacy)
2.4 Manage Clinical Student Placement
3. Manage Medication Supply Chain
3.1 Source Medication
3.2 Maintain Medication Inventory
3.3 Mix & Repackage Medication
3.4 Distribute Medication
3.5 Return Medication
4. Manage & Administrate
4.1 Plan
4.2 Manage Risk
4.3 Monitor Compliance
4.4 Manage Contracts
4.5 Manage Human Resources
4.6 Manage Financial Resources
4.7 Manage Information
4.8 Procure & Maintain Equipment & Facilities
4.9 Provide Operational Oversight
   
122 
 
definition of each business function included in the business competency model.  The source 
of these definitions is an internal document of the host organization.  
The identification of processes was achieved through review of the functions included 
on the Business Competency Model for Medication Management Services (Appendix 12).  
Each function was reviewed and the processes required to deliver the function were listed 
and included in the process reference model.  A single function may require numerous 
processes to deliver it.  Also, some processes can have a relationship with more than one 
function.  An example of this is the process to “monitor training effectiveness”.  This process 
is related to more than one function because the functions are separated based on the 
recipient of the education. Figure 10 Relationship between Process Reference Model Meta-
Objects and Business ArtefactsFigure 10 shows the relationship between the Medication 
Management Process Reference Model and the objects included on two business artefacts 
Value Chain and Business Competency Model. 
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Figure 10 Relationship between Process Reference Model Meta-Objects and Business Artefacts 
 
Two approaches were taken in an effort to validate the completeness of the process 
reference model.  The first was to compare the listed processes to those listed in other 
relevant reference models.  The second was to review the initial draft of the process reference 
model with the Regional Director of Pharmacy within the host organization.  External 
validation of the process reference model was not undertaken. 
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Two relevant reference models were used for comparison:  1) SCOR reference model 
(Supply Chain Council Inc., 2012) and 2) the APQC (PCF) Process Classification 
Framework (American Productivity and Quality Centre (APQC), 2014).   The reason these 
two were used was because these are both open source.  In addition, the SCOR reference 
model could be closely aligned with the supply chain operations included in medication 
management and the APQC PCF was intended to be used by health care organizations. 
The SCOR is specific to supply chain operations and as such was used in respect to 
the process area of Manage Medication Supply Chain.  SCOR also includes management 
processes which were included in the Manage and Administrate process area.  The processes 
included on the SCOR could be related to the processes in two process areas of the 
medication management reference model.  The four groups  of Source, Make, Deliver and 
Return from the SCOR model could be compared to the five groups on the medication 
management reference model of Source Medication, Maintain Medication Inventory, Mix & 
Repackage Medication, Distribute Medication and Return Medication.  The remaining two 
groups from the SCOR specifically Plan and Enable could be compared to the nine groups in 
Manage & Administrate and three of the four groups under Provide Clinical Training & 
Professional Development on the medication management reference model.  The seven 
process groups included in Manage Medication at Point of Care and one group from the 
Provide Clinical Training & Professional Development could not be compared to the SCOR 
model.  Therefore it would appear that at the process group level all process groups from 
SCOR can be found on the medication management reference model.  The additional groups 
included on the Management reference model are not supply chain specific so it is reasonable 
they would not be on the SCOR model. 
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APQC has developed numerous industry specific Process Classification Frameworks 
(PCF) including one related specifically to the provision of health care.  This PCF does not 
differentiate pharmaceutical inventory management between centralized inventory or point of 
care inventory which have different processes and specific legislated considerations.  
Although it can be used as a general guide it was not specific enough for use as a medication 
management process reference model. 
The Regional Director of Pharmacy reviewed and accepted the process reference 
model as a reasonable listing of the processes associated with medication management and 
safety.  Additional validation with other workshop members was anticipated but was not 
undertaken prior to the completion of the research due to availability of workshop 
participants. 
4.5 Summary of Results 
Chapter 4 included results in four areas: 1) medication management business 
artefacts, 2) a completed BPM project in medication management, 3) thematic and 
summative content analysis of interviews and 4) a proposed process reference model for 
medication management.  The comprehensive approach using BPM, BPMO and BA 
represented in this research has yielded some interesting results.  Despite some challenges, 
both host organization participants and leaders acknowledge the benefits of the approach.  
The business artefacts represent foundational documents which could be valuable knowledge 
management and communication tools.  They could help create a better understanding of 
how medication management could be viewed from the perspective of value, business 
competency and process.  The AHP approach to prioritization of the improvement initiatives 
could be useful in any service area in the healthcare organization.  Knowledge from the 
workshop and leader interviews could be used to modify and improve how BPM, BPMO and 
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BA are introduced in other healthcare organizations.  The proposed Process Reference Model 
for Medication Management could be used by other healthcare organizations as they strive to 
understand the processes related to medication management or introduce BPM.  
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5 Discussion and Conclusion 
The primary intention of this research was to expand on the current body of 
knowledge related to the introduction of a combination of BPM, BPMO and BA as a 
comprehensive management approach to improve operational processes in a complex 
adaptive system such as healthcare.  This chapter consists of five sections which discuss 
findings and conclusions derived from the research undertaken.  The first section discusses 
the impact of introducing three management disciplines; specifically, BPM, BPMO and BA 
in a healthcare organization.  The second section discusses the proposed medication 
management Process Reference Model developed as part of this research.  The third section 
discusses the perceived challenges and benefits of using these three management disciplines 
in the host organization.  The fourth section presents the contribution of this research to the 
current body of knowledge and potential avenues for future research and finally, the fifth 
section provides concluding remarks on the research.   
5.1 Integrating BPM, BPMO and BA in a Health Organization 
BPM is a management discipline that has “process” as its focus and more specifically 
end-to-end processes which often span business units and even organizational boundaries.  
Medication management processes within a multi-facility healthcare organization were at the 
centre of this research.  Understanding the processes associated with medication management 
and how those processes fit within the larger organizational context was explored, however, 
no attempt was made to investigate processes outside the organizational boundaries of the 
host organization.  The established BPMO of LEADing Practice was employed to create a 
shared language related to the process objects.  The business artefacts presented in Chapter 4 
included objects related to the process level in addition to objects related to value, business 
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competency and services.  The BPMO includes all these objects demonstrating it could be 
effectively and successfully applied to industries such as healthcare. 
There were four significant impacts realized from the introduction of BPM, BPMO 
and BA in the host organization.  The first was creation of knowledge assets in the form of 
business artefacts to support improvement of medication management in the organization.  
The second was the adoption of a common language that increases understanding across 
organizational areas and facilitates improved communication.  The third was establishment of 
a repeatable process that would support creation of similar business artefacts in other 
organizational service areas.  The fourth was the changed perspective of the individual 
participants which has led to their adoption of new approaches to service planning.  This 
comprehensive approach has led to development of business artefacts that increase 
organizational knowledge which in turn results in an increase in organizational capacity 
previously discussed in section 4.3.2.1.  In reference to research question 1, this research 
demonstrated how a business ontology used in other industries could be effectively applied to 
healthcare services. 
5.2 Proposed Process Reference Model  
Research question 2 asked what processes should be included in a process reference 
model for medication management applicable to both hospitals and long term care facilities.  
The proposed Process Reference Model uses the BPMO of LEADing Practice.  It could be 
employed as a starting point in other healthcare organizations initiating a process architecture 
as it is based on medication management processes which are relatively standard across 
healthcare.  The processes are derived from review of the medication management functions 
(business competencies) included in the Business Competency Model and these are then 
categorized into logical groups.  The groups are then categorized into areas. 
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A common approach to developing a process architecture is to separate the processes 
into one of three types:  core, support or management.  These three types form Level 1 in the 
architecture.  The BPMO refers to this level as an area.  The reference model developed in 
this research has four areas: 1) Manage Medication at Point of Care, 2) Manage Medication 
Supply Chain, 3) Manage and Administrate and 4) Provide Clinical Training and 
Professional Development.  The rationale for including the fourth area is the processes within 
Provide Clinical Training and Professional Development do not align with only one process 
type.  There are processes within the area that could be considered to be support or 
management.  The clinical nature of medication education and clinician’s reliance on 
education being provided by clinical pharmacists warranted it as an area on its own.  This 
area also includes a process group related to training of students and residents from academic 
institutions who complete practicums in the host organization facilities.   
5.3 Challenges and Benefits 
This section summarizes the perceived challenges and benefits of using BPM, BPMO 
and BA in a healthcare organization.  It addresses three of the five research questions from 
Chapter 1.   
3) What performance measurements in addition to medication errors are appropriate 
for monitoring and controlling medication management? 
4) How can BPM be effectively applied to a situation that involves multiple sites and 
multiple business units responsible for Medication Management functions? 
5) What are the benefits and challenges of using BPM and Business Ontology to 
improve Medication Management? 
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In response to question 3, the Measurement Working Group (MWG) identified 
ninety-one key performance indicators and process performance indicators they considered 
appropriate for monitoring and controlling medication management.  The full listing is shown 
in Appendix 7.  Examples of measures related to monitoring include measures of compliance 
with known procedural steps to prevent a medication error such as: “percentage of orders 
compliant with Safe Medication Order Writing Policy” and “percentage of medications 
infused through Medication Drug Library”.  Examples of measures related to controlling 
include:  “cost of expired drugs” and “number of average turns of inventory”.  The MWG 
participants identified eighteen of these indicators that were thought to be relevant at the 
executive level given the relationship of those indicators to the current organizational 
strategy and directions. A listing of these indicators are provided in Table 10.   
In response to question 4, it is the inclusion of BPMO and BA combined with BPM 
that enabled the adoption of BPM across the multiple sites and business units.  Despite the 
challenges, the workshop participants developed business artefacts and a process architecture 
that incorporated all sites and business units within the host organization.  The full lifecycle 
of BPM was not achieved in this research due to time constraints and availability of 
resources.  However, implementation of BPMO and BA of medication management 
processes was achieved.  Organization wide business artefacts were created and development 
of a process architecture for medication management was accomplished.  Table 15 shows the 
stages of the BPM life cycle and comments on specific aspects achieved during the research 
period. 
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Table 15 Comments on Stages of BPM Lifecycle  
Stage Comments 
Process Identification Initial phase includes identifying processes and relationships 
which lead to development of a process architecture.  In 
addition this phase includes identification of process 
performance measures.  Both these objectives were achieved 
as shown by the Medication Management Process Reference 
Model and the Performance Management Plan 
Process Discovery Achieved through the development of current state ‘as is’ 
modeling using BPMN.  Selected medication management 
processes prioritized for improvement have been modeled as 
part of this research.   
Process Analysis Achieved as shown by the ranking of maturity levels and 
identification of improvement initiatives.  The prioritized list 
of initiatives is shown in the Appendix 16. 
Process Redesign Partially completed as described by the example provided in 
Chapter 4 and the design of a medication reconciliation 
process currently being implemented. 
Process Implementation Minimally with a few examples available where the process 
redesign was implemented including the process for training 
on the infusion pumps, development of medication order sets 
and process for establishing inventory levels.  
Monitoring & Controlling Minimally due to the challenges related to developing the 
collection mechanism for the metrics.   
 
In response to question 5, results reported in Chapter 4 revealed organization leaders 
and workshop participants perceived both challenges and benefits in using BPM, BPMO and 
BA.  The responses were themed into six categories:  Capacity Building, Communication, 
Collaboration, Competing Priorities, Connection to Strategy and Culture.  Some of the 
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identified challenges related to the concepts themselves while others related to the process 
used to introduce the concepts.  One recurring concern was that the process followed was 
inadequately resourced resulting in a longer than ideal timeframe to complete the work.  This 
was a legitimate challenge as all members of the working group were contributing to the 
work on an ‘as time permitted basis’.  However, for most participants it was seen to be a 
worthwhile undertaking and they were actively engaged in the development of business 
artefacts.  
There were important lessons learned from introducing BPMO in the healthcare 
sector. The use of language, in other words, how the concepts related to BPMO are 
communicated, must resonate with those involved with the work.  In this case, the use of 
terms such as ‘competency’ and ‘business area’ were not intuitively understood or accepted 
by clinicians in the host organization and became contentious.  Further investigation revealed 
that healthcare clinicians in a publicly funded healthcare organization do not perceive 
themselves to be ‘in business’ which contributed to their resistance and reluctance to describe 
their clinical work as a ‘business area’.  Similarly, there is a significant focus in the clinical 
world on personal competency to safely and effectively deliver specific treatments or 
interventions.   
Notwithstanding the issue with ‘competency’, there was no difficulty observed with 
the BPMO language related to the objects introduced from the other business layers.  One 
example is the group’s rapid adoption of the terms ‘strategic business objective’, ‘critical 
success factor’ and ‘key performance indicator’ including freely referring to these in the 
corresponding acronyms SBOs, CSFs and KPIs.   
Worthy of note in assessing the benefits and challenges of this approach, was the 
emphasis placed on ‘thinking’ by both interview groups.  The benefit of stimulating non-
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traditional thinking and approaches in the health care sector was that the organization was 
able to achieve results and perspectives hitherto unattainable.  Without this fundamental 
change in ‘thinking’ that this approach generated, it is doubtful that notable benefits would 
have been realized.  
There are benefits both to the organization and to the workshop participants resulting 
from the research.  The AHP approach to prioritize the identified improvement initiatives 
was effective and the process can be used in other organizational areas needing to prioritize 
improvement initiatives.  The business artefacts can be reused for numerous purposes 
including employee orientation, monitoring of performance, alignment of activities to 
strategic objectives, business planning and other activities where organizational knowledge 
related to medication management is required.  This research has built capacity within the 
organization and set the stage for future process improvements in medication management. 
The research participants were provided with the opportunity to develop business 
artefacts and contribute their clinical knowledge to advance the information assets of the 
organization.  The discussions and information sharing provided a rare opportunity to look at 
the clinical work from a different perspective. 
5.4 Contribution and Future Research 
There are three notable contributions arising from this research.  The first relates to 
the increase in organizational knowledge and understanding of the medication management 
process within the host organization, the second is the development and documentation of a 
process reference model for medication management and the third is the demonstration that a 
comprehensive management approach combining BPM, BPMO and BA can be achieved in a 
healthcare organization.  The fundamental catalyst in achieving these results was the 
stimulation of non-traditional thinking. 
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This research and non-traditional thinking has led to, and continues to support, 
transformative change in both individuals and the organization.  It has been a journey of 
discovery for those involved in the research, it has armed them with a new language, new 
lines of communication and new vision to see their organization and how it functions.  
Healthcare has been slow to adopt new management practices and this holistic approach 
supports mindful and deliberate change.  It provides powerful linkages between day to day 
work of the individuals on the front lines with the overall organization’s strategies and goals.  
The recipients of healthcare services are the ultimate beneficiaries of improvements in the 
healthcare system.   
Further research is recommended, specifically in the following two areas:  
1) Expanding the breadth and depth of the use of this comprehensive management 
approach in healthcare.  It is recommended that research be undertaken to: 
 Test and validate the medication management process reference model in 
other organizations; 
 Complete a longitudinal research study by repeating the interview process 
with organizational leaders in the host organization one year out and two 
years out to identify to what degree the potential benefits were realized 
and/or challenges overcome; and, 
 Expand use of the comprehensive approach to other end-to-end healthcare 
processes. 
2) Explore the challenges associated with clinicians viewing their practice from a 
business perspective.  
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5.5 Concluding Comments 
Despite the challenges identified, the host organization has embraced the 
comprehensive management approach of using BPM, BPMO and BA to improve services.  
Process identification is currently underway in three other end-to-end processes within the 
host organization: 1) A redesign of home support services that will improve care to clients 
and more closely align home support services with primary care in the organization, 2) 
Design and implementation of a family practice twenty-five bed inpatient unit, and 3) 
Improvement and standardization of the inpatient registration process with the desired 
outcome of improving data quality and information flow.  
On a personal note, I would say leading any organization through adoption of a 
comprehensive approach such as this is not for the fainthearted.  The benefits however, far 
outweighed the challenges.  I was provided with an exceptional opportunity to contribute to 
the body of knowledge related to transferring management approaches from other industries 
into the healthcare sector and at the same time increase the knowledge assets of the host 
organization.  
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Appendices  
Appendix 1. Listing of Ontologies 
Ontology Name Brief Description References 
Business Ontology The Business Ontology is a 
foundational ontology 
applicable to various domains. 
It defines basic notions like 
objects, relations, structure, 
arrangements and so on. It 
provides a meta model of a 
conceptual schema with a 
system of meta-level 
categories. Providing real-word 
enterprise semantics for 
general enterprise modelling 
languages. It was designed in 
collaboration between 
academics and industry 
practitioners 
von Rosing, M., & Laurier, 
W., (2015), An 
Introduction to the 
Business Ontology, 
International Journal of 
Conceptual Structure 
and Smart Applications, 
3, : 20-41 
 
von Rosing, Zachman, J. 
(2017). The Need for a 
Role Ontology. 
International Journal of 
Conceptual Structures 
and Smart Applications. 
Volume 5, Issue 1 
 
BPM Ontology The BPM Ontology is a 
domain ontology based on the 
business ontology by 
specializing the terms to 
process concepts introduced in 
the core-reference ontology. As 
a domain ontology, the BPM 
Ontology could be linked to a 
specific application or task.  
von Rosing, M., Scheer, A. 
W., von Scheel, H., (2015) 
The Business Process 
Management Handbook. 
Boston: Morgan 
Kaufmann. doi:10.1016/ 
B978-0-12-799959-
3.00007-0 
FIBO – Financial Industry 
Business ontology 
Described as a business 
conceptual ontology that 
provides a shared language for 
those involved in the financial 
industry.  It was developed 
through collaboration of 
vendors and members of the 
financial industry. 
http://www.edmcouncil.or
g/financialbusiness 
REA – Resource Event 
Actor Business Ontology 
Based on a conceptual 
accounting framework and 
used in development of 
accounting systems. The 
O’Leary, D.E. (2010) 
Enterprise ontologies:  
Review and an activity 
theory approach, 
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original REA ontology 
included core economic 
phenomena of exchanges, 
resource-agent dependencies, 
resource dependencies, agent 
dependencies and 
commitments.  REA continues 
to be developed and has 
become embedded in some 
software standards. 
International Journal of 
Accounting Information 
Systems, 11: 336-352 
Geerts, G.L. (2000) The 
Ontological Foundation of 
REA Enterprise 
Information Systems 
retrieved March 28 from 
https://www.researchgate.n
et/profile/Cheryl_Dunn/pu
blication/228583572_The_
ontological_foundation_of
_REA_enterprise_informat
ion_systems/links/5425839
20cf238c6ea7411b7.pdf   
 
 
SBMO Strategic Business 
Model Ontology 
The focus of the ontology is on 
the goals of the business which 
is in contrast to the other 
business model ontologies that 
focus more on the value 
creation and participants within 
business 
Samavi, R., Yu, E. and 
Topaloglou, T. (2009) 
Strategic Reasoning about 
business models: a 
conceptual modeling 
approach, Information 
Systems and e-Business 
Management, 7:171-198 
TOVE – Toronto Virtual 
Enterprise 
This is a formal ontology with 
the capability of describing 
enterprise in general.  It is 
made up of a set of 13 sub 
ontologies as follows:  
Activity, Time, Cost, Resource 
Inventory, Quality, 
transportation, Manufacturing 
Resource, Order, 
Organizational, Manufacturing 
Osterwalder, A., (2004) 
The Business Model 
Ontology A Proposition in 
a Design Science 
Approach retrieved March 
25 from 
http://www.uniempre.org.b
r/user-
files/files/TheBusiness-
Model-Ontology.pdf 
O’Leary, D.E. (2010) 
Enterprise ontologies:  
Review and an activity 
theory approach, 
International Journal of 
Accounting Information 
Systems, 11:336-352 
TEO - The Edinburgh 
Enterprise Ontology 
The Edinburgh group has 
developed an ontology that can 
be used to describe enterprises 
generally and can also be used 
Osterwalder, A., (2004) 
The Business Model 
Ontology A Proposition in 
a Design Science 
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to specify software system 
requirements.  This ontology 
has been described as being 
less formal then TOVE. 
Approach retrieved March 
25 from 
http://www.uniempre.org.b
r/user-
files/files/TheBusiness-
Model-Ontology.pdf 
O’Leary, D.E. (2010) 
Enterprise ontologies:  
Review and an activity 
theory approach, 
International Journal of 
Accounting Information 
Systems, 11:336-352 
BFO – Basic Formal 
Ontology 
BFO is an upper level ontology 
widely used in the healthcare 
domain. It consists of many 
sub ontologies which are 
divided into two categories: 
continuant and occurrent.  
Continuant (snapshot or point 
in time) or occurrent (process 
which occurs over time).  
Blobel, B., Goossen, W., & 
Brochhausen, M., (2014), 
Clinical modeling-A 
critical analysis, 
International Journal of 
Medical Informatics 83: 
57-69 
e3Value Focus is e-commerce and is 
based on Value creation. It 
supports a high level 
perspective and includes Actor, 
Value Object, Value Transfer, 
Value Port and Value 
Interface.  These core building 
blocks are then used to 
represent value chains.   
Pombinho, J., Aveiro, D., 
& Tribolet, J. (2014) A 
Matching Ontology for 
e3Value and DEMO A 
sound bridging of Business 
Modelling and Enterprise 
Engineering 
Business Model Ontology Business Model Ontology that 
is built on nine building blocks 
within four areas.  The four 
areas are:  Product, Customer 
Interface, Infrastructure 
Management and Financial 
Aspects,  The nine building 
blocks are:  Value Proposition, 
Target Customer, Distribution 
Channel, Relationship, Value 
Configuration, Capability, 
Partnership, Cost Structure and 
Revenue Model 
Osterwalder, A., (2004) 
The Business Model 
Ontology A Proposition in 
a Design Science 
Approach retrieved March 
25 from 
http://www.uniempre.org.b
r/user-
files/files/TheBusiness-
Model-Ontology.pdf 
 
HL7 – Health Language 7 Service oriented architecture 
healthcare ontology which 
(HL7) Health Level Seven 
International (2015) About 
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focuses on electronic 
information exchange.  Health 
Level Seven International is a 
standard setting organization 
that focuses on setting 
standards that enable exchange, 
integration, sharing and 
retrieval of electronic health 
information  
HL7, accessed January 
2016 from 
http://www.hl7.org/about/i
ndex.cfm?ref=nav  
ARIS – Architecture of 
Integrated Information 
Systems 
Enterprise ontology consisting 
of 12 classes Function, 
Organizational Unit Human 
output, goal, event, application 
software, output, input, 
environmental data, event, 
hardware, and machine  
Scheer, AW, (1998b) 
Business Process 
Engineering, Berlin 
Springer Verlag, as cited 
by O’Leary, D.E. (2010) 
Enterprise ontologies:  
Review and an activity 
theory approach, 
International Journal of 
Accounting Information 
Systems, 11: 336-352 
SAP – Shape Acquisition 
and Processing 
Commercial based and 
provides an extensive 
vocabulary to be used in the 
SAP enterprise software.  It has 
been compared to REA. 
O’Leary, D.E. (2010) 
Enterprise ontologies:  
Review and an activity 
theory approach, 
International Journal of 
Accounting Information 
Systems,  11:336-352 
Table 16 Listing of Ontologies 
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Appendix 2. Interview Guide for NH Leaders 
Interview guide: Post development of Business Architecture Artefacts: 
1. Have you been involved in the development of any of the following artefacts: 
a. Strategy Map,  
b. Business Model 
i. Value Chain 
ii. Accountability Model 
iii. Operating Model 
iv. Performance Model 
2. Was the artefact developed for an organizational business area or for an end-
to-end process within the organization? 
a. Which area or process? 
3. How confident are you that each of the artefacts is complete and appropriately 
represents the organizational business area or end-to-end process for which it was 
created? 
4.  What benefits, if any, do you think these artefacts have for the organization? 
5. Are the artefacts helpful in increasing your understanding of how the overall 
organization is structured? 
6. Do the artefacts provide insight into where improvement efforts should be 
directed? 
7. Does the Performance Model assist you in understanding or communicating 
with others how the day to day processes are contributing to the realization of the 
organizations strategy? 
8. What did you find useful about your participation in this activity? 
9. Do you have any suggestions on how the process could have been improved? 
10. What would you suggest as next steps in the communication or use of 
business architecture artefacts within the organization?  
11. Are there any additional comments you would like to make in respect to the 
development or use of Business Architecture within Northern Health? 
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Appendix 3. Interview Guide for Study Participants  
Interview guide: Post development of the medication management process model: 
1. Have you been involved in the development of the end-to-end process model for 
medication management?  What role did you play? 
2. Are you aware of the performance measures being reported within the organization in 
respect to medication management?  How confident are you that the current performance 
measures being reported for medication management are appropriate?  Why? 
3. How confident are you that the medication management practices in your facility 
minimize the risk of medication errors?  What changes do you think would further reduce 
the risk of medication errors? 
4. Do you think documented processes would be helpful in reducing errors related to 
medication management? How? 
5. How important is it for process to be both effective (achieve what it was intended to 
achieve) and efficient (deliver quality at lowest cost)?   
6. What are your thoughts on the efficiency of the medication management process in 
your facility? 
7. Do you have any suggestions on how the process could be made more efficient? 
8. The medication management process spans several organizational departments.  What 
challenges do you perceive exist in developing an end-to-end process model for processes 
such as medication management that span multiple departments? 
9.  How important do you perceive the need for standard processes to be in respect to 
the medication management process? 
10. Are there any additional comments you would like to make in respect to the 
development or use of the end-to-end process model for medication management? 
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Appendix 4. Workshop Participant Information Letter and Consent Form 
 
 
Date _________________________________ 
 
Incorporating Business Process Management and Business Ontology to Improve Medication 
Management Safety and Quality 
 
 
Project Lead: Bonnie Urquhart 
University of Northern British Columbia 
Prince George, BC V2N 4Z9 
e-mail Urquha2@unbc.ca  and/or (250) 565-2493                                              - 
 
I am conducting a research study that will explore how Business Process 
Management and Business Ontology can be incorporated into an approach to 
improve medication management safety and quality.  This research study is 
undertaken in partial fulfillment of the requirements of my Doctorate of Philosophy 
(PhD) in Health Sciences from the College of Arts, Social and Health Sciences at the 
University of Northern British Columbia.  The application for research regarding this 
study has been reviewed by the Research Ethics Board of both UNBC and Northern 
Health.  
 
I will be carrying a dual role during the study, one as the researcher and the other as 
Regional Director of Planning and Performance Improvement.  My role in respect to 
this study will be to facilitate information sharing related to Business Process 
Management and Business Ontology with staff and physicians as well as collect 
participants perspectives on the barriers and benefits of this approach to support 
quality and process improvement.  All necessary steps will be taken to manage any 
potential conflict of interest arising from my dual role as researcher and Regional 
Director, Planning and Performance Improvement 
 
 
Purpose of Project 
 
Northern Health has committed to improve medication management safety and 
quality.  An oversight governance committee, Medication Safety and Quality 
Committee (MSQC), has been formed under the leadership of Dr. Dana Cole, 
Regional Director Pharmacy Services.  Members of the MSQC as well as members 
of the working groups reporting to that Committee will be invited to participate in this 
study along with staff that engaged in one or more of the quality improvement 
projects endorsed by the Committee during the period of this study.   
 
Two workshops are planned as part of the study.  Workshop invitees will include 
members of the MSQC as well as subject matter experts leading working groups 
reporting to the MSQC. 
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What will happen during the study? 
 
Your participation will consist of attendance at one or two of 3 to 4 hour workshops 
to be held at a Northern Health site.   
 The first workshop will be used to review and validate business 
artefacts related to medication management in Northern Health.  The 
business artefacts to be validated include business competency models, 
strategy maps, performance models, operating models and an end-to-end 
process model for medication management.  The first workshop will also 
include orientation and introduction to Business Process Management, 
business ontology and the business artefacts currently in use in Northern 
Health. 
 The second workshop will be used to identify, prioritize, select, 
sequence and assign quality and process improvement projects related to 
medication management safety and quality. 
 
You are not obligated in any way to participate in this study.  Your participation in the 
research is strictly voluntary.  Participation will consist of your participation in one or 
more workshops where medication management relevant business artefacts will be 
developed and specific processes for improvement will be identified.  Given the 
nature of workshops and group participation confidentiality of the opinions and 
information you share during the workshop(s) cannot be assured.  At no time will any 
specific comments be attributed to an individual in any report out of this study 
without prior consent of that individual.  The study report will include the business 
artefacts derived from the workshop and will also include a record of the process 
used to rank the medication management processes selected for improvement 
projects.   
 
In addition to these two workshops two sets of interviews will be conducted as part of 
this study. 
 The first group of interviewees will be individuals who have 
participated in a quality improvement project during the duration of this 
study.   
 The second group will be senior leaders within Northern Health 
who have had an opportunity to develop or review business artefacts 
using the Layered Enterprise Architecture Design standards for 
business architecture. 
 
These interviews are currently planned to be held in May to June of 2017.  A 
separate information letter and consent form will be provided should you fit the 
selection criteria for either of the interview groups. 
 
Risks or benefits to participating in the project 
 
   
162 
 
I do not anticipate that there will be any personal benefit or risk to participants in this 
study. The interviews will be conducted during your regular worked hours and the 
interview time will be included in your regular compensation.  
 
Physician time will be compensated based on Northern Health practices related to 
physician time spent on quality improvement initiatives. 
 
I anticipate that results from this study will benefit Northern Health and the academic 
community at large by providing insight into the barriers, benefits and challenges of 
using Business Process Management and Business Ontology in addressing safety 
and quality in the healthcare system overall and more specifically in the area of safe 
and high quality medication management services. 
 
 
Study Results 
 
I will be submitting a final report on the study to UNBC as well as sharing the result 
of the study within Northern Health.  I may also pursue academic publication of 
portions of the study in relevant academic journals or present results at academic or 
health related conferences. 
 
Questions or Concerns about the project 
 
If you have any questions regarding this study or your participation please contact 
the Project Lead at the email address or phone number at the top of this document. 
 
If you have any concerns or complaints about your rights as a research participant 
and/or your experiences while participating in this study, contact the UNBC Office of 
Research at 250-960-6735 or by e-mail at reb@unbc.ca. 
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Participant Consent and Withdrawal – Workshop Participants 
 
 
CONSENT 
 
I have read or been described the information presented in the information letter about the 
project:  
 
YES   NO 
 
I have had the opportunity to ask questions about my involvement in this project and to receive 
additional details I requested.   
 
YES   NO 
 
I understand that if I agree to participate in this project, I may withdraw from the project at any 
time up until the report completion, with no consequences of any kind.  I have been given a copy 
of this form. 
 
YES   NO 
 
I agree to be recorded (if applicable).    
 
YES   NO 
 
I agree that my name can be used (if applicable).   
 
YES   NO 
 
Follow-up information can be sent to me at the following e-mail address:  
 
Email:  _____________________________________________________ 
 
 
YES   NO 
 
 
Signature (or note of verbal consent):  
 
Name of Participant (Printed):  
 
Date:  
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Appendix 5. Interview Information Letter & Consent Form  
Information Letter / Consent Form for Interviewees 
 
Date ________________________________ 
 
Incorporating Business Process Management and Business Ontology to Improve Medication 
Management Safety and Quality 
 
 
Project Lead: Bonnie Urquhart 
University of Northern British Columbia 
Prince George, BC V2N 4Z9 
e-mail Urquha2@unbc.ca  and/or (250)613-5581                                           - 
 
I am conducting a research study that will explore how Business Process 
Management and Business Ontology can be incorporated into an approach to 
improve medication management safety and quality.  This research study is 
undertaken in partial fulfillment of the requirements of my Doctorate of Philosophy 
(PhD) in Health Sciences from the College of Arts, Social and Health Sciences at the 
University of Northern British Columbia.  The application for research regarding this 
study has been reviewed by the Research Ethics Board of UNBC and Northern 
Health. 
 
 
 
Purpose of Project 
 
Managers and healthcare practitioners are responsible to provide safe, effective and 
efficient service to their patients.  Services such as medication management span 
numerous providers and organizational groups.  It is proposed that having a shared 
understanding of end-to-end process and being able to connect the individual 
processes to the larger system of services could facilitate quality improvement and 
identification of technical efficiencies within a healthcare organization.  
 
This study will specifically focus on the end-to-end process of medication 
management in Acute Care and Long Term Care facilities.  The study will explore 
the benefits & challenges of using Business Ontology and Business Process 
Management in a multi-site geographically dispersed healthcare organization. 
 
Northern Health has committed to improve medication management safety and 
quality.  An oversight governance committee, Medication Safety and Quality 
Committee (MSQC), has been formed under the leadership of Dr. Dana Cole, 
Regional Director Pharmacy Service.  Members of the MSQC as well as members of 
the working groups reporting to that Committee will be invited to participate in this 
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study along with staff that engaged in one or more of the quality improvement 
projects endorsed by the Committee during the period of this study.  I have been 
invited to sit in on MSQC meetings as a non-voting member. 
 
 
Your Participation 
 
You are being invited to participate in this project because you have participated in a 
quality improvement project in medication management or you are one of the senior 
leaders within Northern Health who have had an opportunity to develop or review 
business artefacts using the Layered Enterprise Architecture Design standards for 
business architecture. 
  
What will happen during the project? 
 
Participation will consist of one audio taped interview with the principal investigator 
(Bonnie Urquhart).  It is anticipated that the interview will take between 30 and 60 
minutes of your time.  The interview will be conducted during your regular scheduled 
worked hours.  The audio tapes will be transcribed by me as the researcher or by a 
transcriptionist who has signed a confidentiality agreement.  Any expense in hiring of 
a transcriptionist will be paid by me as the principal researcher.  The transcribed 
information will be analyzed to identify barriers and benefits of incorporating 
Business Process Management and Business Ontology to support improvements in 
medication management safety and quality. 
 
You are not obligated in any way to participate in this study.  Your participation in the 
research is strictly voluntary.  Anonymity cannot be guaranteed. 
 
All data collected, including the audio tapes of the interviews and the transcribed 
data will be kept secured in a locked cabinet during the study period and destroyed 
upon completion of the study and acceptance of the final report by UNBC.  Data 
collected from your interview will not be made available to anyone other than the 
transcriptionist or me.  All comments will be treated as confidential information and 
any quotes used in the final report will not include identifiable data.  If you participate 
in the study and subsequently decide to withdraw prior to the acceptance of the final 
report by UNBC the data collected from your interview will be removed from the 
report and destroyed within 30 days of your notification to me of your decision to 
withdraw.   
 
 
Risks or benefits to participating in the project 
 
I do not anticipate that there will be any personal benefit or risk to participants in this 
study. The interviews will be conducted during your regular worked hours and the 
interview time will be included in your regular compensation.  
 
I anticipate that results from this study will benefit Northern Health and the academic 
community at large by providing insight into the barriers, benefits and challenges of 
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using Business Process Management and Business Ontology in addressing safety 
and quality in the healthcare system overall and more specifically in the area of safe 
and high quality medication management services. 
 
 
Potential Conflict of Interest 
 
In addition to my role as Principal Investigator on this study I hold the position of 
Regional Director, Planning and Performance Improvement in Northern Health.  In my role 
as Principal Investigator I will be responsible for conducting workshops and interviews in 
addition to creating and reviewing documentation and business artefact related to the 
medication management processes within Northern Health.  The content of the 
documents will be provided by staff and physicians within Northern Health who are 
directly involved in medication management processes or have participated in quality 
improvement projects related to medication management processes. 
 
In my role as Regional Director, Planning and Performance Improvement I may also, as 
time permits, participate in medication management quality improvement projects during 
the study.  
 
All necessary steps will be taken to manage any conflict of issues arising from my role as 
Principal Investigator and Regional Director, Planning and Performance Improvement. 
 
 
 
 
 
 
Study Results 
 
I will be submitting a final report on the study to UNBC as well as sharing the result 
of the study within Northern Health.  I may also pursue academic publication of 
portions of the study in relevant academic journals or present results at academic or 
health related conferences. 
 
Findings from this study will be made available to all participants.  If you are 
interested in receiving a copy of the final report please contact me via email and I will 
provide you with a copy of the final report. 
 
Questions or Concerns about the project 
 
If you have any questions regarding this study or your participation please contact 
the Project Lead at the email address or phone number on the first page. 
 
If you have any concerns or complaints about your rights as a research participant 
and/or your experiences while participating in this study, contact the UNBC Office of 
Research at 250-960-6735 or by e-mail at reb@unbc.ca. 
 
 
Participant Consent and Withdrawal 
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Taking part in this study is entirely up to you.  You have the right to refuse to 
participate in this study.  You have the right to refuse to answer any questions that 
make you feel uncomfortable.  If you decide to take part, you may choose to pull out 
of the study at any time before the acceptance of the final report by UNBC without 
giving a reason and without any negative impact on your employment with Northern 
Health. 
 
CONSENT 
 
I have read or been described the information presented in the information letter about the 
project:  
 
YES   NO 
 
I have had the opportunity to ask questions about my involvement in this project and to receive 
additional details I requested.   
 
YES   NO 
 
I understand that if I agree to participate in this project, I may withdraw from the project at any 
time up until the report completion, with no consequences of any kind.  I have been given a copy 
of this form. 
 
YES   NO 
 
I agree to be recorded (if applicable).    
 
YES   NO 
 
I agree that my name can be used (if applicable).   
 
YES   NO 
 
 
 
Signature (or note of verbal consent):  
 
Name of Participant (Printed):  
 
Date:  
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Appendix 6. Workshop Attendance Log 
Position Title Professional 
Background 
Consent 
on file 
Dec 8 Dec 15 Jan 24 Interviewed 
Regional 
Director 
Pharmacy  
Pharmacist Yes Yes Yes Yes Yes 
Chief Operating 
Officer Northern 
Interior 
Nurse 
Executive 
Yes Yes Yes Declined No 
Director, 
Clinical 
Information 
Systems 
IT 
Administrati
on 
Yes Yes Yes Yes No 
Chief Medical 
Information 
Officer and 
Family 
Physician 
Physician  Yes Yes Yes Declined No 
Regional 
Medication 
Safety Officer 
Nurse Yes Yes Yes Yes Yes 
Regional 
Medication 
Safety & 
Informatics 
Pharmacist 
Pharmacist Yes Yes Yes Yes No 
Director 
Inpatient and 
Restorative 
Services 
Nurse Yes Yes Declined Declined No 
Pharmacy 
Manager 
Northeast 
HSDA 
Pharmacist Yes Yes Yes Declined Yes 
Administrative 
Assistant to 
Regional 
Director 
Pharmacy 
Administrati
on 
Yes Yes Yes Declined No 
Director of Care 
Fort St. John 
Hospital 
Nurse Yes Yes Declined Declined Yes 
Chief Nursing 
Officer, Lead 
Professional 
Nurse Yes Yes Declined Yes No 
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Practice 
Strategy 
Professional 
Practice Leader 
Clinical 
Pharmacy 
Services 
Pharmacist Yes Yes Yes Yes Yes 
Medication Use 
Management 
Pharmacist 
Pharmacist Yes Yes Declined Yes No 
Antimicrobial 
Stewardship 
Pharmacist 
Pharmacist Yes Yes Yes Yes Yes 
Health Service 
Administrator 
FSJ Hospital 
Nurse  yes Yes Declined Declined Yes 
Process 
Architect 
Business Yes Yes Yes Yes Not 
Asked 
Process 
Architect 
Business Yes Yes Declined Yes Not 
Asked 
Pharmacy 
Manager 
University 
Hospital of 
Northern BC 
Pharmacist Yes Yes Declined Declined No 
Regional 
Manager, Risk 
and Compliance 
Risk 
Management 
Yes Yes Yes Yes Yes 
Regional 
Medication Use 
Management 
Pharmacist 
Pharmacist Yes Yes Declined Declined Yes 
Regional 
Manager 
Pharmacy 
Solutions 
IT Yes Yes Yes Yes Yes 
Lead, Regional 
Quality 
Processes 
Business Yes Yes Yes Yes Yes 
Table 17 Workshop Attendance Log 
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Appendix 7. List of Recommended Performance Measures 
# of physician specific order sets;  
 % of compliance with privacy and confidentiality audits 
# of active order sets that are up to date 
# of average turns of inventory 
# of clinical pharmacy hours per 100 inpatient days 
# of facilities meeting National Association of Pharmacy Regulatory Authorities (NAPRA) standards 
# of interventions per hour clinical pharmacist time 
# of IV to PO step down interventions  
# of Medication Utilization Reviews Completed Annually 
# of Medication Utilization Reviews Completed Annually for AMS; 
# of anti‐infective Drug Therapy Problems resolved per inpatient admission  
# of CQI projects completed that identified  and realized efficiency gains 
# of identified Drug Therapy Problems per 100  inpatient admissions 
# of medical students receiving clinical education during their 3rd year rotation 
# of medication doses administered in error per PSLS resulting in harm level greater than or equal 
to level 3 harm  
# of pharmacy residents in NH 
# of pharmacy technician students receiving education annually 
# of regional order sets; 
# of resolved drug therapy problems per 100 outpatient visits 
# of resolved drug therapy problems per 100 resident days 
# of Resolved DTPs per 100 inpatient admissions  
# of staff who have had a performance review in past 24 months 
# of Patient assessments completed by pharmacists or pharmacy technician 
# of site specific order sets 
# of incident reports of staff exposure 
% of facilities with infusion pumps meeting established standard 
% of identified critical processes with process maturity level 3 or above 
% of Interventions accepted in prospective audit and feedback regarding antibiotics 
% of IV medications infused through MDL 
% of meds delivered late per PSLS reports 
% of meds dispensed in unit dose format including ward stock 
% of meetings where all NH representatives attended 
% of nursing units with narcotic and controlled drugs stored in AMDCs 
% of alignment NH formulary to Provincial formulary 
% of discrepancies (requiring intervention) found after/during medication reconciliation 
% of documented processes with Standard Operating Procedures 
% of facilities dispensing patient specific medications on 24 hour batch 
% of formulary reviews completed by NH 
% of individuals expected to complete SMOW education who have taken SMOW 
% of internal shipping errors 
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% of medication errors while AMDC on override  
% of medication orders entered accurately as assessed by pharmacist at verification 
% of medications accessed through AMDC on over‐ride 
% of nurses who have completed SMOW education module 
% of oral to IV of high bioequivalent 
% of orders clarified by Pharmacist ( not therapeutic interchange) 
% of patients educated on Medications by a pharmacist 
% of patients with medication therapy plan documented as part of "care plan" (longitudinal plan) 
% of pharmacists who have completed SMOW education module 
% of pharmacy technicians who have completed SMOW education module 
% of physicians who have completed SMOW education module 
% of staff/physicians accessing education opportunities 
% of unit clerks who have completed SMOW education module 
% of VTE audits where patients received appropriate prophylaxis 
% of oral solid meds with bar code on unit dose packaging; 
% of patients with Medication  Reconciliation Completed within 24 hours of admission  
% of Patients with Medication  Reconciliation Completed at Discharge 
% of patients with medication therapy plan documented as part of "plan of care" (episodic plan) 
% of products with appropriate Beyond Use Dating according to NAPRA standards 
Actual inventory value or estimate based on Value on Hand reported in Cerner for all NH 
Pharmacies 
Average Length of Stay per acute inpatient admission 
Average Turnaround time of medications from order scan to release of medication (Pyxis) 
Cost of antimicrobials per 100 inpatient days 
Cost of expired drugs as % of inventory cost 
Cost of expired drugs as percentage of drug budget 
Cost of expired drugs for credit 
Cost of expired drugs not for Credit as a % of inventory 
Cost of expired drugs not for credit as a % of total expired drugs 
Cost of expired drugs not for credit in pharmacy inventory 
Cost of IV antibiotics per 100 inpatient days 
Cost of oral antibiotics per 100 inpatient days 
Defined Daily Dose (DDD) per 100 patient days for targeted antibiotic 
Door to needle time for thrombolytic 
Drug Cost per 100 inpatient days 
Drug cost per 100 resident days in LTC facilities (non Plan B) 
Drug Costs per inpatient day 
High cost antineoplastic drug utilization in pharmacy  
Order entry average time per pharmacy department (% variance from benchmark) 
Rate of discrepancies from best practice identified during pharmacy audit of narcotics books 
Reported patient satisfaction on medication education provided 
Reported patient satisfaction with pain management during hospital stay 
Student Satisfaction Survey 
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Time of antibiotic administration from ordering 
Total Cost of Expired Drugs 
Turnaround time of internal medication inventory transfers based on established benchmark 
standards. 
Work life Survey ‐ level of satisfaction 
% of orders compliant with Safe Medication Order Writing (SMOW) 
# of pharmacist clinical training weeks provided  
% of pharmacists who meet competency measures for clinical pharmacy  
% of reported errors per orders entered as per PSLS reports  
 Order verification average time per pharmacy department (% variance from benchmark)  
 
Table 18 Complete List of Suggested Measures 
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Appendix 8. Meta Model of Understanding 
 
Figure 11. Meta Model of Understanding 
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Appendix 9. Strategy Map 
Medication Management Strategy Map 
Organization Strategic Business Objective 
  Medication Management Strategic Business Objective 
   Medication Management Critical Success Factor 
    Medication Management Key Performance Indicator 
Improve Clinical Outcomes 
  1.0 Improve Clinical Outcomes 
   1.1 Ensure medication reconciliation at all transitions in care 
    % of discrepancies (requiring intervention) found after/during medication 
reconciliation 
    % of patient with Medication Reconciliation completed within 24 hours of 
admission     % of Patients with Medication Reconciliation Completed at Discharge    1.2 Improve communication of medication care plan and plan of care at all transitions 
   
 
% of patients with medication therapy plan documented as part of  "plan of care" 
(episodic plan) 
   
 
% of patients with medication therapy plan documented as part of  "care plan" 
(longitudinal plan)    1.3 Ensure Optimal Medication is Prescribed 
    # of resolved Drug Therapy Problems per 100 inpatient admissions     # of resolved drug therapy problems per 100 resident days 
    # of resolved drug therapy problems per 100 outpatient visits (need numerator to 
exclude diagnostic outpatient visit)     % of orders clarified by Pharmacist (not therapeutic interchange)     Average Length of Stay per acute inpatient admission     # of clinical Rx hours per 100 inpatient days     # of active order sets that are up to date    1.4 Ensure medications accurately and appropriately dispensed 
   
 
Average turnaround time of medications from order scan to release of medication 
(Pyxis)     % of medications dispensed in unit dose format including ward stock 
    % of medication orders entered accurately as assessed by pharmacist at 
verification     % of facilities dispensing patient specific medications on 24 hour batch     % of reporter errors per order entered as per PSLS reports 
    Order entry average time per pharmacy department (% variance from 
benchmark)    1.5 Ensure medications are accurately and appropriately administered 
   
 # of medication doses administered in error per PSLS per 100 patient days     % of medications infused through MDL     % of medications accessed through AMDC on over‐ride     % of medication errors while AMDC on override    1.6 Improve Antimicrobial Stewardship 
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 # of IV to PO step‐down interventions      # of anti‐infective Drug Therapy Problems resolved per inpatient admission     % of oral to IV of high bioequivalent drugs 
    % of Interventions accepted in prospective audit and feedback regarding 
antibiotics     Defined Daily Dose (DDD) per 100 patient days for targeted antibiotic     DDD of IV vs PO formulations of high bioequivalence antimicrobials     # of Medication Utilization Reviews Completed Annually for AMS;    1.7 Optimize Medication Education and Self‐Management 
   
 % of patients educated by a pharmacist on Medications     Reported patient satisfaction on medication education provided 
Improve patient and family experience 
  2.0 Improve patient and family experience 
   2.1 Ensure informed shared decision making regarding medication therapy 
   2.2 Ensure appropriate information is shared regarding timelines and access 
Improve Provider Engagement 
  3.0 Improve Staff, Physician and Clinical Student Experience 
   3.1 Ensure they have the tools they need to do the job 
    Work Life survey ‐ level of satisfaction    3.2 Provide appropriate development opportunities 
    % of staff/physicians accessing education opportunities    3.3 Improve and share information on performance both personal and medication safety 
   
 # of staff who have had a performance review in past 24 months    3.4 Appropriately match resources to need 
   
 # of clinical pharmacy hours per 100 inpatient days    3.5 Provide meaningful clinical education experience 
    # of medical students receiving clinical education during their 3rd year rotation 
    # of pharmacy technician students receiving education annually     # of clinicians receiving education on clinical pharmacy at orientation    
 Student Satisfaction Survey Scores 
Control per capita cost 
  4.0 Control per patient cost 
   4.1 Increase standardization to reduce arbitrary variation 
 
  % of documented processes with Standard Operating Procedures 
   4.2 Increase focus on CQI to Improve efficiency through reducing non‐value added 
activity    
 # of CQI projects completed that identified  and realized efficiency gains    4.3 Minimize inventory cost 
   
 Cost of expired drugs in pharmacy inventory     Actual inventory  value  for all NH Pharmacies     # of average turns of inventory    4.4 Ensure lowest cost/most effective drug therapy management 
   
 Drug cost per 100 resident days in LT facilities (non Plan B) 
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 Drug cost per inpatient day     4.5 Participate effectively on BCHA P&T, BCSS & HealthPro collaborations 
    % of meetings where all NH representatives attended 
    % of formulary reviews completed by NH 
    % of alignment NH formulary to Provincial formulary 
Table 19 Strategy Map Objects 
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Appendix 10. Strategy Canvas 
 
   
178 
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Figure 12 Strategy Canvas 
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Appendix 11. Business Competency Map 
 
 
 
Strategic Direction Portfolio Management
Strategic Plan and Goals Key Measurements and Performance Indicators
Resource Allocations Pharmacy  & Medication Management Strategy Development
Pharmacy  & Medication Management Governance Planning Regional Services Planning
Research Best Practice
Medication Research Strategy Medication Research Planning
Pharmacy Partner Management Community Management
Government Relationship Pharmacy Public‐Private Partnership
Population Level Surveillance Standardize Process and Practice
 Formulary Management Planning Clinical Trial Planning and Coordination
Business Operations Planning Quality Improvement
Pharmacy & Medication Management Risk Analysis Pharmacy & Medication Management Risk Control (Adverse 
Events)
Pharmacy & Medication Management Risk Measures Pharmacy & Medication Management Risk Rule & Regulations
Pharmacy & Medication Management Risk Monitoring  Pharmacy & Medication Management Risk Compliance
Pharmacy & Medication Management Risk Reporting
Equipment Scheduling Equipment Maintenance
Equipment Renting/Leasing Equipment Tracking & Asset Management
Supplier Collaboration Supplier Evaluation
Supplier Sourcing Supplier Monitoring
Supplier Requirement Management Supplier Negotiation
Pharmacy & Medication Management Access Management Pharmacy & Medication Management Knowledge Management
Pharmacy & Medication Management Information Management Pharmacy & Medication Management Governance Control & 
Monitor
Pharmacy & Medication Management Governance Planning Pharmacy & Medication Management Governance Evaluation & 
Audit
Pharmacy & Medication Management Governance Compliance Pharmacy & Medication Management Continuous Improvement
Integration & Practice Management  Patient Records Management
Operational Budget Management Forecasting
Capital Budget Management Long term business planning
Contract Negotiations Contract Liability Management
Contract Budget Management Contract Compliance Management
Human Resource Staffing Staffing Compliment Management
Staff Performance Management Recruitment
Retention Staff Development
ST
RA
TE
G
IC
Pharmacy & Medication Management Planning
Pharmacy & Medication Management Risk Management
Relationship Management
Service Delivery Planning
TA
CT
IC
AL
Medication Research
Pharmacy & Medication Management Governance Management
Pharmacy Clinical Practice Management 
 Pharmacy Services Financial Management
Pharmacy Services Contract Management
Equipment Management
Supplier Management
Pharmacy Human Resources Management
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Figure 13 Business Competency Map
Order Triage Safe Medication Order Writing
Patient ID and Registration Order Set Development & Management
Medication Reconciliation Pharmaceutical Care
Clinical Support  Medication Administration
Discharge Planning Drug Therapy Monitoring
Community Emergency Response Contract Management and emergency execution
Equipment Maintenance and Cleaning Purchasing
Pharmaceutical Inventory Management Shipping and Receiving
Medication Inventory storage  Medication Mixing & Repackaging
Controlled Substance Management
Transportation Medication Preparation
Medication Distribution to Point of Care Medication Documentation
Medication Assessment
Internal clinical education pharmacy staff External clinical education
Internal clinical education for non pharmacy staff
Fleet Vehicle Mangement Data Quality Improvement
Billing Administrative Reporting
Travel Management Clinical Reporting
Medication Inventory Management Medication Documentation
Medication Dispensing Controlled Substance Management
Medication Administration Medication Reconciliation & Best Possible Medication History
Drug Therapy Monitoring Patient Assessment
Drug Therapy Prescribing
Medication Inventory Management Medication Documentation
Medication Dispensing Controlled Substance Management
Medication Administration Medication Reconciliation & Best Possible Medication History
Drug Therapy Monitoring Patient Assessment
Drug Therapy Prescribing
Medication Administration Medication Documentation
Controlled Substance Management
Medication Inventory Management
Medication & Biological Inventory Management Medication & Biological Documentation
Medication & Biological Dispensing Controlled Substance Management
Medication Administration Medication Reconciliation & BPMH
Medication Inventory Management Medication Documentation
Medication Dispensing Controlled Substance Reporting
Medication Administration Medication Reconciliation & Best Possible Medication History
Drug Therapy Monitoring Patient Assessment
Drug Therapy Prescribing
Medication Inventory Management Medication Documentation
Medication Dispensing Controlled Substance Reporting
Medication Administration Medication Reconciliation & Best Possible Medication History
Drug Therapy Monitoring Patient Assessment
Drug Therapy Prescribing
Client Registration Records Reporting & Analysis
Records Management Services
Extract from other Business Area Business Models specific operational competencies related to Medication 
Management
Home Support Medication Management
Administration
Emergency Preparedness
Clinical Pharmacy Access Management
Dispensing and Distribution (Pharmacy)
Inventory  and Equipment Management
Acute Care Medication Management
Primary Care Medication & Biological Management
Public Health
Medication Reconciliation & Best Possible Medication History
Community Specialized Medication Management
Long Term Care Medication Management
Records Management
O
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Appendix 12. Business Competency Model 
 
Figure 14 Business Competency Model 
 
183 
 
 
Appendix 13. Value Chain 
 
Figure 15 Value Chain 
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Appendix 14. Listing of Criteria Definitions 
 
Table 20 Listing of Criteria Definitions
Criteria for Prioritization of Improvement Initiatives 
What impact will this initiative have on department level stability 
and sustainability?
Department level stability and sustainability refers to the current operations and whether the process 
improvement proposed will jeopardize the ability of the department to meet its mandate in the long 
term.
What impact will this initiative have on system stability and 
sustainability?
System stability refers to looking at the system as a whole and considers risk/benefit to other parts 
of the system.  The proposed change will have a long standing impact on the system. 
Sustainability refers to the ability for the proposed service change to continue into the future.
What is the expected impact on Employee and/or Physician 
Engagement?
Impact from the perspective of our staff and physicians, on workplace environment including:
1) Teamwork and morale
2) Tools and equipment
3) Opportunities to Learn and Grow
4) Well-being and safety
What number of employees and or physicians will be impacted by 
the proposed change?
Change management is a significant component of the feasibility of successful implementation.  One 
of the major considerations in change is the number of individuals involved in the change.
Is there organizational capacity to implement the initiative?
Challenges or Facilitators to the implementation of proposed initiatives based on the following:
1) Risks assessed 
2) Barriers assessed 
3)  Mitigation Plan developed
4)  Organizational experience in leading similar initiative
5)  Experienced resource is readily available 
How will this initiative impact patient safety?
This criterion focuses on reduction in risk of harm to the patient/client from care/service being 
provided.  Risk of harm and also potential degree of harm need to be considered.  This criterion does 
not include factors that have been addressed in other criteria such as accessibility, continuum of 
care and upstream risk factors.
# of patients/residents potentially affected
This criteria measures the number of patients/residents whose risk of an adverse event could 
potntially be impacted by the proposed change
What level of evidence exists that improvements in selected 
process will reduce adverse events?
This criteria measures the level (quality) of evidence that the proposed intervention will result in the 
intended outcomes.
How will this initiative impact worker safety?
This criterion focuses on reduction in risk of harm to workers in the workplace. Risk of harm and also 
potential degree of harm need to be considered.  This criterion does not include factors that have 
been addressed in other criteria such as accessibility, continuum of care and upstream risk factors.
The number of staff or physicians who could have an increase or 
decrease in  work related injuries as a result of the proposed 
initiative?
This criteria measures the number of workers/physicians whose risk of a workplace injury or illness 
could potentially be impacted by the proposed change
To what degree will the initiative result in an increase to process 
maturity across the system?
Process Maturity is measured on a scale of 1 to 5 with 1 being the most immature and 5 being the 
most mature.   The level of process maturity in most cases should be at least at level 3.  There are 
processes where it is feasible and desirable to get to level 5 maturity. 
Is the process one that needs to be standardized in order to take 
advantage of available automation opportunities?
Automation of workflow is known to be an effective strategy to increase efficiency and reduce errors 
however automation of poor processes can have the opposite impact.  In order to take advantage of 
opportunities for automation of tasks the processes being automated need to be documented, 
standardized and monitored to ensure compliance with standardization prior to undertaking 
automation of the tasks.
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Is the process improvement directly related to NH three year 
strategic action plans? 
NH has eight strategic action plans it has proposed to complete over the upcoming 3 years.  The 
proposed process improvement could address more than one of these plans.  Negative impact could 
be considered where the resources required to carry out the process improvement will be diverted 
away from working on the Strategic Action Plan elements.
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Is there an anticipated net savings to the organization? 
This criterion refers to the optimal use of resources to yield maximum benefits and results.  
Evidence of estimated cost of alternative solutions considered should be included in the proposal 
documentation.  
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Criteria Criteria Questions
Definition of Criteria
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Appendix 15. Initiative Ranking  
 
Table 21 Initiative Ranking Tool 
Initiative/Project Title:
Rating
-3 -2 -1 0 1 2 3
What impact will this 
initiative have on 
department level stability 
and sustainability?
Significant negative 
impact at the 
department level with 
no strategy available to 
mitigate
Moderate negative 
impact on department 
level stability/ 
sustainability with 
strategy in place to 
address
Minimal negative 
impact at the 
department level is 
short term and has 
been addressed in the 
implementation plan
No impact on system 
stability/sustainability
minimal positive 
impact on department 
level 
stability/sustainability
Moderate positive 
impact on department 
stability/sustainability
Significant positive 
impact on department 
stability/sustainability
What impact will this 
initiative have on system 
stability and 
sustainability?
Significant negative 
impact at the system 
level with no strategy 
available to mitigate
Moderate negative 
impact on system level 
stability/ sustainability 
with strategy in place 
to address
Minimal negative 
impact at the system 
level is short term and 
has been addressed in 
the implementation 
plan
No impact on system 
stability/sustainability
Minimal positive 
impact on system 
stability/sustainability 
Moderate positive 
impact on system 
stability/sustainability
Significant positive 
impact on system 
stability/sustainability
Subtotal 6.48% 0 0.0000
What is the expected 
impact on Employee 
and/or Physician 
Engagement?
Negatively Impacts 4 of 
the 4 objectives
Negatively Impacts 2 - 
3 of the 4 objectives
Negatively Impacts 1 of 
the 4 objectives no impacts
Positively Impacts 1 of 
the 4 objectives
Positively Impacts 2 - 3 
of the 4 objectives
Positively Impacts 4 of 
the 4 objectives
What number of 
employees and or 
physicians will be 
impacted by the 
proposed change?
Greater than 500 
people affected
200 to 500 people 
affected
100 to 200 people 
affected
50 to 100 People 
affected
25 to 50 people 
affected
Less than 25 people 
affected No people affected
Is there organizational 
capacity to implement the 
initiative?
Significant Risk to 
successful 
implementation and no 
opportunity for 
mitigation identified
Significant Risk to 
successful 
implementation and 
with some degree of 
mitigation identified
Moderate Risk to 
successful 
implementation and no 
opportunity for 
mitigation identified
Moderate Risk to 
successful 
implementation and a 
mitigation plan has 
been developed
Minimal Risk to 
successful 
implementation
Minimal Risk to 
successful 
Implementation and a 
mitigation plan has 
been developed
Risk Assessment has 
been completed and 
no risks have been 
identified
Subtotal 7.63% 0 0.0000
How will this initiative 
impact patient safety?
Potential of significant 
negative impact on 
patient safety
Potential of moderate 
negative impact on 
patient safety
Potential of minimal 
negative impact on 
patient safety
No impact on patient 
safety
Potential minimal 
positive impact on 
patient safety
Potential of moderate 
positive impact on 
patient safety
Potential of significant 
positive impact on 
patient safety 
# of patients/residents 
potentially affected
greater than 10% of 
patients/residentshave 
potential to be  
negatively impacted
5 to 10% of 
patients/residents have 
potential  to be 
negaively impacted
less than 5% of 
patients have potentiall 
to be negatively 
impacted
no impact to any 
residents or patients
less than 25% have 
potential to be 
positively impacted
25% to 50% have 
potential to be 
positively impacted
50% and greater have 
potential to be 
positively impacted
What level of evidence 
exists that improvements 
in selected process will 
reduce adverse events?
No evidence clinical/expert Opinion Local quality 
improvement results
Low reliability evidence 
(not peer reviewed)
Moderately reliable 
evidence 
Highly reliable evidence 
exists in the form of 
peer reviewed studies.
Large randomized 
control trial results
Subtotal 29.48% 0 0.0000
How will this initiative 
impact worker safety?
Potential of significant 
negative impact on 
workplace safety
Potential of moderate 
negative impact on 
workplace safety
Potential of minimal 
negative impact on 
workplace safety
No impact on 
workplace safety
Potential minimal 
positive impact on 
workplace safety
Potential of moderate 
positive impact on 
workplace safety
Potential of significant 
positive impact on 
workplace safety 
The number of staff or 
physicians who could 
have an increase or 
decrease in  work related 
injuries as a result of the 
proposed initiative?
greater than 10% of 
workers/physicians 
potentially negatively 
impacted in respect to 
workplace safety
5 to 10% of 
workers/physicians 
potentially negatively 
impacted in respect to 
workplace safety
less than 5% of 
workers/physicians 
have potentially 
negative impact on 
workplace safety
no workers/physicians 
are expected to incur a 
change in likelihodd of 
workplace injury or 
illness
less than 25% of 
workers/physicians 
potentially will be 
positively impacted in 
respect to workplace 
safety
25% to 50% of workers 
/ physicians potentially 
will be positively 
impacted in respect to 
workplace safety
50% and greater of 
workers/physicians 
potentially will be  
positively impacted in 
respect to workplace 
safety
Subtotal 28.89% 0 0.0000
To what degree will the 
initiative result in an 
increase to process 
maturity across the 
system?
Process maturity will 
decrease to Level 1
Process maturity will 
decrease but not lower 
than Level 2
Process maturity will 
decrease but not lower 
than Level 3
No change in process 
maturity
Potential to move the 
process maturity level 
from level 1 to level 2
Potential to move the 
process maturity level 
from level 1 or 2 to 
Level 3 
Potential to move the 
process maturity level 
above Level 3.
Is the process one that 
needs to be standardized 
in order to take 
advantage of available 
automation 
opportunities?
Implementation of 
initiative would result in 
disruption of current 
automation already in 
place without potential 
for remediation or 
Implementation of 
initiative would result in 
disruption of current 
automation already in 
place with planned 
remediation or 
Implementation of 
initiative would result in 
short term loss of 
automation .
Standardization of 
process would not 
result in efficency gains 
related to automation
Standardization of 
process is beneficial 
but automation 
opportunity minimally 
impacted 
Standardization of 
Process is essential to 
implement future 
automation and realize 
efficiencies
Standardization of 
Process is essential to 
implement current 
automation 
opportunitites and 
realize efficiencies
Subtotal 4.34% 0 0.0000
S
tr
at
eg
ic
 
A
lig
nm
en
t Is the process 
improvement directly 
related to NH three year 
strategic action plans? 
Expected to negatively 
impact the 
achievement of more 
than one element of 
the Strategic Action 
Plans
Expected to negatively 
impact the 
achievement of one 
element of the 
Strategic Action Plans
Identifed the potenital 
risk that it may delay 
acheivement of  an 
element of the 
Strategic Action Plan
Not specifically related 
to any element within 
the Strategic Action 
Plan
Indirectly related to at 
least one element in 
the Strategic Action 
Plans
Directly  addresses a  
Strategic Action Plan 
element
Addresses more than 
one element of 
Strategic Action Plans
0.0000
Subtotal 11.13% 0 0.0000
Fi
na
nc
ia
l 
Im
pa
ct Is there an anticipated 
net savings to the 
organization? 
Significant (>$100k)net 
financial cost to the 
organization in annual 
operating expenses.
Moderate (between 
$50k and $100k) 
financial cost to the 
organization in annual 
operating expenses.
Minimal (<$50k) 
financial cost to the 
organization in annual 
operating expenses
No financial impact to 
the annual operating 
expenses
Minimal (<$50k) 
financial gain to the 
organization in annual 
operating expenses
Moderate (between 
$50k and $100k) 
financial gain to the 
organization in annual 
operating expenses.
Significant (>$100k)net 
financial gain to the 
organization in annual 
operating expenses.
0.0000
Subtotal 12.05% 0 0.0000
Total 100.00% 0.00 0.0000
P
ro
ce
ss
 M
at
ur
ity
Weighted 
Score
B
us
in
es
s 
C
on
tin
ui
ty
Fe
as
ib
ili
ty
P
at
ie
nt
 S
af
et
y
W
or
ke
r 
S
af
et
y
Strategic Action Plan Ref #
Rating Criteria Questions
Criteria 
Weights
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Appendix 16. Results of Prioritization of Improvement Initiatives 
 
Table 22 Results of Prioritization of Improvement Initiatives 
Medication Safety and Quality Improvement Initiatives
3 Year Strategic Action Plans
Ranked based on MCDA tool
Focus Proposal Title Rated Score
1. Medication reconciliation #1‐0001 1.1 Ensure standard clinical workflows and processes include BPMH and Med Rec at all transitions 617.5
3. Medication Prescribing #1‐0005 3.1 Ensure all medication orders adhere to Safe Medication Order Writing (SMOW) 586.3
4. Improve AMS #1‐0009 4.1 Develop and maintain AMS interdisciplinary committee to provide oversight and governance 586.3
4. Improve AMS #1‐0010 4.2 Implement standard processes to ensure improved AMS 586.3
4. Improve AMS #1‐0011 4.3 Establish and maintain process to collect and reporting AMS program metrics 586.3
3. Medication Prescribing #1‐0008 3.4 Facilitate clinical pharmacists involvement in prescribing decision making process 486.6
2. Comm care plan & POC #1‐0003 2.1 Med therapy is effectively communicated in plan of care appropriate patients 464.8
2. Comm care plan & POC #1‐0004 2.2 Med therapy is effectively communicated in care plans for appropriate patients 464.8
5. Medication Dispensing #1‐0016 5.5 Ensure timely and accurate verification and dispensing processes 457.8
8. Medication administration #1‐0026 8.5 Reduce the gap between current and best practice guidelines 424.7
7. Minimize inventory costs #1‐0020 7.1 Implement best practice standard inventory management processes 370.6
3. Medication Prescribing #1‐0006 3.2 Develop and maintain appropriate medication order sets 367.4
8. Medication administration #1‐0024 8.3 Implement quality assurance process for infusion pumps 363.1
3. Medication Prescribing #1‐0007 3.3 Conduct medication use evaluation (MUE) reviews to assess adherence to best practice 277.9
5. Medication Dispensing #1‐0012 5.1 Develop a regional central intravenous admixture (CIVA) plan compliant with standards 158.9
5. Medication Dispensing #1‐0013 5.2 Implement a regional CIVA plan compliant with standards 158.9
8. Medication administration #1‐0022 8.1 Ensure safe handling of hazardous drugs according to provincial guidelines 95.4
Initiatvies Not Ranked
1. Medication reconciliation #1‐0002 1.2 Establish quality assurance processes related to BPMH and Med Rec mandatory
6. Increase standarization #1‐0019 6.3 Achieve maturity level 3 or above for identified critical processes
critical processes not 
identified
7. Minimize inventory costs #1‐0021 7.2 Manage drug shortages in order to minimize patient impact mandatory
8. Medication administration #1‐0025 8.4 Establish process for monitoring use of AMDC access using Knowledge Portal audit function
Inititatives completed prior to Ranking exercise
5. Medication Dispensing #1‐0014 5.3 Develop ranking tool for Automated Medication Dispensing Cabinets and apply to all facilitites complete
5. Medication Dispensing #1‐0015 5.4 Implement AMDCs in accordance with the ranking tool complete
6. Increase standarization #1‐0017 6.1 Develop service model for provision of pharmacy services to residential LTC facilities complete
6. Increase standarization #1‐0018 6.2 Implement service model for provision of pharmacy services to residential LTC facilities complete
8. Medication administration #1‐0023 8.2 Implement regional standard for infusion pumps complete
8. Medication administration #1‐0027 8.6 Develop neonatal parenteral therapy manual complete
8. Medication administration #1‐0028 8.7 Implement neonatal parenteral therapy manual for use in Northern Health complete
8. Medication administration #1‐0029 8.8 Establish audit processes for quality assurance of narcotic handling outside pharmacy complete
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Appendix 17. Reporting Frequency 
Proposed Reporting Frequency of Available Indicators 
 
Adhoc 
 % compliance with privacy and confidentiality audits 
# of Patient assessments completed by pharmacists or pharmacy technician 
% of nurses who have completed SMOW education module 
% of pharmacists who have completed SMOW education module 
% of pharmacy technicians who have completed SMOW education module 
% of physicians who have completed SMOW education module 
% of unit clerks who have completed SMOW education module 
Annual 
# of clinical pharmacy hours per 100 inpatient days 
# of Medication Utilization Reviews Completed Annually for AMS; 
# of medical students receiving clinical education during their 3rd year rotation 
# of pharmacy residents in NH 
# of pharmacy technician students receiving education annually 
% of facilities with infusion pumps meeting established standard 
% of identified critical processes with process maturity level 3 or above 
% of meetings where all NH representatives attended 
% of facilities dispensing patient specific medications on 24 hour batch 
% of formulary reviews completed by NH 
% of staff/physicians accessing education opportunities 
% oral solid meds with bar code on unit dose packaging; 
Reported patient satisfaction on medication education provided 
Reported patient satisfaction with pain management during hospital stay 
Worklife Survey ‐ level of satisfaction 
# of pharmacist clinical training weeks provided  
% of pharmacists who meet competency measures for clinical pharmacy  
Period 
# of interventions per hour clinical pharmacist time 
% of discrepancies (requiring intervention) found after/during medication reconciliation 
% of VTE audits where patients received appropriate prophylaxis 
% of patients with Med Rec Completed within 24 hours of admission  
Cost of expired drugs for credit  
Total Cost of Expired Drugs 
Quarterly 
# of average turns of inventory 
# of IV to PO step‐down interventions  
# of anti‐infective Drug Therapy Problems resolved per inpatient admission  
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# of medication doses administered in error per PSLS resulting in harm level greater 
than or equal to level 3 harm  
# of resolved drug therapy problems per 100 outpatient visits  
# of resolved drug therapy problems per 100 resident days 
# of Resolved DTPs per 100 inpatient admissions  
%of  Interventions accepted in prospective audit and feedback regarding antibiotics 
% of individuals expected to complete SMOW education who have taken SMOW 
% of medication orders entered accurately as assessed by pharmacist at verification 
Actual inventory value or estimate based on Value on Hand reported in Cerner for all 
NH Pharmacies 
Average Length of Stay per acute inpatient admission 
Cost of antimicrobials per 100 inpatient days 
Cost of expired drugs as percentage of drug budget 
Cost of expired drugs not for credit as a % of total expired drugs 
Cost of IV antibiotics per 100 inpatient days 
Cost of oral antibiotics per 100 inpatient days 
Defined Daily Dose (DDD) per 100 patient days for targeted antibiotic 
Drug Cost per 100 inpatient days 
Drug cost per 100 resident days in LTC facilities (non Plan B) 
Drug Costs per inpatient day 
High cost antineoplastic drug utilization in pharmacy 
Turnaround time of internal medication inventory transfers based on established 
benchmark standards. 
% of orders compliant with Safe Medication Order Writing (SMOW) 
% of reported errors per orders entered as per PSLS reports  
Semi‐annual 
# of physician specific order sets;  
# of active order sets that are up to date 
# of regional order sets; 
# of site specific order sets 
# of incident reports of staff exposure 
% of meds delivered late per PSLS reports 
% of alignment NH formulary to Provincial formulary 
% of medications accessed through AMDC on over‐ride 
% of patients educated on Medications by a pharmacist 
Average Turnaround time of medications from order scan to release of medication 
(Pyxis) 
Door to needle time for thrombolytic 
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Appendix 18. Process Reference Model 
1 Manage Medication at Point of Care 
1.1 Register Patient 
1.1.1 Enroll Patient in Appropriate Information System 
1.1.2 Confirm Patient Identification and Identify for Clinical Pharmacy Services 
1.2 Assess Patient 
1.2.1 Interview Patient 
1.2.2 Order Diagnostic Tests 
1.2.3 Interpret Results of Diagnostic Tests 
1.2.4 Diagnose Patient 
1.3 Prescribe Medication 
1.3.1 Conduct Best Possible Medication History Interview 
1.3.2 Conduct Medication Reconciliation 
1.3.3 Order Medication 
1.3.4 Triage medication orders 
1.3.5 Perform Clinical assessment of medication order 
1.4 Dispense Medication at Point of Care 
1.4.1 Maintain Point of Care Inventory 
1.4.2 Manage Patient Owned Medications 
1.4.3 Dispense Medication 
1.5 Administer Medication 
1.5.1 Prepare medication if required 
1.5.2 Administer Medication to Patients 
1.5.3 Complete Medication Administration Record 
1.6 Monitor Patient 
1.6.1 Provide Pharmaceutical Care to Patients 
1.6.2 Deliver Patient Education on Medication Therapy 
1.6.3 Monitor Patient Response to Medication Therapy 
1.7 Transfer or Discharge Patient 
1.7.1 Plan for Patient Discharge 
1.7.2 Discharge Patient 
2 Provide Clinical Training & Professional Development 
2.1 Provide Pharmacy Staff Training 
2.1.1 Identify Training Needs 
2.1.2 Develop Training Materials 
2.1.3 Deliver Training 
2.1.4 Monitor Learner Progress and Provide Feedback 
2.1.5 Monitor Training Effectiveness 
2.2 Provide Clinical Pharmacy Competency Development 
2.2.1 Establish Clinical Pharmacy Competencies 
2.2.2 Develop Competency Evaluation 
2.2.3 Develop Competency Training 
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2.2.4 Deliver Clinical Pharmacy Training 
2.2.5 Monitor Learner Progress & Provide Feedback 
2.2.6 Monitor Training Effectiveness 
2.3 Provide Clinical Education(External to Pharmacy) 
2.3.1 Identify Training Needs 
2.3.2 Develop Training Materials 
2.3.3 Deliver Training 
2.3.4 Monitor Learner Progress and Provide Feedback 
2.3.5 Monitor Training Effectiveness 
2.4 Manage Clinical Student Placement 
2.4.1 Engage with Education Providers 
2.4.2 Identify Potential Candidates & Make Selection 
2.4.3 Develop Training Plan 
2.4.4 Monitor Student Progress & Provide Feedback 
2.4.5 Evaluate Effectiveness of Training Plan 
3 Manage Medication Supply Chain 
3.1 Source Medication 
3.1.1 Establish & Maintain Supplier Requirements  
3.1.2 Evaluate and Approve Potential Suppliers  
3.1.3 Identify and Maintain Supplier List 
3.1.4 Negotiate with Suppliers 
3.1.5 Collaborate with Suppliers 
3.1.6 Monitor Supplier Performance 
3.1.7 Perform Analysis and Response to Drug Shortages 
3.1.8 Purchase Medication 
3.1.9 Receive purchased medication 
3.1.10 Initiate Payment 
3.1.11 Pay Suppliers 
3.2 Maintain Medication Inventory 
3.2.1 Define Inventory Strategies 
3.2.2 Define Inventory Demand 
3.2.3 Create Inventory Plan 
3.2.4 Define Performance Metrics 
3.2.5 Establish Standards for Medication Storage 
3.2.6 Ship Inventory to secondary inventory locations 
3.2.7 Store purchased medication  
3.2.8 Monitor medication storage procedures 
3.2.9 Perform Inventory Count 
3.3 Mix & Repackage Medication 
3.3.1 Issue components from inventory 
3.3.2 Compound Medications Outside Laminar Hood 
3.3.3 Compound Medications within Laminar Hood 
3.3.5 Add Compounded Medications to Inventory 
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3.3.6 Remove bulk packaged goods from inventory location 
3.3.7 Repackage into single use doses 
3.3.8 Restore unit dose packages in inventory 
3.3.9 Repackage medications for 24 hour Batch ( patient specific) 
3.3.10 Pick medication from inventory 
3.3.11 Issue medication from perpetual inventory 
3.4 Distribute Medication 
3.4.1 Transport purchased medication to secondary inventory location 
3.4.2 Document Patient Specific Medication Orders 
3.4.3 Verify Patient Specific Medication Orders 
3.4.4 Dispense Patient Specific Medication 
3.4.5 Replenish Ward Stock 
3.5 Return Medication 
3.5.1 Identify expired medications in Pharmacy Inventory 
3.5.2 Return Expired Drugs to Pharmacy 
3.5.3 Return Expired Drugs eligible for refund to Suppliers 
3.5.4 Dispose of expired controlled substances 
3.5.5 Dispose of expired medications 
4 Manage & Administrate 
4.1 Plan 
4.1.1 Develop Strategic Plan & Goals 
4.1.2 Establish Portfolio Priorities 
4.1.3 Establish Governance Plans 
4.1.4 Allocate Resources 
4.1.5 Develop Strategy for Pharmacy &  Medication Management 
4.1.6 Establish Population Level Surveillance Plan 
4.1.7 Develop & Communicate Regional Services Plan 
4.1.8 Plan Research Strategy 
4.1.9 Develop Medication Research Strategy 
4.1.10 Establish Formulary Management Plan 
4.1.11 Establish Business Operating Plan 
4.1.12 Establish Standards for Pharmacy & Medication Management 
4.1.13 Establish Plan for Clinical Trials  
4.1.14 Identify Quality Improvement Plan 
4.1.15 Plan for long term business operations 
4.1.16 Establish Performance Measurement Plan 
4.1.17 Maintain Drug Formulary 
4.2 Manage Risk 
4.2.1 Establish Risk Analysis Framework 
4.2.2 Establish Risk Measures 
4.2.3 Establish Risk Monitoring Plan 
4.2.4 Establish Risk Reporting 
4.2.5 Establish & Maintain  Response to Adverse Events 
   
192 
 
4.2.6 Establish & Maintain Risk Rules & Regulations 
4.2.7 Establish & Manage Risk Compliance  
4.3 Monitor Compliance 
4.3.1 Manage and Monitor Progress related to Governance Plan 
4.3.2 Establish Compliance Plan and Reporting 
4.3.3 Validate medication orders adhere to Safe Medication Order Writing 
4.3.4 Document  receipt, administration and disposal of controlled substances 
4.3.5 Document  receipt, administration and disposal of controlled substances 
4.3.6 Monitor & Control compliance with Policies & Procedures 
4.3.7 Evaluate & Audit effectiveness of Policies & Procedures 
4.4 Manage Contracts 
4.4.1 Negotiate contracts 
4.4.2 Manage contract Budget 
4.4.3 Evaluate and monitor contract liability 
4.4.4 Evaluate and monitor contract performance and compliance 
4.5 Manage Human Resources 
4.5.1 Identify Human Resource Requirements 
4.5.2 Recruit Staff to meet Identified Needs 
4.5.3 Recruit Staff to identified Needs 
4.5.4 Orientate Staff 
4.5.5 Schedule Staff 
4.5.6 Manage Staff Performance 
4.5.7 Manage Staff Recognition Program 
4.6 Manage Financial Resources 
4.6.1 Identify Operating Budget Requirements 
4.6.2 Monitor Operating Expenditures  
4.6.3 Initiate Operating Budget Remediation Actions  
4.6.4 Identify Capital Budget Requirements 
4.6.5 Monitor Capital Expenditures 
4.6.6 Initiate Capital Budget Remediation Actions  
4.6.7 Forecast operating and capital budget performance 
4.6.8 Initiate Accounts Receivable 
4.6.9 Collect Accounts Receivable 
4.6.10 Manage Employee Travel Expenses 
4.7 Manage Information 
4.7.1 Establish Information System Standards 
4.7.2 Manage Information System Access 
4.7.3 Manage Patient Records 
4.7.4 Monitor & Improve Data Quality 
4.7.5 Maintain clinical pharmacy patient record 
4.7.6 Maintain Medication information resources 
4.7.7 Maintain Inventory Data 
4.7.8 Manage Master Drug Library for Infusion Pumps 
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4.7.9 Develop and Maintain medication order sets 
4.7.10 Develop & Maintain Performance Monitoring Reports 
4.8 Procure & Maintain Equipment & Facilities 
4.8.1 Establish & Manage Equipment Schedule 
4.8.2 Procure Equipment through Renting or Leasing Option 
4.8.3 Establish & Manage Plan for Equipment Maintenance 
4.8.4 Establish & Maintain Asset Tracking Policies & Procedures 
4.9 Provide Operational Oversight 
4.9.1 Establish and Manage Partnerships 
4.9.2 Establish & Manage Provincial Government Relationship 
4.9.3 Establish & Manage Municipal Government Relationships 
4.9.4 Establish & Manage Public Private Partnerships 
4.9.5 Establish & Staff Pharmacy Hours of Operation 
4.9.6 Promote continuous Improvement 
4.9.7 Implement and Maintain Anti‐Microbial Stewardship Program 
4.9.8 Promote Integration & Practice Management 
4.9.9 Develop & Maintain Community & Emergency Response Plan 
4.9.9 Research Best Practice 
4.9.10 Establish Emergency Response Policies & Procedures 
4.9.11 Manage Fleet Vehicles 
4.9.12 Develop & Monitor Administrative Reports 
4.9.13 Develop & Monitor Clinical Reports 
4.9.14 Develop & Publish Performance Reports 
 
 
 
Table 23 Process Reference Model
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Appendix 19. Listing of Functions with Definitions 
STRATEGIC LEVEL FUNCTIONS 
Pharmacy & Medication Management Planning 
Strategic Direction 
Development of an operational strategic course of action that leads to the achievement 
of organizational strategic objectives 
Strategic Plan and Goals 
Development and definition of strategic actions and targets for achievement of the 
operational strategic direction 
Resource Allocations 
Development and management of a plan for assigning and managing available 
resources (human resources, hardware, etc.) for optimizing operations. 
Pharmacy  & Medication 
Management Governance Planning 
Executive and Board governance planning to ensure long term safety and 
effectiveness of mediation management both in the pharmacy and throughout the 
organization. 
Research Best Practice Identifying superior methods of achieving a  
Portfolio Management 
Centralized management of one or more portfolios which includes identifying, 
prioritizing, authorizing, managing and controlling programs and other related work to 
achieve strategic business objectives 
Key Measurements and Performance 
Indicators 
Establish and monitor business metrics used to evaluate operational factors that are 
crucial to the success of the organization and align with organizational strategic goals. 
Pharmacy  & Medication 
Management Strategy Development 
Identifying objectives and the (strategies) means that will be undertaken to achieve 
those objectives 
Regional Services Planning 
 
 
Planning for pharmacy services across the region of particular importance is how 
pharmacy services will be provided to small sites who do not have on site pharmacists.
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Medication Research 
Medication Research Strategy 
Providing an environment of opportunities, options and methodologies for appropriate  
research (as well as continual development of channels for application of research 
findings) that meet applicable ethics and standards 
Medication Research Planning 
Establishing research objectives, types (quantitative and qualitative), and processes for 
research in work environment.  
Relationship Management 
Pharmacy Partner Management 
Management of relationships, communications and services with internal and external 
stakeholders and partners 
Government Relationship 
Organizational representation / stakeholder participation, communication development 
and coordination of policy and legislative efforts by local, provincial and federal 
governments  
Community Management   
Pharmacy Public-Private Partnership 
Development and management of long term contracts between a private party and a 
governmental entity for providing a public service 
Service Delivery Planning 
Population Level Surveillance Surveillance of medication usage and potential need at the population level 
Formulary Management Planning 
Setting objectives, policies and processes for establishing and maintaining medication 
formulary to be used in the organization. 
Business Operations Planning 
Establishing objectives, policies and processes for maintaining or adjusting service 
levels for medication management. 
Standardize Process and Practice 
Continuous improvement and implementation of evidence based practices within 
medication management 
Clinical Trial Planning and 
Coordination 
Establishing objectives, policies and processes when medication related clinical trials 
are being conducted within the organization. 
Quality Improvement The practice of monitoring, evaluating and improving the quality of services provided. 
 
  
   
196 
 
TACTICAL LEVEL FUNCTIONS 
Pharmacy & Medication Management Risk Management 
Pharmacy & Medication 
Management Risk Analysis 
Defining and analyzing the dangers to individuals or business posed by a potential 
natural and/or human-caused adverse event 
Pharmacy & Medication 
Management Risk Measures 
Statistical measures  to assess performance to its benchmark index within and 
accepted standard deviation 
Pharmacy & Medication 
Management Risk Monitoring  
Control projects applied to monitor identified risks, identify new risks, and ensure 
proper execution of planned risks 
Pharmacy & Medication 
Management Risk Reporting 
Development and implementation of a risk measurement performance and reporting 
framework 
Pharmacy & Medication 
Management Risk Control (Adverse 
Events) 
Proactively identify and respond to manage, reduce or eliminate risk 
Pharmacy & Medication 
Management Risk Rule & 
Regulations 
Rules and regulations that are identified and applied to mitigate, manage risk 
Pharmacy & Medication 
Management Risk Compliance 
Management of process which identify the applicable requirements (defined in laws, 
regulations, contracts, strategies and policies), assessment of the state of compliance 
to confirm with requirements, and initiation of any corrective actions deemed 
necessary 
Equipment Management 
Equipment Scheduling The booking and scheduling of equipment as requested/required  
Equipment Renting/Leasing 
Managing rental or short term usage agreements of required equipment that is not 
owned by the organization 
Equipment Maintenance 
Managing, scheduling and monitoring of equipment maintenance requirements as 
defined within standard operating agreements or recommended maintenance 
schedules.  
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Equipment Tracking & Asset 
Management 
Management and monitoring of equipment inventory, frequency of use, and 
evaluation of equipment life cycle requirements 
Supplier Management 
Supplier Collaboration 
Joint pursuit of competitive advantages for the parties involved with appropriate 
parties working together to maximize the benefit for all. 
Supplier Sourcing 
Proactive management of a supply market to identify relevant and potential suppliers 
that meet organizational objectives and ensure access to adequate resources required 
for the long term needs of the organization. 
Supplier Requirement Management 
Management of specifications to optimize external resources to frame agreement with 
suppliers. 
Supplier Evaluation 
Assessment of potential suppliers (product quality, cost and ability to meet demand) to 
meet organizational needs, policies, and budgets.  
Supplier Monitoring 
Ongoing evaluation of supplier's ability to meet organizational needs, policies and 
value for money. 
Supplier Negotiation 
Setting of objectives, development of strategy, understanding supplier's ability to meet 
objectives, and development supplier and cost agreements.  
Pharmacy & Medication Management Governance Management 
Pharmacy & Medication 
Management Access Management 
Establishing criteria for admission to service including routine hours of operation, and 
processes to access after hour services where applicable.  
Pharmacy & Medication 
Management Information 
Management 
The custodianship, quality, security and distribution of information to people or 
systems who need/use it.  
Pharmacy & Medication 
Management Governance Planning 
Efforts by managerial level to ensure governance requirements are included in 
planning activates related to medication management. 
Pharmacy & Medication 
Management Governance 
Compliance 
Monitoring of compliance with standards established in governance plan. 
Pharmacy & Medication 
Management Knowledge 
Management 
Capturing, distributing and effectively using knowledge 
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Pharmacy & Medication 
Management Governance Control & 
Monitor 
Review and evaluate processes for preventing an unacceptable level of uncertainty in 
business objectives 
Pharmacy & Medication 
Management Governance Evaluation 
& Audit 
Systematic review of processes to improve the effectiveness of risk management and 
control. 
Pharmacy & Medication 
Management Continuous 
Improvement 
Quality management that focuses on process, rather than individual, recognizing both 
internal and external stakeholders and promoting the use of objective data to analyze 
and improve processes.  
Pharmacy Clinical Practice Management  
Integration & Practice Management  
Clinical pharmacist efforts to work with other care providers to maximize benefits of 
medication therapy. 
Patient Records Management 
Clinical Pharmacists records related to patient care which are not part of the patient 
chart which eventually are used for Data Abstract Discharge purposes. 
 Pharmacy Services Financial Management 
Operational Budget Management 
Analysis, organization and oversight of costs and expenditures for an organizational 
business unit 
Capital Budget Management 
Analysis, evaluation and oversight of cost, expenses and potential investments for 
organizational business unit plant and equipment over a period greater than a year. 
Forecasting Use of historic data and current plans to determine the direction of future trends 
Long term business planning   
Pharmacy Services Contract Management 
Contract Negotiations 
Discussing points of potential partnership arrangement to meet organizational goals 
under a formalized terms of agreement. 
Contract Budget Management Planning, managing and controlling costs against an agreed budget 
Contract Liability Management 
Management of contracts against organizational governance documents such as 
operating agreements, employment agreements, contractor agreement, licensing 
agreements, etc.  
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Contract Compliance Management 
Management and monitoring of key components in achieving compliance, managing 
risks, and enhancing performance of vendors, partners and employees related to a 
contract.  
Pharmacy Human Resources Management 
Human Resource Staffing 
Staffing management includes utilizing HR information, tools, procedures, guidelines 
and providing advice to employees related to staffing. Ensuring that the hiring of right 
people when and where they are needed, respecting the values of fairness, 
transparency, access and representativeness.  
Staff Performance Management 
Develop, manage and routinely evaluate staff ability to meet role performance 
expectations.   
 
Provide recognition directly to employees individually or organizationally where/ 
when appropriate.   
 
Effectively support employee through appropriate corrective action if required, i.e. 
review of role expectations, appropriate disciplinary steps, labour relations, attendance 
management, etc.  
Retention 
Ensure working environment supports current staff to remain and develop within an 
organization 
Staffing Compliment Management 
Identifying human resources needs and effectively managing the scheduling of the 
staff. 
Recruitment 
Attracting, selecting and appointing suitable candidates for jobs (permanent, 
temporary or casual). Could also include choosing suitable candidates for volunteer 
positions or trainee roles.  
Staff Development 
Managing, mentoring and providing support/leadership for common learning to enable 
a healthy workplace which supports continuous employee learning, formal and 
informal, and the application of new knowledge and skills to the workplace. 
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OPERATIONAL LEVEL FUNCTIONS 
Clinical Pharmacy Access Management 
Order Triage Sequencing of medication orders  
Patient ID and Registration Identifying patients who will be provided with clinical pharmacy services 
Medication Reconciliation 
Reconcile patient’s medication through effective interview techniques and record 
review including documenting best possible medication history.  
Clinical Support  Provision of clinical pharmacy expertise to selected patients 
Safe Medication Order Writing 
Ensuring the appropriate documentation of medication orders to minimize risk of 
incorrect interpretation of the medication order. 
Order Management Manage medication orders to optimize medication therapy. 
Diagnostic & Treatment Activities 
Coordination 
Coordinate diagnostic testing and treatment related to medication therapy.  
Emergency Preparedness 
Community Emergency Response 
Ensuring that patients have access to needed medications when the supply chain is 
affected 
Contract Management and 
emergency execution 
Manage contracts during an emergency such as shortages of critical medications 
Inventory  and Equipment Management 
Equipment Maintenance and 
Cleaning 
Maintenance and cleaning of medication related equipment such as Automated 
Medication Dispensing Cabinets and medication infusion pumps 
Pharmaceutical Inventory 
Management 
Manage centralized inventory of medications 
Medication Inventory storage  
Establishing appropriate storage of medication to ensure access and safekeeping of 
medications 
Purchasing Purchase of medications and related equipment 
Shipping and Receiving 
Receipt of ordered goods and shipping to other facilities where medication inventory 
is located. 
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` 
Transportation Transporting medication within a site from central pharmacy to point of care 
Medication Distribution Distributing medication to point of care 
Medication Assessment 
Assessment of medication orders to determine whether there are any problems with 
the medication order.  Complete and appropriate. 
Medication Documentation Document on the patients file when drugs are administered 
Medication Preparation Prepare medication including repackaging or compounding. 
Medication Administration Administer medication to patient 
Drug Therapy Monitoring Monitor patient to ensure medication therapy is achieving the desired outcome. 
Discharge Planning Plan with the patient and physician for discharge 
Education 
Internal clinical education 
(Pharmacy) 
Development and delivery of clinical education to staff within the pharmacy. 
Internal clinical education for non- 
pharmacy staff 
Development and delivery of clinical education specific to medication management to 
staff outside the pharmacy such as nurses, and physicians. 
External clinical education 
Development and delivery of clinical education and practicum experience for clinical 
students such as pharmacy residents. 
Administration 
Fleet Vehicle Management Manage access for staff to use fleet vehicles 
Billing Generating and transferring information for billing purposes to Finance department.  
Travel Management Manage staff travel including authorization and reconciliation of travel expenses 
Data Quality Improvement Improve the quality of data at source  
Administrative Reporting 
Ensure that where applicable administrative reporting meets organizations 
expectations. 
Clinical Reporting Ensure clinical reporting meets standards. 
Table 24 Listing of Functions with Definitions Source NH internal documents 
 
